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ABSTRACT 
Little is known about the contribution of environmental factors to the etiology of ALS. I have 
developed an online case-control epidemiological questionnaire that contains 165 questions 
about risk factors for ALS, called “ALS Quest”. ALS Quest is anonymous and web-based, 
allowing for rapid collection and analysis of data, and is available in 28 languages. ALS patients 
and controls are recruited primarily via ALS Associations and social media. 1,177 respondents 
have to date completed the questionnaire.  
The methods used to design ALS Quest have been published, and, using data from the 
questionnaire, I have investigated the following four topics (with one publication for each 
topic).  
1. Changes in the ratio of index:ring finger lengths, related to raised prenatal testosterone 
levels, had been suggested to occur in ALS. The large ALS Quest finger length dataset 
showed that the index:ring ratio was the same in ALS and control respondents, indicating 
that this widely-reported hypothesis is unlikely to be correct.  
2. Personality type could underlie the selection of lifestyle factors that could put people at 
risk for ALS. Indeed, ALS respondents were found to be more agreeable, less neurotic, more 
conscientious and more extraverted than controls, which could relate, for example, to a 
greater tendency to smoke (a postulated risk factor for ALS). These findings can also explain 
the frequent observation that people with ALS are particularly “nice”. Personality could 
also potentially be linked to ALS via one or more genetic variants. 
3. Many clinicians and people with ALS consider that stress could be a trigger for the disease. 
On the contrary, our ALS respondents did not have more stress-inducing life event or 
occupational stressors, and were more resilient, than controls. Resilience is largely 
genetically determined, so this opens a new avenue for ALS research.  
4. Mercury has long been suspected to be a neurotoxin that could contribute to ALS. However, 
common sources of mercury exposure (consumption of fish and number of mercury-
containing dental fillings) were similar in ALS and control groups. One item of interest is 
that ALS respondents consumed more shellfish, which are high in BMAA, a postulated risk 
factor for ALS.  
In summary, ALS Quest has proved to be a valuable resource to study risk factors in ALS and 
will continue to recruit respondents for international comparisons of risk factors.  
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Chapter 1: General Introduction 
1.1 Context 
Amyotrophic lateral sclerosis (ALS) (also called motor neuron disease or MND) is a 
neurodegenerative disease with a largely unknown pathogenesis. It is generally accepted that 
in approximately 10 percent of ALS patients the disease has a primarily genetic basis (familial 
ALS), and for the remainder it is considered sporadic (or isolated) ALS, typically occurring in 
only one member of a family and without a known cause [1]. This lack of information 
regarding how and why ALS arises makes it an eminently suitable subject for toxicological and 
epidemiological research. This thesis partially addresses this knowledge gap by investigating 
novel environmental and lifestyle risk factors for ALS, using data collected from an 
international online epidemiological questionnaire that compares the exposures of cases (ALS 
respondents) and non-ALS controls.  
1.2 Orientation to Thesis 
This introductory chapter describes the research problems investigated and summarises the 
objectives and aims of this project. Chapters 2 through 6 are published papers that are 
presented as components of the thesis, with each chapter being preceded by a brief 
introduction.  The final chapter (Chapter 7) is a discussion of the implications of this research 
and ideas for future exploration. The Appendices to the thesis contain i) a copy of ALS Quest, 
the epidemiological case-control questionnaire developed as a part of this thesis; ii) 
supplementary research findings; and iii) copies of poster and oral presentations given at 
conferences. 
1.3 Challenges in ALS Research  
The issue of external causal factors for ALS has been explored in depth by the medical and 
epidemiological community primarily beginning in the 1970s [2,3]. The factors most 
commonly implicated by these studies as contributors to ALS are (in no particular order) 
exposures to toxicants such as cyanobacteria, mercury, lead, pesticides, and air pollution; 
smoking; histories of athletic activity or exercising; and occupational exposures [4]. The most 
voluminous and perhaps persuasive research to date has focused on pesticides, athletic 
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participation or physical activity, heavy metals, and smoking. However, little consensus exists 
regarding which of the many possible environmental exposures and lifestyle choices are in 
fact risk factors for the disease. As a result, clinicians are unable to either offer advice about 
how people might either prevent ALS, or why people who are diagnosed with ALS might have 
developed the disease. 
This lack of validated risk factors is most likely a reflection of the complexity of the process by 
which ALS arises. In the model of ALS pathogenesis proposed by Al-Chalabi and Hardiman [5], 
it was suggested that a genetic component exists before birth, followed by a combination of 
cell damage and environmental exposures over time, that, once it reaches a threshold, leads 
to the onset of the disease. Therefore, rather than any one environmental or lifestyle factor 
serving as the ALS progenitor, a number of them in combination are likely to precipitate the 
disease. In a subsequent analysis, Al-Chalabi and others estimated that the development of 
ALS is a six-step process [6], implying that six distinct environmental exposures or lifestyle 
factors are needed to cause the disease. For those with a genetic predisposition to ALS, 
between two and four steps may be needed to initiate ALS [7]. 
Given this number of necessary risk factors, and the fact that these factors may vary from 
individual to individual, large and diverse epidemiological case-control studies are needed to 
provide adequate power to identify risk factors. Thus far, epidemiological investigations of 
ALS have primarily been conducted using paper-based questionnaires, which are typically 
time- and resource-intensive. In addition, previous case-control questionnaire-based ALS 
epidemiological projects have had other limitations which make them incomplete. These 
include small sample size with limited numbers of questions, time pressure on respondents, 
the effort needed for data transcription and data entry from paper-based-questionnaires, and 
being based in a single country. Results from only one other known online ALS questionnaire 
(regarding muscle cramps in ALS) have been published [8], despite the wide acceptance of 
web-based questionnaires in the epidemiological community [9]. Another challenge in 
conducting epidemiological studies is that ALS has a short course, with a median survival time 
of three years [1], so prompt and comprehensive ascertainment of ALS patients is critical for 
data collection.  
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1.4 Objectives of the Project 
Given the challenges outlined above, the objectives and aims of this project were threefold: 
1. To create a comprehensive ALS epidemiological case-control questionnaire 
encompassing both previously-studied ALS risk factors, as well as novel risk factors. 
2. To base the questionnaire in an online platform, so that it was immediately accessible 
to a large number of people. This reduced the level of effort for data entry and analysis 
and allowed for the questionnaire to be available in many languages. 
3. To use the data collected from this questionnaire to compare various environmental 
exposures and lifestyle aspects between ALS respondents and controls. 
 
The development of this thesis is summarised in the below Figure 1-1.   
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Figure 1-1. Thesis Flowchart 
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Chapter 2: Designing an internationally accessible web-based 
questionnaire to discover risk factors for amyotrophic lateral 
sclerosis 
 
Epidemiological studies of ALS have most often been conducted using traditional tools, such 
as paper-based questionnaires. However, these methods have their limitations – primarily, 
that data collection can be slow and data transcription can be laborious. This study overcame 
these limitations by using an online case-control epidemiological questionnaire, the chief 
benefit being that responses can be collected much more rapidly, which is critical in a disease 
such as ALS where the course is typically short.  
The preparation of the questionnaire was undertaken over a year because of its critical 
importance as the platform upon which the remainder of the analyses rested - creating an 
appropriate questionnaire was key to the success of the project. In addition, as the first major 
online ALS epidemiological questionnaire, it was important to create a robust and valid 
instrument to show that online collection of epidemiological data was suitable for a disease 
like ALS. Another goal was to produce a truly international questionnaire, so the 
questionnaire was translated by volunteers into 27 languages other than English. 
A significant part of the development of ALS Quest involved the revision and expansion of a 
prior paper-based ALS questionnaire [1-7] used by the Australian MND DNA Bank for use in 
the new online format. The updated questionnaire also included several topics sourced from 
previously published ALS questionnaires, with further questions added to address heretofore 
unexplored ALS risk factors. 
The following article included in Chapter 2 provides an overview of the methods used in this 
research project, including considerations made when designing the questionnaire, the 
resources used in compiling the questions, information about how the questionnaire was 
implemented and distributed, how participants were recruited, and how data from the 
questionnaire were managed. The article closes by providing a brief overview of the 
questionnaire results at that time, as well as a summary of the limitations of a web-based 
questionnaire approach.  
A copy of the complete ALS Quest research questionnaire is included as Appendix A.  
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Abstract
Background: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease with a typical survival of three
to five years. Epidemiological studies using paper-based questionnaires in individual countries or continents have failed to find
widely accepted risk factors for the disease. The advantages of online versus paper-based questionnaires have been extensively
reviewed, but few online epidemiological studies into human neurodegenerative diseases have so far been undertaken.
Objective: To design a Web-based questionnaire to identify environmental risk factors for ALS and enable international
comparisons of these risk factors.
Methods: A Web-based epidemiological questionnaire for ALS has been developed based on experience gained from administering
a previous continent-wide paper-based questionnaire for this disease. New and modified questions have been added from our
previous paper-based questionnaire, from literature searches, and from validated ALS questionnaires supplied by other investigators.
New criteria to allow the separation of familial and sporadic ALS cases have been included. The questionnaire addresses many
risk factors that have already been proposed for ALS, as well as a number that have not yet been rigorously examined. To encourage
participation, responses are collected anonymously and no personally identifiable information is requested. The survey is being
translated into a number of languages which will allow many people around the world to read and answer it in their own language.
Results: After the questionnaire had been online for 4 months, it had 379 respondents compared to only 46 respondents for the
same initial period using a paper-based questionnaire. The average age of the first 379 web questionnaire respondents was 54
years compared to the average age of 60 years for the first 379 paper questionnaire respondents. The questionnaire is soon to be
promoted in a number of countries through ALS associations and disease registries.
Conclusions: Web-based questionnaires are a time- and resource-efficient method for performing large epidemiological studies
of neurodegenerative diseases such as ALS. The ability to compare risk factors between different countries using the same analysis
tool will be of particular value for finding robust risk factors that underlie ALS.
(JMIR Res Protoc 2015;4(3):e96)   doi:10.2196/resprot.4840
KEYWORDS
amyotrophic lateral sclerosis (ALS); motor neuron disease (MND); web-based; online; questionnaire; epidemiology; risk factor;
case-control study; international; language translation
Introduction
Amyotrophic lateral sclerosis (ALS, also known as motor neuron
disease or MND) is a progressive neurodegenerative disease of
adults with a usual survival of three to five years after
diagnosis [1]. Epidemiological studies using traditional methods
of collecting data via mailed paper questionnaires or via
telephonic or in-person interviews have so far not revealed any
widely accepted environmental or lifestyle risk factors for ALS.
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Previous epidemiological studies of ALS have had a number
of limitations. ALS has an incidence of about 2-3 per 100,000
in most populations, so it is not a common disorder and
obtaining large numbers of respondents has been difficult [2].
No intercountry comparisons of risk factors for ALS using the
same survey tool have been undertaken. Restricting the
geographical region of recruitment to one country or continent
prevents identification of risk factors that vary across countries
[3] or ethnic groups. As new criteria to classify ALS into its
sporadic and familial forms are proposed, changing diagnostic
criteria will make characterisation of cases in previous studies
difficult [4]. In addition, new potential environmental risk
factors for ALS are continually being proposed, but it is
inconvenient to add questions to non-Web surveys.
We became aware of these and other limitations of paper-based
questionnaires during the course of an Australian study looking
for risk factors for sporadic ALS. Despite this being a
continent-wide survey undertaken over 11 years (2000-2011)
with active recruitment of participants by state-based ALS
associations, responses were obtained from only 812 ALS
patients and 793 nonrelated controls in a population of 23
million people. Although this remains one of the largest
epidemiological case-control databases in ALS with several
publications arising from the study [2,3,5-10], numbers were
too small to analyse subgroups in many categories, such as those
for less common occupations. The majority of respondents were
English-speaking and of western European descent although
people from many language groups live in Australia (some of
this bias can be explained by the questionnaire being available
only in English). The criteria we used for separating familial
and sporadic ALS are under revision, and many of the patients
we classified as having familial ALS would now be considered
to be in the sporadic group [4]. The financial cost to obtain and
process information was high and when funding for staff and
consumables came to an end, the survey had to close. We did
not ask questions about topics such as psychiatric conditions
since the respondents had to identify themselves, and this
understandably would have made many reluctant to give out
such information.
Many of the limitations experienced during our paper-based
study have been overcome by migrating to an online
questionnaire, where respondents are not asked for personally
identifiable information. Our Web-based questionnaire can be
easily translated into other languages for both reading and
answering questions, which will aid recruitment and allow for
international comparisons of risk factors. We describe our
approach to designing this online questionnaire to look for risk
factors in ALS and present the initial responses to this survey.
We also summarise the advantages and disadvantages of
Web-based versus paper-based questionnaires as they pertain
to looking for risk factors for neurodegenerative diseases.
Methods
Questionnaire Software
Questionnaire platforms from a number of providers were
evaluated as potential sources of Web-based survey software.
Most offered user-friendly survey design, secure storage of
respondent data, an online log-in portal that allows users to
access the survey from any Internet browser, and the ability to
download survey data in several formats. Qualtrics [11] was
identified as a good platform for our project because it is flexible
and provides a large diversity of question types.
Questionnaire Design
Overview
Relevant questions from our original paper-based ALS
questionnaire were entered into the Qualtrics platform using
the appropriate question formats (see Multimedia Appendix 1
to view the original paper-based questionnaire). The design of
our online questionnaire was based on recent recommendations
of best practice in this field [12-14].
Pay Careful Attention to the Wording of Questions to
Ensure Clarity
Our experience with our previous paper-based questionnaire
was helpful in identifying types of questions that tended to result
in ambiguous answers.
Use Predetermined Choices to Ensure Standard Answers
For example, questions requiring a written answer in a
paper-based questionnaire (eg, “In which country are you
currently living?”) can be formatted as a single-choice
drop-down menu in a Web-based format. The number of
answers requiring text entry, which can cause transcription
difficulties and delay access to the data, was reduced to a
minimum in the online questionnaire.
Place Questions Into Topic Groups
The online questionnaire is organised according to topics of
interest (eg, occupation, exercise). This improves coherence of
the questionnaire, and it also allows easier topics to be placed
towards the beginning of the survey to increase respondents’
confidence about entering data into the questionnaire.
Use Automated Question Logic
Question logic shows or skips certain questions based on
previous answers. This relieves respondents of the responsibility
of following the logic of a paper-based questionnaire, and
ensures they only need view questions that apply to them.
Question logic largely eliminates commission errors (ie,
answering questions that are not applicable) and omission errors
(ie, not answering questions that are applicable) [14]. Question
logic applies to about 25% of our online questions.
Avoid Use of a Progress Bar
A progress bar, which shows respondents how far into the survey
they are, was not used. First, a progress bar would have been
misleading because it does not take into account the show/skip
logic within the questionnaire. Second, a progress bar is not
recommended on longer surveys because it discourages
completion [14].
Access for Patients With Physical Disabilities
Access to the questionnaire was a concern given that respondents
with ALS could have limited mobility. We therefore ensured
the questionnaire is compatible with speech-to-text programs
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and spoken commands. To aid visibility, we set the default font
size at 12 point, made the text of all questions in bold font, and
implemented a software feature that highlights the question
being worked on.
Access in Different Languages
We plan to translate the questionnaire into many languages,
including all languages spoken in countries within the
International Alliance of ALS/MND Associations. Respondents
will select their preferred language from a list of available
translations before entering the questionnaire. For text entry,
respondents will be able enter answers in their own language.
Since only a few questions are answered by entering text,
translations to English will not be onerous.
Google Translate is used to perform the first rough translation
of non-English languages, but fluent speakers of both English
and the language to be translated need to spend many hours
amending this to obtain the correct meaning and grammar in
the text, based on the English version. For example, in our
question about skin color, the word fair in most languages is
translated as reasonable rather than the intended meaning of
light in color. Qualtrics has a function in which the English and
Google-translated non-English version of the questionnaire can
be presented side-by-side, so the translator can readily edit the
non-English version with reference to the meaning in the English
version.
We have chosen first to check and adjust the translation of
simplified Chinese, one of the languages where Google Translate
appears to give the greatest number of ambiguities. Fluent
speakers of other languages are in the process of checking other
Google translations. The Google-translated languages that have
been checked for accuracy (only simplified Chinese at the time
of manuscript submission) will be indicated in the language list
as available translations.
New Content in the Web-Based Questionnaire
General
The content of our paper-based questionnaire was compared to
the Stanford University ALS Consortium of Epidemiologic
Studies (ACES) questionnaire [15], and questions were added
or modified on topics such as alcohol and tobacco use, medical
history, hobbies and pastimes, and pesticide and chemical
exposures. The differences in our paper- and Web-based
questions can be viewed by comparing the paper-based
questionnaire in Multimedia Appendix 1 and the online
questionnaire [16].
Defining Familial Versus Sporadic ALS
Controversy persists as to the definition of familial versus
sporadic (or isolated) ALS, with some clinicians classifying a
patient as having familial ALS only if close family members
also have the disease [4]. Based on studies of the heritability of
familial ALS, the questionnaire now asks for the number of
first-, second-, and third-degree relatives as well as more distant
relatives who have ALS [4,17,18]. It further asks for the total
number of first-, second-, and third-degree relatives in the
respondent’s family overall, since the familial nature of a disease
is harder to detect in a small family. Having this detailed family
history will allow researchers who have access to our survey
data to use their own criteria to define familial and sporadic
ALS.
Dementia
Questions are now asked about the number of family members
diagnosed with frontotemporal dementia (FTD), a recently
recognised component of an ALS/FTD disease continuum [19].
This will allow our study to identify families where one member
has ALS while another has FTD.
Genetic Variants
We now ask whether any ALS patient or relative has been
identified as having a genetic variant associated with ALS. We
do not ask respondents to identify the particular genetic variant
since rare variants could constitute personally identifiable
information.
ALS Functional Status
People with ALS are asked to complete the ALS Functional
Rating Scale (ALS-FRS) [20] to assess their physical state at
the time of taking the questionnaire. This will allow an
assessment of the rate of progression of the disease, which can
be calculated from the time of disease onset. A Web-based
format for the ALS-FRS has previously been validated by
comparing Web and in-person evaluations [21].
Physical Activity
To evaluate physical activity, which has been suggested to be
a risk factor for ALS [22], questions were obtained from surveys
used by the European Amyotrophic Lateral Sclerosis Consortium
(EURALS) [23] and the European Multidisciplinary ALS
Network Identification to Cure Motor Neuron Degeneration
(Euro-MOTOR) [22].
Ratio of Finger Lengths
The ratio between the length of the ring finger and index finger,
associated with prenatal exposure to testosterone, has been
implicated as a risk factor for ALS [24]. A diagram has been
included to show respondents how to perform and report these
measurements (Figure 1). The reliability of these self-reported
finger measurements is currently being investigated by
photographing 100 volunteers’ hands and comparing their own
finger measurements with measurements by researchers using
the photographs.
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Figure 1. This diagram in the questionnaire shows respondents how to measure the length of their index and ring fingers. Below the question, boxes
are provided (not shown) for respondents to select the measurements from a drop-down menu.
Male Pattern Baldness
It has been suggested that men with early-onset alopecia have
a higher risk of ALS [25]. We therefore included a question
used by the Physicians’ Health Study in which men estimate
the pattern of any hair loss they may have had when they were
45 years old by selecting one of 5 images ranging from no to
marked hair loss [26,27].
Head Trauma
Head trauma has been implicated as a risk factor for ALS [28].
To gauge a history of head trauma, we added questions from
the Retrospective Screening of Traumatic Brain Injury
(RESTBI) Questionnaire [29].
Sun Exposure
Vitamin D deficiency has been implicated as a factor in
ALS [30]. In most countries, sun exposure is the main source
of vitamin D [31], but assessing sunlight exposure over long
periods of time with a questionnaire is difficult [32]. We
therefore asked about two aspects of sun-induced vitamin D
generation, skin color and the reaction of the skin to sunlight,
as used in the NSW Prostate Cancer Care and Outcomes Study
[33].
L-BMAA
Because of the interest in a possible connection between the
environmental toxin β-N-methylamino-L-alanine (L-BMAA)
and ALS, we included questions related to L-BMAA exposure
based on the French BMAALS program questionnaire [34].
Stress
Stress has been suggested as a potential risk factor for ALS [35].
Our questionnaire asks systematic questions about stress as a
risk factor for the disease. To assess lifetime stress we used the
Social Readjustment Rating Scale which scores the stress
associated with a variety of events [36]. To evaluate the likely
impact these stressors would have had on respondents, we used
the Big Five personality traits assessment [37-39], the
Connor-Davidson Resilience Scale [40], and the Geriatric
Anxiety Inventory [41,42]. A Web-based administration of a
scale similar to the Geriatric Anxiety Inventory has been
validated by comparing Web and telephone interview
surveys [43].
Diagnosis of ALS
On our previous paper-based questionnaire, we asked
neurologists of ALS patients to send us copies of their clinical
notes so that the type of ALS the respondent had could be
assessed (there are four major types of the disease). This
required a consent form specific to Australia, and individual
neurologists around the country had to be contacted. No
response was received from neurologists for about 15% of
respondents, whose questionnaire data could not then be used.
Since we designed the current questionnaire to be used for
international comparisons of ALS risk factors, a direct approach
to neurologists in different countries was not ethically feasible.
On the online questionnaire, we therefore ask ALS patients to
choose which type of ALS they have been diagnosed with from
a predetermined list, and ask them to contact their neurologist
or family doctor if they are unsure about the type.
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Avoidance of Culturally Specific Questions
All questions were checked for content that could cause
misunderstandings in different countries and cultures. We
avoided questions that relate specifically to cultural or
environmental aspects of any country.
Information for Participants
Text providing information for participants (administrative
details about the questionnaire), comprehensive instructions
(how to complete the questionnaire), and guidelines (tips for
using the questionnaire) appear after respondents access the
questionnaire. Respondents then need to answer a few questions
before being able to fully access the questionnaire. Respondents
are asked to select age, gender, and whether they have ALS.
They are asked to describe their connection to ALS if they do
not have the disease. If they have a friend or partner with ALS,
respondents are asked to list the length of the relationship. Last,
respondents are asked how they heard about the questionnaire.
After these are answered, an online consent form is displayed;
once this is completed, respondents enter the main body of the
questionnaire. All other questions are voluntary, but if a question
is not able to be answered there is usually an option to explain
why (eg, not applicable).
Pairing of Cases and Matched Controls
ALS patients are asked to nominate (if available) a
spouse/partner and friends to complete the questionnaire. ALS
patients create a unique code and provide it to their
spouse/partner and friends. The code is then used to link the
ALS patient to these matched controls. This enables paired
statistics to be performed on people who are likely to have
similar environmental exposures; these statistics will be used
for comparisons with nonmatched controls. The code does not
allow participants to view other responses.
Questionnaire Distribution
Qualtrics provides two means by which a questionnaire may be
distributed: via an anonymous link or via an email invitation
with a link specific to each respondent. We chose the anonymous
option to maintain participant confidentiality. The questionnaire
does not ask for any personally identifiable information such
as name, email address, employer name, or exact locations lived.
This preserves the anonymity of respondents, which is important
considering the sensitivity of some of the data (eg, psychiatric
history) being collected. In addition, the anonymous option
allows distribution of the questionnaire to a wide international
group of potential respondents.
Recruitment of Participants
People both with and without ALS are being sought to complete
the questionnaire. The only exclusion criterion is being under
the age of 18 years, so there is little possibility for confusion
about eligibility criteria. ALS patients in Australia are recruited
via newsletters, Facebook pages, and meetings of ALS
associations in each state. Nonmatched controls are recruited
in particular among community groups such as Rotary
International. In the United States, participants are recruited
through the government-funded National ALS Registry at the
Agency for Toxic Substances and Disease Registry (Centers
for Disease Control and Prevention), which has been used by
other researchers to recruit participants for ALS online
epidemiological surveys [44]. Participants in other countries
will be recruited through their respective national ALS
associations with the assistance of the International Alliance of
ALS/MND Associations.
Data Collection and Storage
Responses to the questionnaire are initially placed on
password-protected Qualtrics servers in the countries that host
these servers. The Qualtrics servers in the United States are
used in countries that do not have their own Qualtrics servers.
Completed questionnaire responses are downloaded and
transferred from the Qualtrics server into Excel (Microsoft
Corporation) and SPSS (IBM Corporation) program files on a
regular basis. The original responses are deleted from the
Qualtrics servers every six months. Questionnaire responses
are kept in a password-protected file on a password-protected
computer at the University of Sydney. This computer is
connected to Wi-Fi only via password-protected networks.
Results
Cases and Controls
Major groups in the study comprise those who have been
diagnosed by a neurologist as having ALS (cases),
spouse/partners and friends of people with ALS (matched
nonrelated controls), blood relatives of people with ALS who
do not have the disease (matched related controls), and persons
completing the survey who do not fall into the other categories
(nonmatched controls).
The Online Questionnaire
The questionnaire can be viewed online [16]. Examples of
multiple choice questions are shown for Single Choice (Figure
2), Select All That Apply (Figure 3), and Drop-Down Menu
(Figure 4) questions. An example of a Side-by-Side question is
shown in Figure 5.
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Figure 2. Example of a single-choice question. Only one choice of place of birth is allowed.
Figure 3. In an all-that-apply question respondents can tick as many answers as they want. In this particular question about occupational exposures
there is a possible mix of tick-boxes and script entries.
Figure 4. In these three questions about caffeine consumption respondents pick predetermined answers from drop-down lists.
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Figure 5. A large amount of information about the type, duration, intensity, and category of an activity can be obtained using side-by-side drop-down
menus and script entry.
Pilot Assessment
Ten people were asked to complete the questionnaire and
provide feedback to test the clarity of the questions and the
functionality of the questionnaire on multiple Internet browsers
and devices. Based on this feedback, we adjusted some of the
instructions for completing the questionnaire and edited the
wording and format of some questions and choices of answers.
In addition, after the survey first went online we received email
feedback from some of the first 112 respondents. On the basis
of this feedback a few minor changes were made and some
questions were added. These changes did not affect the validity
of the initial 112 responses.
Acceptance and Initial Uptake of the Questionnaire
After approval from an institutional ethics committee, the
questionnaire was placed online on 30 January 2015. Four
months later, 379 responses (204 from ALS patients and 175
from controls) had been collected. In comparison, after 4 months
we had received only 46 respondents from the same population
using our paper-based questionnaire.
Spontaneous feedback via email; verbal feedback at meetings
of ALS patients (including those with physical disabilities) and
their partners; and comments from scientific and medical
colleagues concerning the questionnaire format, its content, and
ease of use have been positive. However, because we did not
formally ask for this information from all respondents this
feedback is not quantifiable.
Respondents report taking about two hours to complete the
survey, and some appeared to complete it over multiple sessions.
The majority of respondents so far have been from Australia
since recruitment from countries outside Australia is in the
initial stages. We will be promoting the non-English language
versions of the questionnaire as their Google-translated versions
are checked.
Ages of Respondents in the Paper- and Web-Based
Questionnaires
The average age of the first 379 respondents to the online
questionnaire was 54 years (SD 15, range 18-86) compared to
an average age of the first 379 respondents to the paper-based
questionnaire of 60 years (SD 11, range 28-90).
Discussion
Advantages of Web-Based Questionnaires in
Neurodegenerative Diseases
Large numbers of responses can be acquired at low cost with
minimal staff requirements and within a short period of time.
This is especially relevant to some of the less common
neurodegenerative disorders with short survival periods where
traditional survey methods have had difficulty recruiting
adequate numbers of respondents. Questions can be added easily
when newly proposed risk factors are suggested. New risk
factors for neurodegenerative diseases are continually being
proposed, and with the advent of next generation DNA
sequencing, the search for gene-environment interactions
underlying these diseases is likely to accelerate. Automatic
transfer of response data into database, spreadsheet, and statistics
programs virtually eliminates the possibility of transcription
errors and speeds up the data analysis. It also reduces the cost
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of running these surveys so they can be operated for longer
periods, an important consideration when recruiting respondents
with rare diseases. Other advantages of Web-based
questionnaires have been well documented [45-49].
Studies Comparing Online Versus Other Survey Modes
A review of 29 studies with a combined total of more than
15,000 respondents comparing different survey modes (postal
mail, fax, email, and Web-based surveys) reported that
Web-based surveys provided a better quality of response, greater
level of detail, and greater compliance in answering open-ended
questions than mail surveys [50]. The authors calculated similar
response rates for the Web-based (52%) and mailed (51%)
modes but found that average response times for Web surveys
(7 days) were shorter than for mail (17 days). A population
survey of 3148 Danish parents concerning their children’s health
and welfare found similar response rates comparing paper, paper
with Web option, Web-only, and Web with incentive
formats [51].
The Black Women’s Health Study of 59,000 African-American
women reported that Web-based surveys were filled out more
completely than paper surveys and cost only 25% of paper
surveys. Web-based response rates were greatest for younger
age groups [52]. In the French NutriNet-Santé study of lifestyle
and health, 94% of 147 volunteers stated a preference for the
Web-based over the paper version [53]. Furthermore, this study
found that the Web-based version prevented the omission of
approximately 2% of answers (more than 550 values), which
increased the value of each response. It also noted the cost
benefits of the Web-based approach.
These studies demonstrate that Web-based surveys are as
effective or better than other modes in garnering survey
responses and obtaining sound data. These findings largely
address the fundamental concerns of maintaining data validity
and obtaining sufficient numbers of responses raised when
making the decision to migrate to a Web-based platform.
Online Surveys in Epidemiological Research
Despite results showing that Web-based questionnaires are as
good or better than other survey modes, the field of
epidemiological research has been slow to adopt Web-based
methodology. A meta-analysis of epidemiology-related
publications in seven high-impact general medical and
epidemiological journals in 2008-2009 found that only 1% had
used any form of Web-based data collection, while interviews
were used in 28% and paper-based questionnaires in 29% (some
used multiple formats) [45]. There is therefore potential for
growth in the use of Web-based data collection tools for
epidemiological purposes. The migration to Web-based
questionnaires is likely to increase as a growing proportion of
the population gains Web access. For example, World Bank
data show that 83% of Australian and 46% of Chinese
populations now use the Internet [54].
Online Surveys in ALS Research
There appears to be only one other Web-based epidemiological
study of ALS [44]. In that study, ALS patients who had enrolled
electronically with the US National ALS Registry were recruited
via email. Inclusion criteria were a diagnosis of ALS confirmed
by a physician, knowledge of English, residence in the United
States for at least 10 years, and age 21 years or older. Exclusion
criteria were having also been diagnosed with Parkinson disease,
parkinsonism, Alzheimer disease, dementia, poliomyelitis, or
post-polio syndrome or having a family member with ALS.
From the 2232 emails sent, completed surveys were received
from 256 respondents who fulfilled the eligibility criteria, an
enrollment rate of 11.5%. Among the topics covered in the
survey were lifetime occupational history, occupational
exposures, residential history, hobbies, physical activity, and
military history.
We have also been given permission to recruit ALS patients
from the US National ALS Registry. It will be of interest to
compare our enrollment rate with that of Malek et al [44] since
we have fewer exclusion criteria. Also, because our
questionnaire is anonymous we predict more people will feel
comfortable supplying personal information about themselves.
Limitations of a Web-Based Questionnaire
Nonresponse Errors
A major concern in any survey is that the responses received
are not representative of the population sampled (ie, nonresponse
errors). It has been noted that the demographics of Internet users
differ from the general population in that they tend to be younger
and more educated [46,47]. However, one study that examined
computer literacy and educational status among Web survey
participants found that a substantial portion of their respondents
considered themselves inexperienced in computer and Internet
skills, and that those with less education were more accepting
of the burden of completing an Internet survey [34].
A review of 11 Web-based surveys of people aged 65 years or
older found that limitations for this age group were similar to
those among all age groups [55]. One of the studies included
in this review found that the mean age of Web-based participants
(70 years) was lower than the age of face-to-face respondents
(81 years) [56]. In our study, the average age of Web-based
respondents (54 years) was slightly younger than that of
paper-based respondents (60 years). This may imply some
preference for the Web-based questionnaire among younger
people, but direct comparisons between respondents in these
two questionnaires are difficult to make. In our paper-based
questionnaire, for example, all respondents also had to give a
blood sample, which may have discouraged some younger
people from participating.
Of note in our study, respondents are likely to be in the 40 to
70 year age group since this is the typical range for ALS.
Therefore, age and educational status are unlikely to
substantially limit participation in our Web-based questionnaire.
We think that nonresponse error for our questionnaire will be
minimal since most respondents are likely to have a strong
interest in the subject.
Concerns About Safety of Personal Information
As with all uses of the Internet, there are concerns about safety
and confidentiality of the data provided [45]. Our questionnaire
largely circumvents this issue because all data are being
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collected as anonymous responses, and our data are secured on
password-protected servers and computers.
Inability to Get Further Information or DNA Samples
From Respondents
Since we have no identifying details on our respondents, we
cannot contact them individually to ask them further questions
or to ask for DNA samples to look for gene-environment
interactions. However, there are now a number of databases
containing large numbers of DNA samples from ALS patients,
and should our study find risk factors for ALS, the same factors
could be sought from patients who have donated DNA to these
registries.
Inability to Obtain Physician Confirmation of Diagnosis
Since the responses are anonymous, we cannot obtain physician
confirmation of the diagnosis of ALS or classify the cases using
El Escorial criteria [57]. This is unlikely to be a major limitation
since most ALS patients are well aware of their diagnosis. For
example, of 88 people who self-reported a diagnosis of ALS to
the US National ALS Registry, a check of their physician reports
identified only 5 (6%) who did not have ALS [44]. We think
the accuracy of the self-reporting of ALS diagnosis by our
respondents will be improved by requesting them to select which
subtype of ALS they have and asking them to contact their
physician if they do not know this.
Conclusions
The majority of epidemiological studies have been conducted
using paper-based questionnaires, face-to-face interviews, or
telephone surveys. The literature now shows that Web-based
questionnaires offer many advantages over traditional methods
with few drawbacks. Our experience creating an online
questionnaire illustrates these advantages. Furthermore, our
questionnaire is being translated into non-English languages
and opened up to participation worldwide. We hope the data
obtained from this project will accelerate our understanding of
ALS and lead to the development of effective treatment options
and preventative strategies.
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Multimedia Appendix 1
The previous paper-based ALS risk factor questionnaire used by the Australian MND DNA Bank. A number of these questions
were modified to fit the present online format.
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Chapter 3: Does the index to-ring finger length ratio (2D:4D) 
differ in amyotrophic lateral sclerosis (ALS)? 
 
After completing the development of ALS Quest, the questionnaire was launched in January 
2015. To enable ALS Quest to reach a worldwide audience, work had also commenced on 
obtaining translations of the questionnaire. This effort, as well as an overview of the 
implementation of the questionnaire, is summarized further in Appendix B. This information 
was presented at the annual meeting of the International Alliance of ALS/MND Associations 
in 2017 (Appendix C) and as a poster at the 28th International Symposium on ALS/MND in 
2017 (Appendix D).  
Once ALS Quest had been opened to participants, responses were collected quickly. 
Therefore, analysis of the data began within a relatively short time frame. Preliminary results 
from ALS Quest were presented in a poster at the MND Australia meeting in November 2015 
(Appendix E). By late 2016, 800 responses had been collected so that sufficient data were 
available for further analyses.  
One goal of ALS Quest was to assess novel risk factors that were either not published in the 
literature or had only been tested in a limited fashion. One such risk factor was prenatal 
testosterone, which can be evaluated by looking at the ratio of the index and ring fingers, the 
2D:4D ratio. The lower this ratio, the higher the exposure to prenatal testosterone. This topic 
was chosen because it might provide insight into a link between physical activity and ALS. 
While physical activity has often been examined as a risk factor for ALS, the basis for such a 
link is unclear. It may not be athletic participation per se that leads to ALS, but rather that the 
link between athletics and ALS may be that both are related to higher prenatal exposure to 
testosterone, represented by a lower ratio of the 2D to 4D finger lengths [2-4]. 
One study had suggested such a link between prenatal testosterone and ALS based on finger 
lengths [2]. However, the numbers of participants were small and the control group was 
primarily composed of the female spouses of male ALS patients, which resulted in a lopsided 
gender balance (and finger ratios are influenced by gender). I was able, with the large number 
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of respondents available, to analyse male and female results separately, which also took into 
account the gender differences that have been described in ALS [1].  
This analysis was conducted and published as the following paper in this chapter. The results 
showed that the group of respondents to ALS Quest had the same male-female difference in 
2D:4D ratio noted in the literature, but that the 2D:4D ratios did not differ between ALS 
respondents and controls. These results were presented in a poster at the 28th International 
Symposium on ALS/MND in 2017 (Appendix F). 
To complement this work, I conducted a validation study to evaluate how accurately people 
could measure their fingers, by comparing personal measurements with researcher 
measurements from photographs (Appendix G). 
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AbstrAct
Objectives The ratio of the length of the index finger 
(2D) to the ring finger (4D) (2D:4D) has been reported 
to be lower (ie, 2D<4D) in people with amyotrophic 
lateral sclerosis (ALS) than non-ALS controls. This has 
led to suggestions that exposure to increased prenatal 
testosterone, which also lowers this ratio, could be a risk 
factor for ALS. In an attempt to test this hypothesis, we 
examined 2D:4Ds from large numbers of patients with ALS 
and controls.
setting An online multilingual questionnaire enabling 
respondents to measure their own index and ring finger 
lengths.
Participants Of the initial 949 respondents, 572 remained 
for analysis after elimination for inability to straighten 
fingers, not answering the question, statistical outliers and 
aged <40 years. Respondents remaining for analysis were 
202 patients with ALS (125 males, 77 females) and 370 
non-ALS controls (112 males, 258 females).
results Unpaired t-tests with 95% CIs were used 
to assess differences in mean 2D:4Ds. Males had 
significantly lower mean 2D:4Ds than females, in both 
ALS and control groups, for both left and right hands. No 
significant differences were found in 2D:4Ds between 
ALS and control groups, in either males or females, for 
either left or right hands. Receiver operating characteristic 
curves showed no power for 2D:4Ds to predict ALS status 
in either males or females.
conclusions 2D:4Ds did not differ between patients 
with ALS and controls in this study. This was despite the 
dataset being large enough to confirm the established 
finding of lower 2D:4Ds in males compared with females. 
These findings do not support the hypothesis that 
exposure to increased prenatal testosterone is a risk factor 
for ALS. A putative lower 2D:4D has been proposed to 
explain the link between ALS and exercise, but our results 
indicate that other exercise-related factors are more likely 
to explain this association.
IntrOductIOn
Gender differences in the ratio of the length 
of the index finger (2D) to the ring finger 
(4D) (2D:4D) have been studied for over a 
century, with a lower mean ratio (ie, 2D<4D) 
being repeatedly found in males compared 
with females,1–3 though with considerable 
overlap. The smaller average male 2D:4D is 
considered to be due to increased amounts 
of intrauterine testosterone relative to 
oestrogen.4 5 The reason for this appears to be 
that during development the fetal ring finger 
has more plentiful androgen and oestrogen 
receptors than the index finger and so grows 
longer in the presence of a relative excess of 
testosterone.6 7
The 2D:4D has been used as an index of 
prenatal hormone exposure in a variety of 
physiological and psychological conditions, 
including athletic ability and strength,3 8–10 
fertility,4 various behaviours11 and sexual orien-
tation.12 The ratio has also been reported to 
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strengths and limitations of this study
 ► Use of an online questionnaire enabled recruitment 
of larger numbers of patients with amyotrophic 
lateral sclerosis  (ALS) and controls than previously 
available for this type of study.
 ► The larger numbers of respondents allowed for 
statistically robust separate analyses of male and 
female length of the index finger (2D) to the ring 
finger (4D) ratios.
 ► The accuracy of self-measured finger lengths was 
validated by the finding of similar gender differences 
(2D<4D in males, 2D≥4D in females) to those 
reported in previous studies.
 ► This was an international study, with comparable 
national, ethnic and cultural backgrounds in ALS and 
non-ALS respondents.
 ► Although patients with ALS had to self-report their 
disease status, self-reporting of ALS compared with 
physician’s assessments has been shown to be 
accurate in over 90% of participants.
 ► 10% of ALS patients and 2% of controls were unable 
to straighten their fingers to provide measurements.
 ► Numbers of respondents are too limited to investigate 
interethnic and internation 2D:4D differences.
 ► More random errors and larger SD are generally 
found in self-reported data.
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Figure 1 The diagram that appears in the online 
questionnaire to assist respondents to measure their finger 
lengths.
be different in diseases where gender imbalances can be 
marked or in which prenatal influences are suspected, 
including breast cancer,13 prostate cancer,14 Alzheimer’s 
disease15 and multiple sclerosis.16
Amyotrophic lateral sclerosis (ALS), also known as 
motor neuron disease (MND), is a progressive neurode-
generative disease with a usual postdiagnosis survival time 
of 2–5 years.17 A previous study reported a lower mean 
2D:4D in patients with ALS compared with controls.18 
However, subject numbers in this study were too limited 
to detect the lower 2D:4D usually reported in males. To 
see if the results of this study could be validated with a 
larger number of subjects, we used data from an interna-
tional online questionnaire19 in which ALS and non-ALS 
respondents self-measured the lengths of their ring and 
index fingers.
MethOds
Setting
This is a case–control study using data from an inter-
national, multilingual, web-based questionnaire (‘ALS 
Quest’) designed to look for risk factors for ALS. Details 
on the design and implementation of the questionnaire 
have been published.19 The full questionnaire, which 
uses Qualtrics survey software, can be viewed at www. 
alsquest. org and completed online. A PDF version of 
the questionnaire is available for downloading as online 
supplementary file S1 .
Responses to the questionnaire collected between 
January 2015 and February 2017 were used for anal-
ysis. Respondents for the questionnaire were recruited 
via national and state ALS/MND associations, national 
ALS registries, the internet and social media. No 
personally identifying data were collected to allow the 
respondents to remain anonymous. The project was 
approved by the Human Ethics Committee of the Sydney 
Local Health District.
Cases were respondents who replied to a question about 
having been diagnosed as having ALS with ‘Yes, I have 
been diagnosed with ALS/MND’. Controls were partic-
ipants who answered this question with ‘No, I have not 
been diagnosed with ALS/MND’. To maintain anonymity, 
information on disease status was not requested from 
attending physicians but was self-reported.
Finger measurements
The guide on how to perform finger measurements 
consisted of a diagram (figure 1) together with the 
following instructions: ‘Please measure the lengths of your 
index (second) and ring (fourth) fingers on each hand. 
The diagram below shows you how to make the measure-
ments. If you can only straighten out the fingers on one 
hand, only record the measurements for that hand. If 
possible, please take off any rings prior to measuring 
your fingers. First lay the back of your hand out flat on 
a level surface, with your fingers together. Then, with 
a rigid millimetre ruler (not a tape measure), measure 
from (1) the tip of the finger to (2) the middle of the 
crease at the bottom of the finger. The ring finger often 
has two of these creases, so here measure from the crease 
that is closest to the wrist’. Drop-down lists with numbers 
ranging from 35 to 135 mm allowed respondents to select 
the relevant finger lengths.
Other data analysed
Other questionnaire data used in the study (answers 
mostly selected from drop-down lists) were: date when 
consent was given to conduct the questionnaire, age, 
gender, country of residence, country of birth, ancestry, 
cultural group, dominant hand and family history of 
ALS. People with ALS were asked their date of diagnosis, 
subtype of ALS and to complete the ALS Functional 
Rating Scale (ALSFRS-R)20 which for this study was scored 
in reverse so that higher scores indicated more advanced 
disease.
statistical analyses
Data from the survey software were transferred to a 
Microsoft Excel file, where 2D:4Ds were calculated by 
dividing the length of the index finger by the length of 
the ring finger. IBM SPSS Statistics for Macintosh (V.22) 
and GraphPad Prism V.7 were used to create percentage 
frequency histograms, calculate unpaired t-tests with 
95% CIs to compare means and perform Pearson’s test 
for correlations. Receiver operating characteristic (ROC) 
curves assessed the sensitivity and specificity of 2D:4Ds to 
distinguish between ALS and controls. Effect sizes were 
calculated using G*Power.21 Significance was assessed at 
the 0.05 level.
exclusion criteria
Respondents were excluded from analysis (figure 2) if 
they: (1) could not straighten the fingers of both their 
hands, (2) did not answer the finger length question, 
(3) had extreme outlier results (identified on SPSS as 
being more than three times the IQR) and (4) were 
under the age of 40 years (to limit the number of control 
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Figure 2 Flow chart of the selection of study 
respondents. ALS, amyotrophic lateral sclerosis.
respondents who might later be diagnosed with ALS) or 
did not answer the age question.
results
Cases and controls
Extreme outliers were five 2D:4D results and one left 
hand/right hand 2D:4D difference; when these were 
excluded, all self-measured values produced ratios 
ranging from 0.8 to 1.2, the range considered to be likely 
to reflect real values.22 After all exclusion criteria were 
applied, the original number of 949 respondents was 
reduced to a final dataset number of 572 (figure 2). These 
remaining respondents comprised 202 ALS cases (125 
male, 77 female) and 370 non-ALS controls (112 male, 
258 female). The mean age of ALS patients was 61.7 years 
(SD 9.1 years, range 40–83 years) and of controls was 57.4 
years (SD 10.4 years, range 40–86 years). Original finger 
length measurements from the analysed respondents 
(with genders and ages) are available as online  supple-
mentary file S2.
sources of information about the questionnaire
The most common sources of information about the 
questionnaire cited by respondents were: ALS associa-
tions (36% of respondents), the internet (22%), friends 
(9%), patients with ALS (7%), health professionals (6%), 
community groups (5%), Facebook (4%), the USA CDC 
National ALS Registry (3%), the Canadian Neuromus-
cular Disease Registry (2%) and ALS researchers (2%).
demographic and clinical characteristics
The composition of the ALS and control groups was 
similar with regards to country of birth, country of resi-
dence, ancestry and cultural group (table 1). The majority 
of respondents resided in Australia, the USA and Canada, 
though residents of a further 26 countries supplied 
responses. As reported by the ALS respondents, 52% had 
‘classic’ (upper and lower motor neuron variant) ALS, 
10% progressive bulbar palsy, 10% primary lateral scle-
rosis (upper motor variant), 7% progressive muscular 
atrophy (lower motor neuron variant), 9% ‘other’ and 
9% did not know their subtype of ALS. Seven per cent of 
ALS patients had a relative with ALS and were classified as 
‘familial’ ALS. Most controls (68%) reported no relatives 
with ALS, whereas 24% had one relative with ALS and 8% 
had more than one relative with ALS.
comparison of 2d:4ds between males and females
Left and right hand 2D:4Ds were significantly smaller in 
males compared with females, both in patients with ALS 
and controls (figure 3). The mean difference was slightly 
greater in patients with ALS than in controls (table 2).
comparison of 2d:4ds between patients with Als and 
controls
Because of the mean 2D:4D differences found between 
our male and females, comparisons between ALS and 
control groups were undertaken in males and females 
separately. The frequency distributions of 2D:4Ds from 
both the left and right hands of ALS and control respon-
dents were similar (figure 4). No significant differences 
in mean 2D:4Ds were seen between ALS and controls 
groups, in either the left or right hands, of either males or 
females (figure 3, table 2). Mean 2D:4Ds differed at only 
the third decimal place between these groups, and the 
95% CIs spanned the zero difference in means (figure 3).
ROC curves of left and right hands showed that 2D:4Ds 
did not predict ALS status in either males or females 
(figure 5). The curves were close to the diagonal along 
the line of no-discrimination, with areas under the curve 
close to 0.5, indicating that the 2D:4Ds were neither sensi-
tive nor specific to ALS status.
rate of Als progression
An estimate of the rate of ALS progression was obtained 
by dividing the reverse ALSFRS-R score by the number 
of months since diagnosis. The rate of ALS progression 
did not correlate significantly with 2D:4D, in either the 
left hand (r 0.072, p 0.317) or the right hand (r 0.082, p 
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Table 1 Demographic characteristics of respondents
ALS n (%) Control n (%)
Country of birth
  USA 72 (36) Australia 228 (62)
  Australia 55 (27) Other (<3% each) 65 (18)
  Canada 32 (16) USA 33 (9)
  Other (<3% each) 22 (11) UK 23 (6)
  UK 11 (5) South Africa 10 (3)
  South Africa 5 (3) Spain 10 (3)
  Spain 5 (3)
Country of residence
  USA 73 (36) Australia 282 (76)
  Australia 69 (34) USA 39 (11)
  Canada 38 (19) Other* (<1% each) 27 (7)
  Other* (<3% each) 12 (6) Canada 5 (1)
  South Africa 5 (3) New Zealand 5 (1)
  Spain 5 (3)
Ancestry
  Other (<6% each) 82 (41) Other (<4% each) 125 (34%)
  Australian 34 (17) Australian 105 (28)
  English 28 (14) English 66 (18)
  American 16 (8) Irish 35 (10)
  Irish 16 (8) British 20 (5)
  Canadian 13 (6) Scottish 15 (4)
  German 13 (6)
Cultural group
  Australian 57 (28) Australian 238 (64)
  American 43 (21) Other (<2% each) 63 (17)
  Other (<3% each) 43 (21) American 24 (7)
  Canadian 29 (14) English 22 (6)
  English 17 (8) Spanish 10 (3)
  German 6 (3) Dutch 8 (2)
*Other countries of residence (in alphabetical order): Argentina, Belgium, Brazil, China, Colombia, Denmark, Ecuador, Egypt, Finland, 
Germany, Iran, Ireland, Italy, Japan, Lebanon, Luxembourg, Mexico, the Netherlands, Portugal, Russia, Slovakia, South Korea, Sweden, 
Switzerland, Turkey and UK.
Some subsets do not add up to the total number of respondents because of answers to particular questions not being given.
ALS, amyotrophic lateral sclerosis.
0.251), indicating the ratio had no influence on disease 
progression.
sporadic and familial Als
People with sporadic ALS (93% of cases) had no signif-
icant differences in 2D:4Ds to those with familial ALS 
(7%), for either the left or right hands, in either males 
or females. Similarly, no significant differences were seen 
in 2D:4Ds between non-ALS controls who had either no 
family member with ALS (68%), one family member with 
ALS (24%) or two or more family members with ALS 
(8%), for either hand in either gender.
left–right symmetry of finger lengths and 2d:4ds
No significant differences were found between the 
lengths of the left and right index fingers, or the left 
and right ring fingers, in either gender or either disease 
status group, indicating no asymmetry of left-right finger 
lengths in our respondents.
No significant differences between left and right hand 
2D:4Ds of individual respondents were found, suggesting 
that respondents did not have difficulty measuring 
fingers of either their left or right hands. 2D:4Ds were 
also compared between male/female and ALS/control 
groups using dominant or non-dominant hands for 
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Figure 3 Differences in mean 2D:4Ds between male and females (upper segment, orange) and between patients with ALS 
and controls (lower segment, black). Mean 2D:4Ds (filled circles) are significantly smaller in males compared with females, 
in both control and ALS groups. No differences are seen in mean 2D:4Ds between control and ALS respondents, for either 
males or females, with the mean differences all close to zero, and the 95% CIs (bars) spanning the zero difference (dotted 
line). 2D:4D, ratio of the length of the index finger (2D) to the ring finger (4D); ALS, amyotrophic lateral sclerosis
Table 2 Differences in mean 2D:4D ratios (with p values and effect sizes) between males and females, and between patients 
with ALS and controls
Groups (n) Mean 2D:4D (SD) Mean 2D:4D difference (95% CI) p Value Effect size (d)
Male–female left hand
  Male control (112) 0.978 (0.0467) −0.015 (-0.026 to −0.0028) 0.016 0.28
  Female control (258) 0.993 (0.0557)
  Male ALS (124) 0.979 (0.0521) −0.017 (-0.032 to −0.0017) 0.029 0.32
  Female ALS (75) 0.996 (0.0537)
Male–female right hand
  Male control (111) 0.979 (0.0461) −0.014 (-0.025 to −0.0023) 0.019 0.28
  Female control (258) 0.993 (0.0542)
  Male ALS (124) 0.978 (0.0508) −0.017 (-0.032 to −0.0026) 0.021 0.34
  Female ALS (77) 0.995 (0.0529)
Control–ALS left hand
  Male control (112) 0.978 (0.047) −0.00094 (-0.014 to 0.012) 0.884
  Male ALS (124) 0.979 (0.0521)
  Female control (258) 0.993 (0.0557) −0.0033 (-0.018 to 0.011) 0.649
  Female ALS (75) 0.996 (0.0537)
Control–ALS right hand
  Male control (111) 0.979 (0.0461) 0.0013 (-0.011 to 0.014) 0.835
  Male ALS (124) 0.978 (0.0508)
  Female control (258) 0.993 (0.0542) −0.0022 (-0.016 to 0.012) 0.751
  Female ALS (77) 0.995 (0.0529)
2D:4D, ratio of the length of the index finger (2D) to the ring finger (4D); ALS, amyotrophic lateral sclerosis.
measuring (85% of respondents were right-hand domi-
nant, 10% left-hand dominant and 5% ambidextrous). 
The results of these analyses were the same as above (ie, 
males had lower 2D:4Ds, but no 2D:4D differences were 
found between patients with ALS and controls), indi-
cating that use of the non-dominant hand to hold the 
ruler did not affect measurements.
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Figure 4 Overlapping histograms show the similar percentage frequency distributions of 2D:4Ds between ALS and control 
respondents, for both males (A: left hand, B: right hand) and females (C: left hand, D: right hand). 2D:4D, ratio of the length of 
the index finger (2D) to the ring finger (4D); ALS, amyotrophic lateral sclerosis.
Figure 5 Receiver operating characteristic curves of 2D:4Ds 
in both males (A) and females (B) are close to the diagonal 
line of no-discrimination (not drawn since it would obscure 
the curves). Areas under the curve are close to 0.5, indicating 
that the 2D:4Ds are neither sensitive nor specific to ALS 
status. 2D:4D, ratio of the length of the index finger (2D) to 
the ring finger (4D); ALS, amyotrophic lateral sclerosis.
dIscussIOn
We found no differences in mean 2D:4Ds between ALS 
and non-ALS respondents, with males and females being 
analysed separately, and 2D:4Ds had no ability to predict 
ALS status. This was despite our dataset being large 
enough to confirm the established lower mean 2D:4D 
found in males compared with females.
Internet surveys are able to gather data from large 
numbers of participants, but concerns have been raised 
about superficial answering of questions and multiple 
responses from individuals.23 These would be unlikely in 
the present survey, with most respondents either having 
the serious condition of ALS or having knowledge about 
the disease. Furthermore, the ALS Quest survey is detailed 
and extensive, taking most respondents about 2 hours to 
complete, often in multiple sessions, so respondents who 
complete the survey are likely to be motivated to give 
accurate data. Multiple answers are also not likely since 
the questionnaire is set up to allow only one response per 
internet browser/computer.
An important issue concerns the accuracy of the 
self-measured finger lengths in this study. Comparisons 
between large numbers of Internet and convention-
ally collected survey data have shown consistency with 
researcher-measured samples.23 Web-based 2D:4D 
measurements appear to add some random noise to the 
data, but do not lead to systemic errors.24 When self-re-
ported finger measurements were compared with those 
measured on photocopies by researchers, the self-re-
ported lengths were found to be valid for the study of 
2D:4D, provided outliers were removed and large sample 
numbers were available.25 These recommendations were 
followed in the present study: after a few extreme outliers 
(only 1% of the total) were removed, our self-reported 
2D:4Ds produced ratios ranging from 0.8 to 1.2. Values 
within this range are considered to represent real values, 
as reported in another online 2D:4D study.22 Neverthe-
less, the 2D:4D ratios in our study have larger SD than 
those in an experimenter-measured finger length study.26 
Our calculated 2D:4Ds therefore have relatively high 
levels of random error, with weakening of any relation-
ships between 2D:4D and ALS. This can also be seen 
from our gender difference findings, which while signif-
icant and being close to those previously reported,27 had 
smaller effect sizes, with a reduction from d values of 
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0.5–0.6 in experimenter-measured studies26 to 0.25–0.35 
in our online study. This emphasises the need for large 
numbers of subjects in web-based 2D:4D studies.
Ideally, to be able to confidently exclude small between-
group differences in 2D:4D, future studies in ALS would 
be of about 200 male and female ALS and control subjects 
(ie, 800 subjects in all). In addition to direct experimenter 
measurements of finger lengths, it would be useful to 
photograph the hands under consistent conditions (eg, 
image size, lighting, camera–finger distance) and use 
a computer-based measurement tool on the images to 
assess inter-rater and test–retest reliability. However, 
undertaking such a large study in a single clinical setting 
would be difficult. As a rule of thumb, any study that is 
insufficiently powered to detect the known gender differ-
ences in 2D:4D is unlikely to be able to detect biologically 
significant 2D:4D differences between disease and control 
groups.
Other limitations of our study are: (1) in order for 
respondents to remain anonymous they had to self-report 
their ALS status. We could not therefore classify their types 
of ALS using El Escorial criteria or more recently suggested 
classification methods.28 However, self-reporting of ALS 
status has previously been found to be 94% accurate 
when compared with physicians’ responses.29 Indirect 
confirmation of an accurate ALS diagnosis is suggested 
by 88% of ALS respondents being able to choose their 
subtype of ALS via a multiple choice question (patients 
were encouraged to contact their physician if they were 
unsure of their subtype) and by 98% of ALS respondents 
completing the ALSFRS-R, which when completed online 
has been shown to compare well with clinical evaluation. 
(2) The results may be biased towards selecting people 
with early ALS, since people with advanced ALS are those 
who would be most likely to be unable to straighten their 
fingers for measurements. However, there is no evidence 
that the pathogenesis of ALS differs between the early 
and later stage of the disease, so this should not affect our 
conclusions. (3) Some people with ALS have cognitive 
deficits30 and so may not have been able to measure their 
fingers accurately. However, it is unlikely that anybody 
with a clinically significant cognitive deficit would have 
been able to complete the extensive online questionnaire.
Our results do not corroborate the findings of a previous 
study that suggested the 2D:4D is lower in patients with 
ALS than in controls.18 This study had modest numbers 
of participants, with 33 ALS males (70%) and 14 ALS 
females (30%), compared with 20 control males (32%) 
and 43 control females (68%). The combination of an 
excess of males (with gender-related 2D<4D) in the ALS 
group and an excess of females (with gender-related 
2D≥4D) in the control group could have led to a finding 
of a decreased mean 2D:4D in the ALS group, though 
raw results were not available to test this. The authors of 
this study acknowledge that insufficient numbers were 
available to look for 2D:4D gender differences.18 Our 
failure to replicate the results of this study are perhaps 
not surprising, given that it is androgen deficiency that 
affects motoneurons adversely,31 32 so androgen excess 
during development (which causes a low 2D:4D) would 
not a priori be expected to be a risk factor for later moto-
neuron loss.
A lower 2D:4D ratio is found in people who have 
athletic ability.3 33 Based on the previous report of a 
lower 2D:4D in ALS patients,18 it was hypothesised that 
the suspected association of physical activity with ALS 
is because people with ALS have a prenatal disposition 
to both ALS and athleticism due to exposure to higher 
prenatal testosterone, rather than the physical activity 
itself being responsible for the increased ALS risk.18 34 
Our finding of no lower 2D:4D in ALS makes this hypoth-
esis unlikely. Moreover, the evidence for physical activity 
as a risk factor for ALS has recently been questioned.35 
However, if further studies confirm this ALS–exercise 
link, other reasons for physical activity being associated 
with ALS need to be considered, such as those listed for 
football (soccer) players who have an increased risk of 
ALS, which include the use of toxic substances to improve 
performance, exposure to environmental toxins such 
as fertilisers or herbicides on playing fields or sport-re-
lated trauma.36 A further suggestion that has been put 
forward to explain an ALS–exercise link is that exercise 
increases transmission of circulating toxicants across the 
neuromuscular junction into motor axons, from where 
the toxicants travel to the motoneuron cell body by retro-
grade axonal transport and trigger the disease.37
Three future 2D:4D studies could be undertaken once 
more responses to international questionnaires such as 
ours are available. (1) A study using self-measured finger 
lengths has shown that the 2D:4D varies with ethnicity38 
(this would not have affected our results since our respon-
dents were mostly of European origin). In addition, 
2D:4Ds may be different within gene pools from people 
of the same ethnicity.39 Examination of ALS-related 
2D:4D differences in various ethnic groups and between 
different nations will be possible once more respondents 
from other ethnic groups and countries provide relevant 
finger length data. (2) The 2D:4D appears to be lower 
in people born in late autumn, possibly because of the 
effects of melatonin on fetal testosterone.40 This time of 
season overlaps with the same period (late summer to 
early winter) in which ALS birth rates have been reported 
to be increased.41 A future study on season/ALS/2D:4D 
interactions will be possible once sufficient data on these 
variables are collected. (3) Between-nation gender differ-
ences in 2D:4D have been described,42 so it would be of 
interest to gather sufficient numbers of ALS and control 
responses from different countries to be able to compare 
2D:4Ds between these countries.
In conclusion, our online case–control study found 
no differences between the 2D:4Ds of ALS and non-ALS 
respondents. The study does not therefore support the 
hypothesis that exposure to prenatal testosterone is a risk 
factor for ALS. If physical activity is confirmed to be a 
risk factor for ALS, reasons other than a low 2D:4D need 
to be sought to explain this association. Future studies 
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of ethnic, time-of-birth and multination subgroups 
may detect more nuanced relationships between ALS 
and 2D:4D when data from larger numbers of ALS and 
non-ALS respondents become available.
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Chapter 4: Are people with amyotrophic lateral sclerosis (ALS) 
particularly nice? An online international study of the Big Five 
personality factors 
 
An aspect of ALS that had been more in the realm of anecdote than scientifically studied is 
that ALS patients are generally considered “nice.” However, this had until now only been 
qualitatively assessed [1].  
The ALS Quest questionnaire included a personality inventory that could provide insight into 
the personality types of ALS patients. A comparison of the personalities of controls and ALS 
respondents, which were evaluated separately by gender, found that male ALS respondents 
had higher scores than male controls for Conscientiousness and Extraversion. Female ALS 
respondents had higher scores than female controls for Agreeableness, Conscientiousness, 
and Extraversion, and a lower score for Neuroticism.  
These findings, which are presented as a publication in this chapter, indicate that there are 
personality differences between ALS and control respondents. These differences could arise 
as a result of germline genetic variants, since personality can be considered to result partially 
from genetic factors [2].  
This study of personality of people with ALS also raises the possibility that personality 
contributes to some of the purported risk factors for ALS – for example, if people who get ALS 
are more extroverted, they may be more likely to smoke [3].  
These results were presented in a poster at the 28th International Symposium on ALS/MND in 
2017 (Appendix H). 
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Abstract
Background:	Many	people	with	ALS	have	been	suggested	to	have	a	“nice”	personal‐
ity,	but	most	ALS	personality	studies	to	date	have	had	 limited	numbers	of	partici‐
pants and have not taken into account personality differences between genders. We 
used	Big	Five	Inventory	data	obtained	from	an	online	questionnaire	looking	for	risk	
factors	for	ALS	to	investigate	personality	traits	in	large	numbers	of	people	with	ALS	
and controls.
Methods:	A	total	of	741	questionnaire	respondents	aged	40	years	and	over	indicated	
the	extent	to	which	they	agreed	with	each	of	the	44	Big	Five	Inventory	statements.	
Respondents	were	339	with	ALS	(212	male,	127	female)	who	responded	to	the	state‐
ments	as	they	applied	to	them	before	their	diagnosis	and	402	controls	(120	male,	282	
female).	Unpaired	t tests with 95% confidence intervals were used to compare mean 
values	of	Big	Five‐factor	scores.
Results: Female respondents taken together had higher mean scores for 
Agreeableness	and	Neuroticism	than	all	male	respondents.	Male	ALS	respondents	
had higher mean scores than male controls for Conscientiousness and Extraversion. 
Female	 ALS	 respondents	 had	 higher	 mean	 scores	 than	 female	 controls	 for	
Agreeableness,	 Conscientiousness,	 and	 Extraversion,	 and	 a	 lower	 score	 for	
Neuroticism.
Conclusions:	Many	people	with	ALS	have	personality	traits	that	are	likely	to	underlie	
the	 perception	 they	 are	 particularly	 “nice.”	 This	 raises	 the	 possibility	 that	 genetic	
polymorphisms	that	influence	personality	could	play	a	role	in	ALS.	Furthermore,	dif‐
ferent personality traits could underlie lifestyle choices that are currently thought to 
be	risk	factors	for	ALS.
K E Y W O R D S
amyotrophic	lateral	sclerosis,	Big	Five	Inventory,	case‐control	study,	international,	online	
questionnaire,	personality,	risk	factors
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1  | INTRODUC TION
People	with	amyotrophic	lateral	sclerosis	(ALS),	also	known	as	motor	
neuron	disease,	are	often	described	by	clinicians	as	having	a	partic‐
ularly	pleasant	personality,	which	could	be	interpreted	as	“niceness”	
(Mehl,	Jordan,	&	Zierz,	2017).	Interest	has	persisted	in	this	subject	
because of the possibility that a characteristic personality profile for 
ALS	could	give	clues	as	to	the	underlying	pathogenesis	of	the	disease	
(Brown	&	Mueller,	1970;	Grossman,	Levin,	&	Bradley,	2006;	Mehl	et	
al.,	2017).
The	previous	studies	of	personality	differences	in	ALS	go	back	
to	1947	when	ALS	patients	were	reported	to	have	a	“cheerful”	at‐
titude	 (Veit,	 1947).	 In	1970,	 a	 range	of	 psychological	 tests	 char‐
acterized	10	ALS	patients	as	having	“active	mastery”	and	“denial	
of	affect,”	with	the	conclusion	that	an	“association	of	ALS	with	a	
characteristic	personality	style,	if	confirmed,	might	have	etiologic	
and	prognostic	 implications”	 (Brown	&	Mueller,	1970).	 In	1977,	a	
study	of	40	ALS	patients,	 using	 a	 variety	of	psychological	 tests,	
was	 unable	 to	 find	 any	 of	 the	 denial	 of	 affect	 (Houpt,	Gould,	&	
Norris,	 1977)	 that	 had	 been	 reported	 in	 the	 1970	 study.	 It	 was	
suggested	that	small	numbers,	and	 issues	with	patient	selection,	
were	 the	 reasons	 for	 this	discrepancy.	The	next	ALS	personality	
study	 in	 1978	 found	 no	 differences	 in	 Minnesota	 Multiphasic	
Personality	Inventory	profiles	of	38	ALS	patients	compared	with	
a large number of medical patients without serious conditions 
(Peters,	Swenson,	&	Mulder,	1978).
A	different	 approach	was	 taken	 in	2006	when	49	 caregivers	
were	 asked	 to	 rate	 the	 premorbid	 personality	 traits	 of	 ALS	 pa‐
tients,	 compared	 to	 non‐ALS	 patients	 with	 chronic	 progressive	
conditions,	 using	 the	 NEO	 Five‐Factor	 Personality	 Inventory	
(Grossman	et	al.,	2006).	ALS	patients	were	rated	as	having	com‐
paratively	 lower	openness,	but	 the	other	 factors	of	neuroticism,	
extraversion,	agreeableness,	and	conscientiousness	did	not	differ	
between the two groups.
When	36	physicians	 assessed	 the	personality	of	 their	ALS	pa‐
tients	in	a	2017	study,	using	a	shortened	version	of	the	NEO	Five‐
Factor	Personality	Inventory,	agreeableness	was	rated	more	highly	
than	 that	 reported	by	physicians	caring	 for	patients	with	non‐ALS	
illnesses	(Mehl	et	al.,	2017).	This	supported	the	anecdotal	descrip‐
tion	of	people	with	ALS	as	being	“nice.”
In	 summary,	ALS	premorbid	personality	 studies	have	 to	date	
given mixed results. No systematic studies of premorbid person‐
ality	 in	 large	 numbers	 of	 people	 with	 ALS	 have	 been	 reported,	
and none has taken into account gender differences in person‐
ality. In an attempt to find out if certain personality types are 
more	 common	 in	 people	 with	 ALS,	 including	 those	 associated	
F I G U R E  1   Selection of individuals 
for analysis. The flowchart shows the 
final	dataset	of	741	respondents	after	
exclusion criteria were applied and final 
numbers	of	ALS	and	control	individuals
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with	 “niceness,”	 we	 used	 personality	 data	 generated	 by	 the	 Big	
Five	Inventory	(John,	Naumann,	&	Soto,	2008)	from	ALS	Quest,	an	
online	 international	questionnaire	designed	 to	 study	 risk	 factors	
for	ALS	(Parkin	Kullmann,	Hayes,	Wang,	&	Pamphlett,	2015).	The	
large	numbers	of	ALS	and	control	 respondents	 to	 this	question‐
naire enabled the study of personality factors in men and women 
separately.
2  | METHODS
2.1 | Setting
This	case–control	study	used	data	collected	between	January	2015	
and	 February	 2017	 from	 a	 multilingual	 web‐based	 questionnaire,	
ALS	Quest	(www.alsquest.org)	(Parkin	Kullmann	&	Pamphlett,	2017;	
Parkin	Kullmann	et	al.,	2015).	Respondents	were	recruited	via	world‐
wide	 national	 and	 state	ALS	Associations,	 national	 ALS	 registries,	
the	Internet,	and	social	media.	No	personally	identifying	data	were	
collected so respondents remained anonymous. Information on dis‐
ease status was self‐reported. Cases were respondents who stated 
“Yes,	I	have	been	diagnosed	with	ALS/MND.”	Controls	were	partici‐
pants	who	stated	“No,	I	have	not	been	diagnosed	with	ALS/MND.”
2.2 | Ethics, consent, and permissions
The	project	was	approved	by	the	Human	Ethics	Committee	of	the	
Sydney	 Local	 Health	 District.	 Participants	 consented	 to	 submit	
their	 questionnaire	 responses	 by	 clicking	 an	 “I	 consent”	 button	
after acknowledging that they had read the preceding Information 
for	Participants	section	of	the	questionnaire	and	agreeing	that	they	
“Understand	 that	 I	will	 not	be	 asked	 for	 any	personal	 information	
that	could	identify	me,	so	the	study	is	anonymous	and	strictly	con‐
fidential”	and	“Freely	choose	to	participate	in	the	study	and	under‐
stand	that	I	can	withdraw	my	questionnaire	answers	at	any	time	until	
I	click	the	Submit	button	at	the	end	of	the	questionnaire.”
ALS n (%) CONTROL n (%)
Country of birth United States 128	(38) Australia 248	(62)
Australia 83	(25) Other	(<2%	each) 67	(17)
Canada 48	(14) United States 38	(10)
Other	(<1%	each) 52	(15) United	Kingdom 24	(6)
United	Kingdom 17	(5) Spain 13	(3)
Spain 10	(3) South	Africa 10	(3)
Country of 
residence
United States 136	(40) Australia 305	(76)
Australia 103	(34) United States 44	(11)
Canada 56	(17) Other*	(<1%	
each)
28	(7)
Other*	(<1%	each) 34	(10) Spain 13	(3)
Spain 9	(3) Canada 5	(1)
New	Zealand 5	(1)
Ancestry Other	(<5%	each) 162	(49) Other	(<4%	each) 138	(35)
Australian 51	(15) Australian 115	(29)
English 51	(15) English 69	(17)
American 27	(8) Irish 37	(9)
Irish 21	(6) British 22	(6)
German 21	(6) Scottish 16	(4)
Cultural group Australian 87	(27) Australian 255	(64)
American 81	(25) Other	(<2%	each) 65	(16)
Other	(<2%	each) 79	(24) American 29	(7)
Canadian 39	(12) English 27	(7)
English 28	(9) Spanish 13	(3)
Spanish 10	(3) Dutch 8	(2)
Note.	Other*	countries	of	residence:	Argentina,	Belgium,	Brazil,	China,	Colombia,	Denmark,	Ecuador,	
Egypt,	Finland,	Germany,	 Iran,	 Ireland,	 Italy,	 Luxembourg,	Mexico,	Netherlands,	Portugal,	Russia,	
Slovakia,	South	Africa,	South	Korea,	Sweden,	Switzerland,	Turkey,	and	the	United	Kingdom.
ALS:	amyotrophic	lateral	sclerosis.
TA B L E  1   Demographic characteristics 
of respondents
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2.3 | The Big Five Inventory
The	Big	Five	Inventory	provides	scores	for	the	personality	factors	
of	 Agreeableness,	 Conscientiousness,	 Extraversion,	 Neuroticism,	
and	Openness	(John	et	al.,	2008).	These	are	calculated	from	a	set	of	
44	statements	about	personality.	Each	statement	is	rated	on	a	five‐
point	Likert	scale	ranging	from	strongly	disagree	to	strongly	agree.	
Descriptors	 for	 these	 factors	 by	 the	Big	Five	 Inventory	develop‐
ers	are	as	follows:	(a)	Agreeableness:	altruism,	tender	mindedness,	
trust,	and	modesty;	(b)	Conscientiousness:	thinking	before	acting,	
delaying	gratification,	following	norms	and	rules,	and	planning,	or‐
ganizing,	and	prioritizing	tasks;	(c)	Extraversion:	sociability,	activity,	
assertiveness,	 and	 positive	 emotionality;	 (d)	 Neuroticism:	 feeling	
anxious,	nervous,	 sad,	 and	 tense;	 and	 (e)	Openness:	 the	breadth,	
depth,	originality,	and	complexity	of	a	person’s	mental	and	expe‐
riential	 life.	 The	 Big	 Five	 Inventory	 statements	 were	 translated	
into	 the	 language	used	by	 the	 respondent	 to	complete	 the	ques‐
tionnaire.	People	with	ALS	were	asked	to	provide	responses	they	
would have given to the statements before	 their	diagnosis	of	ALS	
was made.
2.4 | Exclusion criteria
Respondents	were	excluded	from	analysis	(Figure	1)	if	they	did	not	
complete	 the	Big	Five	 Inventory,	 they	did	not	 supply	 their	 age,	or	
they	were	under	the	age	of	40	years.	The	latter	exclusion	was	to	limit	
the	number	of	control	respondents	who	might	later	develop	ALS	and	
to avoid differences in personality between younger and older indi‐
viduals	(Srivastava,	John,	Gosling,	&	Potter,	2003).
2.5 | Big five‐factor scores
A	mean	score,	ranging	from	1	to	5,	was	calculated	for	each	factor,	
with higher scores indicating a greater expression of the factor. 
Percentage	frequency	histograms	were	created	to	compare	the	dis‐
tributions	of	scores	between	ALS	respondents	and	controls.
2.6 | Clinical characteristics
People	with	ALS	were	asked	to	complete	the	online	version	of	the	
ALS	Functional	Rating	Scale‐Revised	that	has	been	designed	for	
self‐assessment	(Maier	et	al.,	2012;	Parkin	Kullmann	et	al.,	2015)	
to	assess	their	physical	state	at	the	time	of	taking	the	question‐
naire; scores were inverted from the standard scale so that the 
higher	the	score	the	more	impaired	the	function,	with	0	indicat‐
ing	no	impairment	and	48	indicating	very	severe	impairment.	This	
online	 self‐assessment	of	ALS	 severity	has	been	 shown	 to	have	
excellent agreement with face‐to‐face application of the rating 
scale	 (Maier	 et	 al.,	 2012).	 The	 disease	 duration	 at	 the	 time	 of	
completing	 the	questionnaire	was	 calculated	by	 subtracting	 the	
year of disease onset from the year of consenting to complete the 
questionnaire.
2.7 | Data analysis
Data	from	the	Qualtrics	server	were	transferred	to	GraphPad	Prism	
7	files.	F	tests	were	used	to	compare	variances	between	groups,	be‐
fore unpaired t tests with 95% confidence intervals were used to com‐
pare	mean	values	of	Big	Five	scores.	In	only	two	groups	(ALS	male	vs.	
female	for	Agreeableness	and	female	ALS	vs.	control	for	Openness)	
were	slight	differences	 in	variances	found,	but	when	these	analyses	
were	 repeated	using	nonparametric	Mann–Whitney	 tests,	 the	same	
F I G U R E  2  Mean	differences	(filled	circles)	and	95%	confidence	
intervals	(bars)	in	Big	Five	factors	in	males	and	females.	Graphs	for	
(a)	males	and	female	combined,	(b)	ALS	males	and	females,	and	 
(c)	control	males	and	females	show	the	differences	in	mean	scores	
between	groups.	For	example,	in	(a),	it	can	be	seen	that	women	
overall	scored	significantly	more	(i.e.,	the	95%	CI	bars	do	not	cross	
the	dotted	zero	line)	for	Agreeableness	than	men,	while	men	
tended to score more for Openness
-0.6 -0.4 -0.2 0.0 0.2 0.4 0.6
Openness
Neuroticism
Extraversion
Conscientiousness
Agreeableness
Male-Female: All (mean difference ± 95%CI)
-0.6 -0.4 -0.2 0.0 0.2 0.4 0.6
Openness
Neuroticism
Extraversion
Conscientiousness
Agreeableness
Male-Female: ALS (mean difference ± 95%CI)
-0.6 -0.4 -0.2 0.0 0.2 0.4 0.6
Openness
Neuroticism
Extraversion
Conscientiousness
Agreeableness
Male-Female: Control (mean difference ± 95%CI)
(a)
(b)
(c)
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results were found. Correlations between the personality scores and 
the	 ALSFRS‐R	 inverted	 scale	 and	 disease	 duration	 were	 measured	
with	 Spearman	 nonparametric	 r	 coefficients.	 Effect	 sizes	 (d)	 were	
calculated	using	G*Power	software.	Significance	was	assessed	at	the	
0.05 level.
Lucidchart	software	was	used	to	create	Figures	1	and	7.
3  | RESULTS
3.1 | Cases and controls
A	 total	 of	 741	 respondents	 were	 eligible	 for	 analysis	 after	 ex‐
clusion	 criteria	 were	 applied	 (Figure	 1).	 These	 comprised	 339	
ALS	 respondents	 (212	male	 and	 127	 female)	 and	 402	 non‐ALS	
controls	 (120	 male	 and	 282	 female).	 The	 mean	 age	 of	 ALS	 re‐
spondents	was	61.3	years	(SD:	9.3	years,	range:	40–84	years)	and	
of	controls	was	57.3	years	 (SD:	10.6	years,	 range:	40–89	years).	
Information	on	countries	of	birth	and	residence,	ancestries,	and	
cultural groups of respondents can be viewed in Table 1. The 
composition	 of	 the	 ALS	 and	 control	 groups	 was	 similar	 with	
regard	 to	 country	 of	 birth,	 country	 of	 residence,	 ancestry,	 and	
cultural	group.	The	majority	of	respondents	resided	in	Australia,	
the	USA,	and	Canada,	though	residents	of	a	further	27	countries	
supplied responses.
Sources	of	information	about	the	questionnaire	cited	by	respon‐
dents	were	as	follows:	ALS	Associations	 (36%),	the	Internet	 (22%),	
friends	(9%),	people	with	ALS	(7%),	health	professionals	(6%),	com‐
munity	 groups	 (5%),	 Facebook	 (4%),	 the	 USA	 CDC	 National	 ALS	
Registry	 (3%),	 the	Canadian	Neuromuscular	Disease	Registry	 (2%),	
and	ALS	researchers	(2%).
About	9%	of	ALS	respondents	had	at	least	one	relative	who	had	
been	diagnosed	with	ALS	and	were	classified	as	having	familial	ALS.	
The	other	91%	of	ALS	 respondents	were	classified	as	having	spo‐
radic	 (or	 isolated)	ALS.	As	 reported	by	 the	ALS	 respondents,	58%	
had	“classic”	 (upper	and	lower	motor	neuron	variant)	ALS,	9%	pro‐
gressive	muscular	atrophy	(lower	motor	neuron	variant),	8%	progres‐
sive	bulbar	palsy,	8%	primary	lateral	sclerosis	(upper	motor	variant),	
7%	“other,”	2%	ALS/FTD	(frontotemporal	dementia),	and	8%	did	not	
know	their	subtype	of	ALS.
When control participants were asked what their connection 
with	 ALS	 was,	 responses	 were	 (blood	 and	 nonblood)	 relatives	
(45%),	 spouses	 (10%),	 or	 friends	 (13%)	 of	 people	with	ALS,	 indi‐
viduals	from	community,	research,	or	medical	professional	groups	
(9%),	or	no	specific	(or	another	type	of)	connection	to	ALS/MND	
(23%).	When	controls	were	asked	to	identify	what	blood	relatives	
with	 ALS	 they	 had,	 58%	 reported	 no	 blood	 relatives	 with	 ALS,	
whereas	29%	had	one,	and	13%	more	 than	one,	blood	relative/s	
with	ALS.
TA B L E  2  Differences	in	Big	Five‐factor	scores	between	male	(control	n	=	120,	ALS	n	=	212)	and	female	(control	n	=	282,	ALS	n	=	127)	
respondents
Big Five factors Group
Big Five‐factor score 
mean (SD)
Big Five‐factor score mean 
difference (95% CI) p Value Effect size (d)
1.	Agreeableness Male control 3.71	(0.51)
−0.11	(−0.21	to	−0.01) 0.03 0.23
Female control 3.83	(0.46)
Male	ALS 3.83	(0.51)
−0.23	(−0.34	to	−0.13) <0.001 0.49
Female	ALS 4.06	(0.43)
2. Conscientiousness Male control 3.84	(0.52)
−0.04	(−0.15	to	0.08) 0.54
Female control 3.88	(0.51)
Male	ALS 3.97	(0.56)
−0.10	(−0.22	to	0.03) 0.12
Female	ALS 4.07	(0.53)
3. Extraversion Male control 3.10	(0.70)
−0.07	(−0.22	to	0.08) 0.36
Female control 3.17	(0.71)
Male	ALS 3.32	(0.70)
−0.19	(−0.35	to	−0.04) 0.02 0.27
Female	ALS 3.51	(0.71)
4.	Neuroticism Male control 2.60	(0.63)
−0.17	(−0.31	to	−0.03) 0.02 0.26
Female control 2.77	(0.64)
Male	ALS 2.52	(0.75)
−0.05	(−0.21	to	0.11) 0.54
Female	ALS 2.57	(0.69)
5. Openness Male control 3.52	(0.54)
0.05	(−0.07	to	0.16) 0.40
Female control 3.47	(0.53)
Male	ALS 3.57	(0.56)
0.09	(−0.04	to	0.22) 0.18
Female	ALS 3.48	(0.62)
Note.	ALS:	amyotrophic	lateral	sclerosis;	SD: standard deviation; CI: confidence interval.
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3.2 | Big Five‐factor mean scores
3.2.1 | Male versus female differences
When	 all	 men	 and	 all	 women	 were	 compared,	 women	 scored	
higher	 than	 men	 for	 Agreeableness	 and	 Neuroticism	 (Figure	 2a).	
No significant differences were seen between men and women for 
Extraversion,	Conscientiousness,	or	Openness.
ALS	 females	 scored	 higher	 than	 ALS	males	 for	 Agreeableness	
(effect	size	d	=	0.49)	and	Extraversion	(d	=	0.27)	(Figure	2b,	Table	2).	
No significant differences were found between these two groups for 
Conscientiousness,	Openness,	or	Neuroticism.
Control females scored higher than control males for 
Agreeableness	 (d	=	0.23)	 and	 Neuroticism	 (d	=	0.26)	 (Figure	 2c,	
Table	2).	No	significant	differences	were	found	between	these	two	
groups	for	Conscientiousness,	Openness,	or	Extraversion.
3.2.2 | ALS versus control differences
When	 all	 ALS	 respondents	 were	 compared	 to	 all	 controls,	 ALS	
respondents	 scored	 higher	 than	 controls	 for	 Agreeableness,	
Conscientiousness,	 and	 Extraversion,	 and	 lower	 than	 controls	 for	
Neuroticism	(Figure	3a,	Table	3).	No	significant	difference	was	seen	
in Openness.
Male	 ALS	 respondents	 scored	 higher	 than	 male	 controls	
for	 Extraversion	 (d	=	0.31)	 and	 Conscientiousness	 (d	=	0.24)	
(Figure	 3b,	 Table	 3).	 No	 significant	 differences	 were	 found	 for	
Openness,	Neuroticism,	or	Agreeableness.
Female	 ALS	 respondents	 scored	 higher	 than	 female	 controls	
for	 Agreeableness	 (d	=	0.54),	 Conscientiousness	 (d	=	0.24),	 and	
Extraversion	 (d	=	0.48),	 and	 lower	 than	 controls	 for	 Neuroticism	
(d	=	0.30)	(Figure	3c,	Table	3).	No	significant	differences	were	found	
for Openness.
No significant differences in mean scores were seen when the 
91%	of	 sporadic	ALS	 respondents	were	compared	with	 the	9%	of	
familial	ALS	respondents	(data	not	shown).
3.3 | Correlation of Big Five‐factor scores with ALS 
functional state and duration
Most	ALS	respondents	had	only	mild	or	moderate	loss	of	function	
as	measured	by	 the	ALSFRS‐R	 inverted	score	 (Figure	4a);	 the	me‐
dian	ALSFRS‐R	 inverted	score	was	14.	Most	responded	within	the	
first	 four	years	after	 their	ALS	disease	onset,	with	a	 long	tail	con‐
taining	 a	 few	 long‐term	 survivors	 (Figure	 4b);	 the	median	 disease	
duration was 3 years. Correlation coefficients between the person‐
ality	 factors	 of	 Agreeableness,	 Conscientiousness,	 Extraversion,	
Neuroticism,	 Openness,	 and	 the	 ALSFRS‐S	 inverted	 scores	 were	
low	 (respectively,	 r	=	−0.03,	0.06,	0.02,	0.02,	 and	0.08,	 all	 nonsig‐
nificant),	with	similar	low	personality	score	correlations	with	disease	
duration	(respectively,	r	=	0.06,	0.00,	0.10,	0.01,	and	0.03,	all	nonsig‐
nificant).	The	ALSFRS‐R	inverted	score	correlated	significantly	with	
disease	duration	(r	=	0.31,	p	<	0.001).
3.4 | Big Five‐factor frequency distributions: ALS 
versus controls
Frequency	percentage	histograms	showed	overlap	in	Big	Five	scores	
between	ALS	respondents	and	controls,	both	for	men	(Figure	5)	and	
women	(Figure	6),	but	with	shifts	 in	some	ALS	distributions	to	the	
right or left in line with the mean score results.
F I G U R E  3  Mean	differences	(filled	circles)	and	95%	confidence	
intervals	(bars)	in	Big	Five	factors	in	ALS	respondents	and	controls.	
Graphs	for	(a)	males	and	female	combined,	(b)	ALS	males	and	
controls,	and	(c)	ALS	females	and	controls	show	differences	
in	mean	scores.	For	example,	in	(a),	it	can	be	seen	that	ALS	
respondents	overall	scored	significantly	more	for	Agreeableness,	
Conscientiousness,	and	Extraversion,	less	for	Neuroticism,	and	
similarly for Openness
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4  | DISCUSSION
We sought first to find out whether personality differences existed 
between our men and women respondents. Women scored higher 
than	men	for	Agreeableness	and	Neuroticism,	as	has	been	reported	
in	other	studies	(Weisberg,	Deyoung,	&	Hirsh,	2011),	so	to	compare	
ALS	and	control	individuals,	we	analyzed	male	and	female	respond‐
ents	 separately.	 The	 mean	 Big	 Five	 scores	 for	 ALS	 males	 were	
higher	 for	 Extraversion	 and	Conscientiousness.	 For	ALS	 females,	
the	scores	were	higher	for	Agreeableness,	Conscientiousness,	and	
Extraversion,	 and	 lower	 for	 Neuroticism.	 These	 particular	 ALS	
traits	 taken	 together	 would	 accord	 with	 many	 people’s	 concept	
of	 what	 constitutes	 “niceness.”	 For	 example,	 the	 Oxford	 English	
Dictionary	provides	the	following	synonyms	for	“nice”	when	refer‐
ring	to	a	person:	“pleasant,	likeable,	agreeable,	personable,	charm‐
ing,	 delightful,	 amiable,	 affable,	 friendly,	 kindly,	 genial,	 congenial,	
good‐natured,	 engaging,	 gracious,	 sympathetic,	 understanding,	
compassionate,	 good”	 (https://en.oxforddictionaries.com/defini‐
tion/nice).	 Several	 descriptors	 in	 this	 list	 could	 be	 applied	 to	 our	
findings	 in	 ALS	 of	 increased	 Agreeableness,	 Extraversion,	 and	
Conscientiousness,	 as	well	 as	 decreased	Neuroticism.	These	per‐
sonality	traits	could	therefore	underlie	the	widespread	perception,	
in	particular	among	treating	physicians,	 that	people	with	ALS	are	
unusually	pleasant,	even	in	the	face	of	a	devastating	disease	(Mehl	
et	al.,	2017).
None	 of	 the	 Big	 Five	 scores	 for	 ALS	 respondents	 correlated	
significantly	with	 the	ALS	 Functional	 Rating	 Scale	 scores,	 indicat‐
ing	that	disease	severity	at	the	time	of	taking	the	questionnaire	did	
not influence their recall of items used to measure the personality 
factors.	Similarly,	no	correlation	was	found	between	any	of	the	Big	
Five	scores	and	disease	duration,	indicating	that	time	elapsed	after	
disease onset did not affect the reporting of premorbid personality 
scores.
The	 fact	 that	 ALS	 individuals	 in	 this	 study	 were	 more	
likely	 than	 people	 without	 ALS	 to	 have	 higher	 Agreeableness,	
Conscientiousness,	 and	 Extraversion,	 and	 lower	Neuroticism,	may	
have implications for the pathogenesis of the disease. Personality 
has	a	major	genetic	component	 (Vukasovic	&	Bratko,	2015),	and	 it	
has been suggested that the same genetic factors that give rise to 
personality	could	predispose	people	to	developing	ALS	 (Grossman	
et	 al.,	 2006).	 Increasing	 numbers	 of	 studies	 have	 linked	 individual	
personality	traits	(in	particular	extraversion,	which	was	strongly	as‐
sociated	with	ALS	in	the	present	study)	with	genomic	loci	(Lo	et	al.,	
2017).	It	may	therefore	be	worthwhile	examining	the	frequency	of	
polymorphisms in these loci in the large genomic databases of peo‐
ple	with	and	without	ALS	that	are	now	available.
One	possible	link	between	personality	traits	and	ALS	is	that	the	
premorbid	 personality	 differences	 seen	 in	 people	with	 ALS	 could	
lead to behaviors that are reported to be risk factors for the dis‐
ease	(Figure	7).	Connections	between	personality	traits	and	ALS	risk	
TA B L E  3  Differences	in	Big	Five‐factor	scores	between	ALS	(male	n	=	212,	female	n	=	127)	and	control	(male	n	=	120,	female	n	=	282)	
respondents
Big Five factors Group Big Five‐factor score 
mean (SD)
Big Five‐factor score mean 
difference (95% CI)
p Value Effect 
size (d)
1.	Agreeableness Male control 3.71	(0.50)
−0.11	(−0.23	to	0.002) 0.06
Male	ALS 3.83	(0.51)
Female control 3.83	(0.46)
−0.23	(−0.33	to	−0.14) <0.001 0.54
Female	ALS 4.06	(0.43)
2. Conscientiousness Male control 3.84	(0.52)
−0.13	(−0.25	to	−0.009) 0.04 0.24
Male	ALS 3.97	(0.56)
Female control 3.88	(0.51)
−0.19	(−0.30	to	−0.08) 0.001 0.38
Female	ALS 4.07	(0.53)
3. Extraversion Male control 3.10	(0.70)
−0.22	(−0.37	to	−0.06) 0.007 0.31
Male	ALS 3.32	(0.70)
Female control 3.17	(0.71)
−0.34	(−0.49	to	−0.19) <0.001 0.48
Female	ALS 3.51	(0.71)
4.	Neuroticism Male control 2.60	(0.67)
0.08	(−0.08	to	0.25) 0.32
Male	ALS 2.52	(0.75)
Female control 2.77	(0.64)
0.20	(0.06	to	0.34) 0.005 0.30
Female	ALS 2.57	(0.69)
5. Openness Male control 3.52	(0.54)
−0.05	(−0.18	to	0.07) 0.39
Male	ALS 3.57	(0.56)
Female control 3.47	(0.53)
−0.01	(−0.13	to	0.10) 0.82
Female	ALS 3.48	(0.62)
Note.	ALS:	amyotrophic	lateral	sclerosis;	SD: standard deviation; CI: confidence interval.
8 of 12  |     PARKIN KULLMANN et AL.
factors	could,	for	example,	exist	between	extraversion‐linked	smok‐
ing	(Buczkowski	et	al.,	2017),	a	reported	risk	factor	for	ALS	(Armon,	
2009);	 extraversion‐linked	 risk‐taking	 behavior	 (Levenson,	 1990),	
which could lead to the increased numbers of head injuries reported 
in	 ALS	 (Schmidt,	 Kwee,	 Allen,	 &	 Oddone,	 2010);	 conscientious‐
ness‐linked	 physical	 exercise	 (Malinauskas,	Dumciene,	Mamkus,	&	
Venckunas,	2014),	another	suggested	risk	factor	for	ALS	(Beghi	et	al.,	
2010);	conscientiousness‐linked	low	alcohol	intake	(Lunn,	Nowson,	
Worsley,	&	Torres,	2014),	which	is	associated	with	ALS	(de	Jong	et	
al.,	2012);	conscientiousness‐linked	adherence	to	dietary	advice	on	
increased	fish	intake	(Lunn	et	al.,	2014),	which	may	be	a	risk	factor	
for	ALS	due	to	mercury	ingestion	(Andrew	et	al.,	2018);	and	either	
conscientiousness,	 openness,	 neuroticism,	 or	 agreeableness	 all	 of	
which	 can	 influence	 choice	of	 occupation	 (Zhao	&	Seibert,	 2006),	
since	 certain	occupations	have	been	associated	with	ALS	 (Sutedja	
et	al.,	2009).	These	potential	 links	 imply	 that	some	of	 the	 lifestyle	
habits	and	choices	thought	to	be	risk	factors	for	ALS	may	not	be	risk	
factors	per	 se,	 but	 rather	 the	 consequence	of	 an	underlying,	 sub‐
stantially	genetically	determined,	personality	type.
Results	of	ALS	risk	factor	studies	often	vary	between	different	
countries.	For	example,	smoking	 is	reported	to	be	an	ALS	risk	fac‐
tor	 in	some	countries	 (Armon,	2009),	but	not	 in	others	 (Pamphlett	
&	Ward,	2012).	The	same	is	true	for	exercise,	with	variable	results	
between	countries	(Lacorte	et	al.,	2016).	This	puzzling	feature	may	
be	 related	 to	personality,	 since	 large	variations	 in	personality,	par‐
ticularly	in	conscientiousness	and	neuroticism,	have	been	described	
across	ten	world	regions	(Schmitt	et	al.,	2007).	This	means	that	peo‐
ple in different parts of the world may be predisposed to expose 
themselves	to	dissimilar	risk	factors.	For	example,	populations	hav‐
ing higher levels of conscientiousness might be less likely to smoke 
and those with lower conscientiousness more likely to smoke. We do 
not yet have sufficient numbers of respondents from different coun‐
tries to investigate the effects of nation‐specific personality types 
on	ALS,	but	we	plan	to	do	so	when	we	obtain	more	questionnaire	
respondents in this ongoing project.
The	limitations	of	online	questionnaires	in	the	investigation	of	
ALS	risk	factors	have	recently	been	summarized	(Parkin	Kullmann	
&	Pamphlett,	2017).	Limitations	specific	to	the	present	study	are	
as	 follows:	 (a)	 ALS	 respondents	 were	 asked	 to	 remember	 their	
personality aspects that applied to them before they were diag‐
nosed.	This	is,	however,	of	less	concern	in	a	disease	like	ALS	which	
usually	has	a	short	course	(as	shown	by	the	median	disease	dura‐
tion	of	3	years	 in	 the	present	study),	 than	 in	disorders	with	 long	
courses	 such	 as	multiple	 sclerosis,	where	 people	would	 need	 to	
recall	these	aspects	many	years	after	diagnosis.	(b)	A	potential	lim‐
itation	is	that	people	with	a	particular	personality	type,	especially	
those	with	high	conscientiousness,	are	more	likely	to	complete	a	
detailed	 questionnaire.	 This	would,	 however,	 apply	 to	 both	 ALS	
respondents and controls and should not therefore affect the 
comparative	 results.	 (c)	 Our	 ALS	 respondents	 provided	 a	 ques‐
tionnaire	response	at	only	one	time	point	in	their	disease	course,	
so we are not able to determine whether premorbid personality 
had an effect on the rate of disease progress or the total dura‐
tion	of	disease	until	death.	However,	others	have	studied	the	ef‐
fects	of	post‐ALS	onset	psychological	factors	and	disease	course	
(Krampe	 et	 al.,	 2008;	 van	 Groenestijn,	 Kruitwagen‐van	 Reenen,	
Visser‐Meily,	 Berg,	 &	 Schroder,	 2016).	 (d)	 People	with	 ALS‐FTD	
are	often	prone	to	disinhibited	behavior,	which	might	be	regarded	
as	 extraversion.	 However,	 only	 2%	 of	 our	 ALS	 respondents	 re‐
ported	 being	 diagnosed	 with	 ALS‐FTD,	 so	 the	 inclusion	 of	 this	
group is unlikely to have had a significant effect on the overall 
results.	Furthermore,	it	is	unlikely	that	respondents	with	moderate	
or severe dementia would be capable of completing the detailed 
questionnaire.	(e)	Numbers	of	respondents	in	the	nonclassical	ALS	
subgroups	 (progressive	muscular	 atrophy,	 primary	 lateral	 sclero‐
sis,	progressive	bulbar	palsy,	and	ALS/FTD)	were	too	small,	when	
separated	 by	 gender,	 to	 assess	 whether	 personality	 differences	
were	 statistically	 different	 in	 these	 individual	 subgroups.	 (f)	We	
have	no	way	of	telling	if	some	people	with	ALS,	most	likely	due	to	
F I G U R E  4  ALS	functional	state	and	duration.	(a)	Most	ALS	
respondents were in the mild or moderate functional impairment 
range	(on	the	left	side	of	the	histogram)	as	measured	by	the	
ALS	Functional	Rating	Scale	(ALSFRS‐R)	inverted	score.	A	few	
respondents	(on	the	right	side	of	the	histogram)	were	severely	
affected.	(b)	The	majority	of	ALS	respondents	replied	to	the	
questionnaire	within	the	first	four	years	after	disease	onset	(on	the	
left	side	of	the	histogram),	though	a	few	long‐term	survivors	also	
completed	the	questionnaire	(on	the	right	side	of	the	histogram)
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muscle	weakness,	needed	help	from	another	person	to	complete	
the	questionnaire.	The	questionnaire	format	was	compatible	with	
computer	assistive	technologies	such	as	voice‐activated	systems,	
but some people with bulbar weakness would not have been able 
to	use	this.	We	think,	however,	that	having	help	to	complete	the	
questionnaire	would	not	affect	the	results.	(g)	There	is	a	possibility	
that	non‐ALS	controls	over	the	age	of	40	years	could	develop	ALS	
later.	However,	ALS	is	a	relatively	uncommon	disorder,	with	a	life‐
time	risk	of	about	1:350	for	men	and	1:400	for	women	(Van	Es	et	
al.,	2017),	so	since	we	had	120	male	and	282	female	controls,	only	
one	of	our	 controls	 in	 total	 is	 likely	 to	develop	ALS	during	 their	
lifetime,	which	would	not	affect	the	results.
In	conclusion,	people	with	ALS	appear	more	likely	than	controls	to	
have	personality	traits	that	can	be	considered	to	represent	“niceness.”	
F I G U R E  5  Percentage	frequency	distributions	of	male	ALS	and	control	individuals.	The	two	distributions	overlap,	but	male	ALS	
distributions	are	shifted	to	the	right	for	Agreeableness,	Conscientiousness,	and	Extraversion,	and	slightly	to	the	left	for	Neuroticism
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Possibilities that need to be considered are whether personality dif‐
ferences	in	ALS	influence	lifestyle	choices	(and	therefore	disease	risk	
factors)	and	whether	genetic	variants	 influencing	personality	could	
be	associated	with	ALS	itself.	To	take	into	account	the	influence	of	
personality	on	lifestyle	choices,	we	recommend	that	personality	test‐
ing	be	included	in	future	investigations	of	risk	factors	for	ALS.
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Chapter 5: Is psychological stress a predisposing factor for 
amyotrophic lateral sclerosis (ALS)? An online international 
case-control study of premorbid life events, occupational 
stress, resilience and anxiety 
 
Another novel risk factor that was investigated as part of this project was how psychological 
stress might be related to ALS. Interest in this factor arose due to i) a potential increased 
uptake of toxins due to exposure to stress [1], ii) a possible link between the biological effects 
of stress and the mechanism by which ALS develops [2], and iii) the anecdotal reporting from 
ALS patients of stress as a contributing cause of their disease.  
A link between stress and ALS has never been systematically explored. Only one study has 
looked at stress in ALS, and that was in a cursory fashion [3]. Therefore, there was a need for 
a robust analysis of the relationship of stressful life events with ALS.  
To evaluate stress and its role in ALS, the questionnaire included an inventory of stressful life 
events – a modified version of the Social Readjustment Rating Scale [4] – which indicated the 
lifetime stress experienced by respondents. The study also assessed whether resilience or 
anxiety affected the levels of stress experienced by respondents.  
The results in the publication in this chapter indicate that the levels of stress experienced by 
ALS respondents were not higher those experienced by controls. In fact, some controls had 
higher exposure to stress than people with ALS. Furthermore, ALS patients had higher 
resilience, indicating the potential for a better response to stress when it did occur. Therefore, 
this study does not support stress as a risk factor for ALS. 
These results were presented in a platform presentation at the 29th International Symposium 
on ALS/MND in 2018 (Appendix I). 
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Abstract
Psychological stress has been suggested to be relevant to the pathogenesis of neurodegen-
erative disorders, possibly via the generation of oxygen free radicals. We therefore sought
to determine whether people with amyotrophic lateral sclerosis (ALS) had been subjected to
more potentially stressful life events or occupations than controls, and whether they had dif-
ferences in resilience or trait anxiety that would moderate their responses to these stressors.
An online anonymous multilingual questionnaire was used to collect data on significant life
events from people with and without ALS, using items from a modified Social Readjustment
Rating Scale and from self-described significant events, which were combined to create a
Life Events Inventory. Inventory scores were subdivided into 0–20 years and 21–40 years
age ranges, and for the preceding 2, 5 and 10 years. Respondents also rated levels of stress
experienced during different occupations. Resilience was measured using the Connor-
Davidson Resilience Scale, and trait anxiety with a modified Geriatric Anxiety Inventory.
Scores were compared using nonparametric statistics. Data from 400 ALS (251 male, 149
female) and 450 control (130 male, 320 female) respondents aged 40 years and over
showed that Life Events Inventory scores were similar in male ALS respondents and con-
trols, but lower in female ALS respondents than female controls for the preceding 5-year
and 10-year periods. Occupational stress did not differ between ALS respondents and con-
trols. Both male and female ALS respondents had higher resilience scores than controls.
Anxiety scores did not differ between ALS and control groups. In conclusion, people with
ALS reported no raised levels of potentially stressful premorbid life events or occupational
stress, and did not have reduced levels of resilience, or increased levels of anxiety, that
would augment the deleterious effects of stressors. On the contrary, ALS respondents had
higher resilience than controls, though this conclusion relies on ALS respondents recalling
their premorbid status. These results do not support the hypothesis that psychological stress
from significant life events or occupational stress plays a role in the pathogenesis of ALS.
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Introduction
Stress can be defined as the response of an organism to stressors such as changes in a work sit-
uation, a death in the family, or moving house [1,2]. Stress experienced as the result of an
external stressor can be irrespective of its perceived negativity or positivity; for example, mar-
riage and divorce are two of the most impactful stressors [3]. The primary filter for under-
standing and responding to stressors is the brain, which first processes the stressor and then
creates a response (ie, the stress), which can include adaptive physiological or psychological
changes to the individual [4]. Physiological components of the response include increased oxi-
dative stress, which can lead to tissue damage in a chronically-stressed individual [5,6].
Stress has been proposed as a risk factor for a number of neurological diseases. For example,
stressful life events appear to be more frequent in people with multiple sclerosis [7,8] and
stressful life events that compromise the immune system may be associated with the onset of
multiple sclerosis [9]. Midlife psychological stress may be a risk factor for the development of
Alzheimer disease and other form of dementia [10]. Chronic restraint stress in rodents triggers
dopaminergic and noradrenergic degeneration, a pattern of cell loss that is characteristic of
Parkinson disease [11]. Overall, however, there is not a strong body of human evidence to sup-
port the concept of psychological stress being a trigger factor for these common neurological
diseases.
In amyotrophic lateral sclerosis (ALS, also known as motor neuron disease) stressors could
increase the uptake of neurotoxins, such as mercury, into a stress-activated locus ceruleus,
with a subsequent decrease in noradrenaline output to the brain and spinal cord [12]. Another
possible connection between stress and ALS is reduced telomerase activity and telomere short-
ening due to stress in early life [13]. Only one study has looked for links between premorbid
psychological stress and ALS. In this study, either low or high self-reported stress was consid-
ered in combination with personality type (A or B) and factors that might increase oxidative
stress (eg, physical activity and smoking), as well as those that might reduce oxidative stress
(eg, consumption of vegetables) [14]. Findings were that high stress, a type A personality, and
physical activity were present more often in people with ALS. However, this study did not use
any standard measurements of stress or personality, and results were not compared between
genders [15].
In an attempt to determine whether people with ALS have been subjected to more signifi-
cant life events (and therefore more potential stressors) or workplace stressors than controls,
and whether they have different levels of resilience or anxiety that could affect their responses
to these stressors [16], we asked ALS and non-ALS participants to complete a web-based ques-
tionnaire with items designed to measure the occurrence of significant life events, occupational
stress, and levels of resilience and anxiety.
Methods
Setting
This case-control study used data collected between January 2015 and September 2017 from a
multilingual web-based questionnaire, ALS Quest [17]. The questionnaire, which uses Qual-
trics survey software, can be viewed at www.alsquest.org. Respondents for the questionnaire
were recruited via worldwide national and state ALS Associations, national ALS registries, the
Internet and social media. No personally-identifying data were collected so respondents
remained anonymous. Information on disease status was self-reported. Cases were respon-
dents who stated ’Yes, I have been diagnosed with ALS/MND.’ Controls were participants who
stated ’No, I have not been diagnosed with ALS/MND.’
Is psychological stress a risk factor for amyotrophic lateral sclerosis?
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Online consent
Participants consented to submit their questionnaire responses for inclusion in the study by
clicking an ’I consent’ button, after agreeing that ’I: 1. Acknowledge that I have read the Infor-
mation for Participants above and agree to participate in the research, 2. Understand that I will
not be asked for any personal information that could identify me, so the study is anonymous
and strictly confidential, and 3. Freely choose to participate in the study and understand that I
can withdraw my questionnaire answers at any time until I click the Submit button at the end
of the questionnaire.’
Ethics
The project, ’ALS-Quest: An online questionnaire for research into amyotrophic lateral sclero-
sis’ (X14-357), was approved by the Human Ethics Committee of the Sydney Local Health Dis-
trict (RPAH Zone).
Overview of model to estimate lifetime psychological stress
To estimate lifetime psychological stress, we devised a method to first identify significant life
events that could give rise to stress, as well as occupational stress, and then to measure person-
ality factors that could either reduce or increase the amount of stress induced (Fig 1).
Life events
Pre-defined life events: Modified Social Readjustment Rating Scale (mSRRS). The
1967 SRRS list consists of 43 events, ranging in severity from ’death of a spouse’ (rated as 100)
to ’minor violations of the law’ (rated as 11) [3], and is the most widely used instrument for the
Fig 1. Method to estimate lifetime psychological stress. Lifetime stressors can arise from potentially-stressful significant life events, identified either from a
pre-determined list or by those described by respondents, and self-reported occupational stress. A high level of resilience would tend to reduce the amount of
psychological stress induced by these stressors, whereas high levels of anxiety would tend to increase psychological stress. CDRS: Connor-Davidson Resilience
Scale, mGAI: modified Geriatric Anxiety Inventory, mSRRS: modified Social Readjustment Rating Scale.
https://doi.org/10.1371/journal.pone.0204424.g001
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measurement of a person’s experience of psychological stress [18]. To develop the ratings in
the SRRS, respondents are asked to score events based on the amount of ’social readjustment’
required per event, judging by their experience and the experiences of people they knew, irre-
spective of the age at which the event occurred and the number of times it occurred. Use of the
SRRS for measuring stress has been criticised on some grounds, including the fact that a par-
ticular event, eg, marriage, could be either stressful or enjoyable. However, stress experienced
as the result of an external stressor can be irrespective of its perceived negativity or positivity
[3]. Nevertheless, a number of modifying variables have been sought that could moderate the
capacity of a significant life event to cause stress, such as asking respondents to rate the desir-
ability of each item [18,19]. We did not ask our respondents to do this, because this would
introduce an unacceptable level of subjectivity to the responses since respondents would have
to try to remember their feelings about events throughout their lives, and not only in the last
12 months as is usual for studies using the SRRS.
Having pre-defined events as a measure of stress enables our method to be compared with
those in other neurological disorders such as multiple sclerosis where stress has been impli-
cated as a disease trigger [9]. Therefore, to provide an objective measure of stress, we did not
exclude events (except a few noted below) and we did not adjust or weight our results [18].
Instead, we modified the SRRS by: (1) omitting items used to assess stress in the preceding
year only (ie, ’Revision of Personal Habits,’ ’Vacation,’ and ’Christmas’), (2) allowing respon-
dents to report up to five occurrences of each significant event, and to select their age when
each event occurred, (3) Separating the results for men and women, since there are gender dif-
ferences in the incidence of ALS [20], occupational choices, types of significant life events [21]
and stress and coping styles [15], and (4) Updating monetary amounts quoted in the mSRRS
to 2014 values, based on the inflation rate in the United States of America since 1967 (http://
www.usinflationcalculator.com/).
Self-described events. Respondents were invited to list up to five significant events, not
covered in the mSRRS, that had occurred in their lives, and the age at each occurrence. These
events were scored as 36 points, the average score of the mSRRS events.
The scores from the mSRRS items and the Self-Described Events were added to give a Life
Events Inventory (ie, potential life event stressors) score. ALS respondents were asked to
include only events occuring before their age of diagnosis. For controls, all events were
included. For example, a 62 year-old ALS respondent, diagnosed when 58 years old, who had
selected the three mSRRS items ’I got married’ (50 points) when 33 years old, ’I changed to a
different occupation’ when 42 years and 51 years old (each 36 points), and ’My sleeping habits
changed significantly’ (16 points) when 60 years old, and three Self-Described Events at ages
23, 46 and 50 years (36 points per event), would have a Life Events Inventory score of 230, ie,
50+36+36+(36x3). Note that this calculated total excludes the event that occurred at age 60
years because this was after the age at which ALS was diagnosed.
Life Events Inventory scores were calculated for all events, as well as for events occurring
during the timespans of 0–20 years and 21–40 years, and for events that had occurred during
the previous 2, 5 and 10 years before ALS diagnosis. The 2-year time period before diagnosis
was chosen to assess whether stressors occurring a short time before the onset of ALS could
trigger the disease. The average period of time from clinical onset of ALS to the time a neurolo-
gist makes the diagnosis (the diagnostic delay) is close to one year [22]. An ALS respondent
would therefore have to report any life events that had occurred two years before diagnosis to
ensure that the one year of pre-disease-onset events were included. Control respondents were
also asked to report events in the same 2-year period, to ensure consistency between groups as
regards the recall of events.
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Occupational stress
Respondents were asked to document all occupations they had held for six months or longer,
and to report the level of stress associated with each. Answers were rated as 0 for none, 1 for
mild, 2 for moderate and 3 for severe stress. Scores were multiplied by the number of years
worked in each occupation, summed, and divided by the total number of years in the occupa-
tions to estimate overall occupational stress. For example, a person who had worked at a mildly
stressful occupation for 30 years and a moderately stressful occupation for 10 years would have
a score of 1.25, ie, [(30x1) + (10x2)]/40.
Resilience
The Connor-Davidson Resilience Scale (CDRS) consists of 25 statements which respondents
rated on a 5-point scale from ’strongly disagree’ to ’strongly agree’ [23]. Answers were scored
from 0 to 4 to create a total score that ranged from 0 to 100, with higher numbers denoting
greater resilience. People with ALS were asked to provide responses they would have given to
the statements before their ALS diagnosis.
Anxiety. The original Geriatric Anxiety Inventory consists of 20 statements asking how
respondents felt (eg, ’I worry a lot of the time’) in the month before completing the Inventory,
and scored as Yes (1) or No (0) to give a score ranging than 0 to 20, with lower numbers indi-
cating a lower level of anxiety [24]. The Geriatric Anxiety Inventory was modified for this proj-
ect by asking respondents to rate each statement on a 5-point scale from ’strongly disagree’
(scored as 0) to ’strongly agree’ (scored as 4), giving a final score that ranged from 0 to 80. ALS
respondents provided responses they would have given to the modified Geriatric Anxiety
Inventory (mGAI) statements in a typical month before their ALS diagnosis.
Exclusion criteria
Respondents were excluded from analysis (Fig 2) if they did not complete at least one of the
inventories (Life Events Inventory, CDRS, or mGAI), they did not supply their age, or they
were under the age of 40 years at the time of completing the questionnaire; the latter was to
limit the number of control respondents who might later develop ALS, and to limit different
life event perceptions and frequencies between younger and older individuals [25].
Data analysis
Data from the Qualtrics server were transferred to GraphPad Prism 7 files. Some variables
were not normally distributed so non-parametric Mann-Whitney U tests were used to com-
pare two groups. Non-parametric effect sizes (r) were calculated as z/sqrt(N). Significance was
assessed at the 0.05 level.
Results
Cases and controls
850 respondents remained after exclusion criteria were applied (Fig 2). These comprised 400
ALS respondents (251 male, 149 female) and 450 non-ALS controls (130 male, 320 female).
The mean age of ALS respondents (male and female combined) was 61.5 years (SD 9.2 years,
range 40–87 years) and of controls was 57.3 years (SD 10.5 years, range 40–89 years), a signifi-
cant difference. Male ALS respondents (mean age 62.0 years) and male controls (mean age
61.8 years) did not differ significantly in age. Female ALS respondents (mean age 60.7 years)
were significantly older than female controls (mean age 55.5 years).
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Common sources of information about the questionnaire cited by respondents were: ALS
Associations (39%), the Internet (21%), friends (9%), ALS patients (6%), the USA CDC
National ALS Registry (5%), health professionals (5%), community groups (4%), Facebook
(4%), the Canadian Neuromuscular Disease Registry (2%), and ALS researchers (2%).
The composition of ALS and control groups was similar with regards to country of birth,
country of residence, ancestry and cultural group (Table 1). The majority of respondents resided
in Australia, the USA and Canada, though residents of a further 29 countries supplied responses.
Clinical characteristics
Sporadic and familial ALS. Nine percent of ALS respondents had at least one relative
who had been diagnosed with ALS and were deemed to have familial ALS. The other 91%
were categorised as having sporadic (‘isolated’) ALS.
Fig 2. Selection of individuals for analysis. The final dataset of 850 respondents was obtained after exclusion criteria
were applied for younger age and not completing at least one of the stress-related items.
https://doi.org/10.1371/journal.pone.0204424.g002
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Subtypes of ALS. 58% of ALS respondents had ‘classic’ (upper and lower motor neuron
variant) ALS, 9% progressive muscular atrophy (lower motor neuron variant), 9% progressive
bulbar palsy, 8% primary lateral sclerosis (upper motor variant), 2% ALS/frontotemporal
dementia, 6% ‘other’, and 8% did not know their subtype of ALS.
ALS functional rating scale. People with ALS were asked to complete the ALS Functional
Rating Scale-Revised designed for online use [26] to assess their physical state at the time of taking
the questionnaire. Scores were inverted from the standard scale so that the higher the score the
more impaired the function, with 0 indicating no impairment and 48 indicating very severe
impairment. The median Functional Rating scale was 13, and this and the distribution of the rat-
ing scores (Fig 3A) are those expected for a generally rapidly progressive disease like ALS [22].
Duration of ALS. The duration of ALS at the time of completing the questionnaire was
calculated by subtracting the year of diagnosis from the year of consenting to complete the
questionnaire. The median duration of disease was 1 year, and this, and the disease duration
distribution (Fig 3B), are those expected in a usually short-lasting disease like ALS [22].
Controls. Control participants comprised (blood or non-blood) relatives (45%), friends of
ALS respondents (13%), partners (including spouses) (10%), and individuals from
Table 1. Demographic characteristics of respondents.
ALS Number (%) Control Number (%)
Country of birth
United States 170 (43%) Australia 276 (62%)
Australia 94 (24%) Other (<2% each) 73 (16%)
Canada 49 (12%) United States 42 (9%)
Other (<1% each) 57 (14%) United Kingdom 28 (6%)
United Kingdom 18 (5%) New Zealand 15 (3%)
Spain 10 (3%) Spain 14 (3%)
Country of residence
United States 179 (45%) Australia 338 (75%)
Australia 116 (29%) United States 48 (11%)
Canada 57 (14%) Other (<2% each) 36 (8%)
Other (<2% each) 37 (9%) Spain 14 (3%)
Spain 9 (2%) New Zealand 12 (3%)
Ancestry
Other (<6% each) 184 (47%) Other (<4% each) 153 (34%)
Australian 60 (15%) Australian 130 (29%)
English 57 (15%) English 77 (17%)
American 36 (9%) Irish 40 (9%)
German 32 (8%) British 25 (6%)
Irish 23 (6%) Scottish 19 (4%)
Cultural group
American 111 (29%) Australian 285 (64%)
Australian 98 (26%) Other (<2% each) 76 (17%)
Other (<3% each) 93 (24%) American 32 (7%)
Canadian 40 (10%) English 27 (6%)
English 28 (7%) Spanish 14 (3%)
German 13 (3%) New Zealander 11 (2%)
Other (countries of residence): Argentina, Belgium, Brazil, Cape Verde, China, Colombia, Czech Republic, Denmark, Ecuador, Egypt, Finland, Germany, Iran, Ireland,
Italy, Luxembourg, Mexico, Netherlands, Portugal, Russia, Slovakia, South Africa, South Korea, Sweden, Switzerland, Turkey, United Kingdom.
https://doi.org/10.1371/journal.pone.0204424.t001
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Fig 3. Disability and disease duration in ALS respondents. (A) Most ALS respondents had mild or moderate disability (with
lower ALSFRS-R inverted scores, on the left), while fewer had severe disability (higher ALSFRS-R inverted scores, on the right).
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community, research, and medical professional groups (9%). 23% of controls reported either
no specific or another type of connection to ALS. Most controls (56%) reported no blood rela-
tives with ALS, whereas 32% had one, and 12% more than one, blood relative/s with ALS.
Life events inventory
Males and females. Females had higher Life Events Inventory scores than males for all
ages combined, for the age ranges of 0–20 years and 21–40 years, and for the previous 2, 5 and
10 years (Table 2). Effect sizes ranged from 0.12 (for the previous 5 years) to 0.18 (for the age
range 21–40 years).
ALS and controls. No differences in Life Events Inventory scores were found between
male ALS and male control respondents for all ages combined (Figs 4A and 5A), for the age
ranges of 0–20 years and 21–40 years, or for the previous 2, 5 and 10 years (Table 3). Life
(B) Most ALS respondents completed the questionnaire within four years of being diagnosed. A small number of long-term ALS
survivors (on the right) also completed the questionnaire.
https://doi.org/10.1371/journal.pone.0204424.g003
Table 2. Male-female comparisons in scores for the life events inventory, occupational stress, resilience and anxiety.
Respondents (number) Median Mean rank Mann-Whitney p Effect size r
Life Events Inventory
All ages
Male (370) 659 380 <0.001 0.15
Female (467) 748 450
Age 0–20 y
Male (370) 66 383 <0.001 0.13
Female (467) 106 447
Age 21–40 y
Male (370) 281 371 <0.001 0.18
Female (467) 345 457
Previous 2 y
Male (370) 20 386 <0.001 0.13
Female (467 39 445
Previous 5 y
Male (370) 70 387 0.001 0.12
Female (467) 92 444
Previous 10 y
Male (370) 136 380 <0.001 0.15
Female (467) 185 450
Occupational Stress
Male (363) 1.90 432 0.005 0.10
Female (449) 1.81 386
Connor-Davidson Resilience Scale
Male (378) 74 413 0.24 0.04
Female (469) 75 433
Modified Geriatric Anxiety Inventory
Male (379) 20 400 0.012 0.08
Female (469) 22 444
: p<0.05
https://doi.org/10.1371/journal.pone.0204424.t002
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Events Inventory scores were similar in female ALS respondents and controls for all ages com-
bined (Figs 4A and 5B), but were lower in female ALS respondents compared to female con-
trols for the previous 5-year and 10-year periods (Table 3).
Control groups. Life Events Inventory scores were compared between partners, relatives
and others to assess the degree of homogeneity between the three different control groups.
Scores between the three groups differed for the most recent 2 years (p = 0.002), the 5-year
time point (p = 0.002), and the 10-year time point (p = 0.001). However, when each of the
three control groups was compared to ALS respondents for these variables, the control group
had either a higher or no significantly different median rank to the ALS group. This indicates
that inter-control differences are unlikely to affect the overall ALS vs control results, and that
overmatching with the use of partner controls is not a major factor [27], probably because only
10% of controls were partners.
Comparison of mSRRS and self-described events scores. Only 85 respondents (10% of
the total) reported one or more self-described significant event/s. Eleven male controls (8%)
had an average of 2.5, and 24 male ALS respondents (10%) an average of 1.9, Self-Described
Events. Thirty-four female controls (11%) had an average of 2.8, and 16 female ALS respon-
dents (11%) an average of 2.4, Self-Described Events. To examine the relationship between
mSRRS and Self-Described Events scores, Life Events Inventory scores were calculated without
Self-Described Events to remove their contribution, as well as using 100 as the score for Self-
Described Events (to maximise their potential contribution, since this is the maximum possi-
ble score in the mSRRS). This did not change the outcome of the statistical tests at either of the
extremes (results not shown), indicating that the outcome was not affected by inclusion of the
Self-Described Events.
Occupational stress
Male respondents reported higher occupational stress than female respondents (Table 2).
Occupational stress scores did not differ between male or female ALS respondents and their
respective gender controls (Table 3).
Connor-davidson resilience scale
Resilience did not differ between male and female respondents, with similar CDRS scores in
these gender groups (Table 2). Both male and female ALS respondents had higher CDRS resil-
ience scores than their respective gender controls (Table 3). The differences in distributions of
resilience scores and median values can be seen in Fig 4B. Frequency distribution histograms
show the shift to the right of resilience scores for male and female ALS respondents (Fig 5C
and 5D).
Modified geriatric anxiety inventory
Anxiety (mGAI) scores were higher in females than males (Table 2). Anxiety scores were not
significantly different between male and female ALS respondents and their respective gender
controls (Table 3). Distributions and median values of anxiety scores for male ALS and control
Fig 4. Distributions and median values of scores for the Life Events Inventory (all ages), resilience and anxiety.
(A) The distribution and median values of Life Events Inventory scores are similar between male and female ALS and
control respondents. (B) Both male and female ALS and control respondents have higher median values for resilience
(CDRS scores) than their gender controls. (C) Male ALS and control respondents have similar distributions and
median values for anxiety (mGAI scores), while female ALS respondents have lower anxiety levels than female
controls. CDRS: Connor-Davidson Resilience Scale, mGAI: modified Geriatric Anxiety Inventory.
https://doi.org/10.1371/journal.pone.0204424.g004
Is psychological stress a risk factor for amyotrophic lateral sclerosis?
PLOS ONE | https://doi.org/10.1371/journal.pone.0204424 September 21, 2018 11 / 18
Page 69 of 221
respondents (Fig 4C), and their percentage frequencies (Fig 5E), were similar. Female ALS
respondents had a non-significant tendency to have lower anxiety levels than female controls,
as seen in slight differences in anxiety score distributions and median values (Fig 4C), with the
percentage frequency of ALS female anxiety scores being shifted slightly to the left (Fig 5F).
Fig 5. Frequency distributions of scores for the Life Events Inventory (all ages), resilience, and anxiety. The frequency distributions of
Life Event Inventory scores are similar between ALS and control males (A), as well as between ALS and control females (B). Resilience
scores (CDRS) are shifted to the right (ie, greater resilience) in both male (C) and female (D) ALS respondents. The frequency
distribution of anxiety scores (mGAI) are similar in both male (E) and female (F) ALS and control respondents. CDRS: Connor-
Davidson Resilience Scale, mGAI: modified Geriatric Anxiety Inventory.
https://doi.org/10.1371/journal.pone.0204424.g005
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Table 3. ALS-control comparisons in scores for the life events inventory, occupational stress, resilience and anxiety.
Respondents (number) Median Mean rank Mann-Whitney p Effect size r
MALES
Life Events Inventory
All ages
ALS (243) 639 188 0.528 0.03
Control (127) 661 181
Age 0–20 y
ALS (243) 68 189 0.364 0.05
Control (127) 65 179
Age 21–40 y
ALS (243) 288 189 0.342 0.05
Control (127) 268 178
Previous 2 y
ALS (243) 19 180 0.177 0.07
Control (127) 29 195
Previous 5 y
ALS (243) 63 180 0.187 0.07
Control (127) 81 196
Previous 10 y
ALS (243) 128 178 0.100 0.09
Control (127) 152 198
Occupational Stress
ALS (239) 1.92 185 0.446 0.04
Control (124) 1.89 176
Connor-Davidson Resilience Scale
ALS (250) 76 198 0.028 0.11
Control (128) 72 172
Modified Geriatric Anxiety Inventory
ALS (249) 20 194 0.355 0.05
Control (130) 20 183
FEMALES
Life Events Inventory
All ages
ALS (149) 726 230 0.685 0.02
Control (318) 753 236
Age 0–20 y
ALS (149) 92 230 0.652 0.02
Control (318) 107 236
Age 21–40 y
ALS (149) 345 226 0.351 0.04
Control (318) 345 238
Previous 2 y
ALS (149) 36 218 0.075 0.08
Control (318) 44 241
Previous 5 y
ALS (149) 73 211 0.010 0.12
Control (318) 98 245
Previous 10 y
(Continued)
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Discussion
We found no differences between ALS respondents and controls in exposures to potentially
stressful life events. On the contrary, some female ALS subgroups had fewer Life Events Inven-
tory scores than controls, findings opposite to those expected if stress were related to ALS. In
addition, self-reported stress from occupations was the same in people with ALS and controls.
ALS respondents had on average higher resilience than controls, indicating they would be
more likely to be able cope better with stressful events. Finally, people with ALS were not more
anxious than controls. Our results do not therefore support the hypothesis that psychological
stress is a risk factor for developing ALS.
ALS respondents in this study were found to be more resilient than controls when using a
validated method of testing resilience, the Connor-Davidson Resilience Scale [23]. Resilience
can be defined as a ’measure of successful stress-coping ability’ [23] and is thought to arise
from a combination of factors that are personality-related, genetic or biological, and social or
environmental (eg, having strong social networks) [28]. The characteristic personality profile
of resilient individuals is greater conscientiousness, higher extraversion, and lower neuroti-
cism [29], features similar to the personality type that has been described in people with ALS
[30]. Extraversion can manifest itself as a greater ability to communicate positive feelings and a
greater ability to access social networks, which would result in a person being better able to
manage stressors [4]. People with higher conscientiousness and extraversion feel their life
stressors are less stressful than others [31], and could be considered to exhibit greater resil-
ience. Some evidence therefore links resilience to personality types in ALS.
The questionnaire we used for this project is an anonymous online international survey
looking at a range of risk factors for ALS [17]. The 165 items in the questionnaire include the
Holmes and Rahe checklist for potentially stressful life events [3], to date the most commonly
used method to measure life event stressors [32]. Life event checklists have, however, been crit-
icised, predominantly on the basis that the actual responses to a broad category, eg, ’serious
physical illness or injury’ could result in some respondents including minor illnesses but oth-
ers including only major illnesses such as cancer, a problem of intracategory variability [32].
To overcome this deficiency in checklists, several approaches have been canvassed, the most
promising being prospective semi-structured interviews, performed by trained raters who
judge the importance of individual events [32,33]. We were unable to gather this type of
detailed narrative information since our respondents were anonymous and unable to be
Table 3. (Continued)
Respondents (number) Median Mean rank Mann-Whitney p Effect size r
ALS (149) 155 212 0.018 0.11
Control (318) 190 244
Occupational Stress
ALS (143) 1.83 234 0.305 0.05
Control (306) 1.78 221
Connor-Davidson Resilience Scale
ALS (149) 80 269 <0.001 0.17
Control (320) 73 219
Modified Geriatric Anxiety Inventory
ALS (149) 20 218 0.062 0.09
Control (320) 23 243
: p<0.05
https://doi.org/10.1371/journal.pone.0204424.t003
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contacted. However, future life event stressor studies in ALS and other neurodegenerative dis-
orders could use this narrative approach, which is now considered be the gold standard for life
event studies [33]. These would face challenges, though, such as the considerable costs of
employing trained raters over the prolonged period of time it would take to interview 800 peo-
ple, since 400 respondents per disease and control group are required for statistical robustness
[32], and with less common conditions such as ALS patient recruitment can take a number of
years. This economic consideration is the main reason interview-based methods have been
used so far in only a small minority of life event studies [32]. It would, in addition, be difficult
to undertake interviews in the numerous languages used in an international study such as
ours, and ethics approvals for such studies would need to be obtained from multiple institu-
tions in each country, so replicating such narrative studies in ALS or other neurodegenerative
diseases would be a major undertaking. Some advantages to using checklists for life events do
remain: respondents are more likely to be forthcoming about nominating stressful life events
in an anonymous checklist than during an interview, and there is no need to account for inter-
rater reliability between interviewers.
Increased resilience in people with ALS is of interest given that several genetic influences
on resilience have been described [34]. The genes involved include those related to the hypo-
thalamus-pituitary-adrenal axis and to the serotonin transporter, COMT that degrades dopa-
mine and noradrenaline, as well as NPY and BDNF. It would be of interest to see if similar
genetic polymorphisms are more frequent in people with ALS. Furthermore, both gene-gene
and gene-environment interactions could underlie variabilities in stress responses, which may
be worth exploring in ALS. Epigenetic mechanisms related to resilience are found in mice
[34], and these epigenetic changes may be of relevance to ALS since ALS-discordant monozy-
gous twins with no DNA genetic differences on whole genome sequencing [35] have be shown
to have numerous epigenetic dissimilarities [36].
Our study has some limitations. (1) ALS patients were asked to remember their psychologi-
cal state before they were diagnosed. This is, however, of limited concern in a disease like ALS
which usually has a short course (as shown by the median disease duration of 1 year in this
study), compared to disorders with long courses such as multiple sclerosis, where patients
would need to recall these aspects many years after diagnosis. (2) The Geriatric Anxiety Inven-
tory was developed for use in a geriatric population, but in this study it assessed people aged 40
years and above. However, the content of the Geriatric Anxiety Inventory is generic and could
be applied to a person of any age, and our results showing that females exhibited greater anxi-
ety than males are consistent with other studies where the Geriatric Anxiety Inventory has
been used in geriatric populations [37]. (3) It is possible that some control respondents could
develop ALS later in life. However, ALS is a relatively uncommon disorder, with a lifetime risk
of 1:350 for men and 1:400 for women [38]. Since we had 120 male and 282 female controls,
only one of our controls in total would be likely to develop ALS during their lifetime, which
would not affect the results. (4) Recall bias needs to be considered as a factor in all case-control
questionnaire studies. Our ALS respondents did not report more checklist life events than con-
trols, suggesting little recall bias. In addition, similar proportions of both ALS and non-ALS
respondents reported self-volunteered significant life events, further indicating that recall bias
was unlikely to be a confounding factor in this study.
Conclusion
Our results do not support the concept that psychological stress from significant life events or
stressful occupations plays a role in the pathogenesis of ALS. The higher levels of resilience we
found in people with ALS may be associated with pre-morbid personality differences that have
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been described in this disease, and further investigations looking for shared genetic variants
between people with ALS and those reported in resilience may be of value in investigating the
pathogenesis of ALS.
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Chapter 6: A comparison of mercury exposure from seafood 
consumption and dental amalgam fillings in people with and 
without amyotrophic lateral sclerosis (ALS) 
 
One of my particular interests is environmental epidemiology and the role of chemicals in the 
development of disease. I therefore evaluated exposures to sources of mercury and their 
relevance to ALS. The possibility that heavy metals such as mercury may be involved in ALS 
pathogenesis appears compelling because of the known neurotoxicity of these compounds. 
Much of the difficulty in ascertaining whether or not these metals contribute to developing 
ALS lies in accurately assessing exposure to these compounds, both from occupational and 
incidental sources (for example, the local environment and hobbies). Mercury exposure has 
been evaluated as a risk factor for ALS before, but studies have been limited in scope and size 
[1]. One early study found an association between exposure to mercury and ALS [2], as did 
some more recent studies [3-5]. However, a definitive link between ALS and mercury remains 
elusive, since a greater number of studies have not shown any relationship between mercury 
and ALS [6-15].  
I looked at the main sources of environmental exposures to mercury, fish consumption and 
dental amalgam fillings, to see if these exposures were different between ALS and control 
respondents. These exposures could represent an accumulating source of mercury, since 
mercury is known to be taken up into the CNS and remain in neurons indefinitely [16]. 
The results, presented as a publication in this chapter, found that neither consumption of 
mercury in seafood nor mercury dental fillings were higher in ALS than controls respondents. 
It was concluded that, if mercury is a risk factor for ALS, there must be additional sources of 
mercury exposure that are unaccounted for, or that people with ALS have some particular 
(probably genetic) susceptibility to mercury toxicity. 
These results were presented in a poster at the 29th International Symposium on ALS/MND in 
2018 (Appendix J). 
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Abstract: Exposures to toxic metals such as mercury have been suggested to be risk factors for
amyotrophic lateral sclerosis (ALS). Human intake of mercury commonly occurs via consumption of
seafood or from mercury-containing amalgam dental restorations (‘mercury fillings’). We therefore
compared mercury exposures from these sources in 401 ALS and 452 non-ALS respondents, using an
internationally-available online questionnaire that asked respondents how often they ate seafood
and what their favourite types of seafoods were. Respondents were also asked to record numbers of
current or former mercury fillings. ALS and non-ALS respondents did not differ in their frequency of
seafood consumption or in monthly mercury intake from favourite seafoods. Both groups had similar
numbers of current, as well as former, mercury fillings. In conclusion, this study found no evidence
that mercury exposure from eating seafood, or from mercury dental fillings, was associated with
the risk of developing ALS. Therefore, if mercury does play a role in the pathogenesis of ALS, other
sources of exposure to mercury in the environment or workplace need to be considered. Alternatively,
a susceptibility to mercury toxicity in ALS, such as genetic or epigenetic variations, multiple toxic
metal interactions, or selenium deficiency, may be present.
Keywords: amyotrophic lateral sclerosis; ALS; motor neuron disease; mercury; seafood; fish
consumption; dental amalgam filling; case-control study; online questionnaire; international study
1. Introduction
Toxic metals, and mercury in particular, have long been suspected to play a part in the
pathogenesis of amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND) [1–3].
Mercury can initiate oxygen free radical formation, induce excitotoxicity, reduce DNA, RNA and
protein synthesis, cause epigenetic changes, activate autoimmunity, and interact with microtubules [4],
all mechanisms that have been implicated in ALS [5]. Electron microscopic studies indicate that
mercury binds selectively to intracellular sulfhydryl-rich membranes such as those of mitochondria, the
nucleus, the Golgi apparatus, the endoplasmic reticulum and lysosomes [6], organelles whose functions
have been reported to be impaired in ALS [5,7]. Systemically-administered mercury is taken up
selectively by rodent spinal and brain stem motor neurons [8]. Mercury is also taken up preferentially
by human spinal alpha motor neurons [9], spinal interneurons [10], and corticomotoneurons [11], and
has been located in human astrocytes and oligodendrocytes [12]. All of these cells appear to play a
part in the pathogenesis of ALS [5,13–15].
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Environmental mercury remains a strong candidate as a precipitating factor for ALS, particularly
if combined with a genetic predisposition to mercury toxicity [3]. However, despite toxic metals
having biological plausibility and some epidemiological links with ALS, caution is advised regarding
the limitations of methods used to assess human exposure [16]. One such limitation is that blood or
cerebrospinal levels of toxic metals may not necessarily reflect the extent of previous exposure [17],
since, for example, mercury remains in motor neurons for long periods after it has been removed
from other organs [18]. Major sources of human exposure to mercury are via the consumption of
seafood, especially of large predatory fish such as shark, swordfish, mackerel and tuna [19], and from
mercury-containing ‘silver’ dental amalgam restorations [20], here termed ‘mercury fillings’ [21].
There is concern among people with ALS (as judged by online comments) as to whether they
should attempt to reduce their mercury intake by having their dental amalgam fillings removed, or
whether they should limit their fish intake. Interest has been rekindled in the mercury hypothesis for
ALS [22] with a report of increased toenail mercury in people with ALS, possibly related to seafood
consumption [23]. In addition, occasional reports have suggested that removing dental amalgam
fillings, or chelation therapy, can result in stabilization or recovery from some forms of ALS [24].
We therefore sought to determine whether people with ALS are more likely than controls without
ALS to be exposed to higher levels of mercury from these sources, using an online international
questionnaire that gathered data on seafood and dental amalgam sources of mercury. Our results
suggest that mercury exposure from these sources alone is not likely to be associated with the risk of
developing ALS.
2. Methods
2.1. Setting
This case-control study used data collected between January 2015 and September 2017 from a
multilingual web-based questionnaire, ALS Quest [25]. Cases were respondents who stated ‘Yes, I
have been diagnosed with ALS/MND.’ Controls were participants who stated ‘No, I have not been
diagnosed with ALS/MND.’
2.2. Ethics Approval
The project was conducted in accordance with the Declaration of Helsinki, and was approved
by the Human Ethics Committee of the Sydney Local Health District, reference number X14-0357.
Responses used for the study were those where respondents consented by clicking an ‘I consent’ button
and then submitted their responses.
2.3. Frequency of Seafood Consumption
Participants were asked ‘How often do you eat fish or shellfish?’ on an increasing 8-point scale of:
Never, Less than once a month, Once a month, 2–3 times a month, Once a week, 2–3 times a week,
4–6 times a week, or Daily.
2.4. Favourite Seafoods
Seafood varies in its content of mercury, so participants were asked ‘Please list up to three of your
favourite fish to eat’. Names of seafood entered in non-English languages were translated into English
(unless it was a country-specific indigenous fish). The average mercury content of individual seafoods
was based on the USA Food and Drug Administration (FDA) report of mercury levels in commercial
fish and shellfish [19]. The mercury content of Australian seafood species not present in the USA FDA
report was taken from an Australian report [26].
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2.5. Estimation of Monthly Mercury Exposure from Seafood
The average mercury concentration in µg/g of up to three favourite seafoods was multiplied
by 227 g (8 ounces, the weight of a typical seafood serving) [27], and then by the frequency of
seafood consumption (adjusted to a monthly value), to get an estimate of monthly mercury exposure
from seafood in micrograms (Figure 1). Assumptions underlying this estimate were that seafood
mercury levels around the world are similar to those in the USA FDA list, and that the frequency of
seafood consumption and favoured types of seafood remain reasonably stable over a long period of
time. To compare types of seafood eaten, shellfish (e.g., prawn, crab and lobster) and cephalopods
(e.g., squid, calamari and octopus) were categorised separately from finfish.
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Figure 1. Estimating mercury exposure from seafood consumption. The average mercury concentration
in µg/g from up to three favourite seafoods was multiplied by a standard portion size of seafood
(227 g), then multiplied by the monthly frequency of seafood consumption to estimate monthly mercury
exposure from seafood in micrograms.
2.6. Mercury-Containing Dental Fillings
Respondents were asked ‘Have you ever had an amalgam restoration (silver filling) as part of
dental care?’. If they responded ‘Yes’ they were asked: ‘How many amalgam silver dental fillings do
you currently have? For people with ALS/MND, enter the number you had before being diagnosed.
You may need somebody to help you count the silver fillings in your mouth.’ Respondents were
requested to indicate how many current fillings were occlusal, i.e., ‘those that involve the top surface of
the tooth (where you bite)’ and non-occlusal, i.e., ‘those that involve the side of the tooth only’. If they
had no current mercury fillings they were asked to enter ‘0’ for the current number of fillings, and then
‘If you currently have no silver amalgam dental fillings, how many have you had in the past?’ i.e.,
‘former-only’ fillings. Responses were excluded if non-zero entries were made in both the current and
former-only mercury filling categories, or if respondents ntered ‘Yes’ to having ever had a filling but
did not list any number of fillings. Respondents who responded ‘No’ wer assigned a value of 0 for
the number of curre t (combined occlusal and n n-occlusal) and former-only fillings.
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2.7. Statistical Analyses
Data from the Qualtrics server were transferred to IBM Statistical Package for the Social Sciences
(SPSS) for Macintosh (version 22, IBM, Armonk, NY, USA) and GraphPad Prism 7 files. Extreme outliers
(more than three times the inter-quartile range) in continuous variables were removed (numbers can be
seen in the flow diagram). Nonparametric continuous variables were compared using Mann-Whitney
U tests, and normally-distributed continuous variables with t-tests. Odds ratios with 95% confidence
intervals and Fisher’s exact tests were used for categorical variables when all cell numbers were ≥5.
Significance was assessed at the 0.05 level. No significant male vs. female differences were found in
any of the seafood or mercury filling variables (data not shown, see Table S1) so the genders were
analysed together.
3. Results
3.1. Cases and Controls
From an initial pool of 1097 questionnaire respondents, 853 eligible ones remained after inclusion
criteria (i.e., aged 40 years and over, answered seafood and/or dental questions) were applied
(Figure 2).
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Figure 2. Selection of respondents for analysis. The final datasets of respondents used for analyses was
achieved after exclusion criteria were applied for younger age, not answering questions on seafood
consumption or dental fillings, and removal of outlier values. CON: control; current: current dental
fillings; former: former-only dental fillings; frequency: frequency of seafood consumption; mercury:
mercury content of favourite fish; never: replied ‘never had any current or former mercury fillings’;
outlier: extreme outliers (more than three times the inter-quartile range); M: male; F: Female.
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These comprised 401 ALS respondents (252 male, 149 female) and 452 non-ALS controls (130 male,
322 female). The mean age of ALS respondents was 61.5 years (SD 9.2 years, range 40–87 years) and
of controls was 57.3 years (SD 10.4 years, range 40–89 years), a significant difference on t-testing
(p < 0.001). When evaluated by gender, the mean ages of male ALS respondents (62.0 years) and
male controls (61.8 years) were not significantly different, while female ALS respondents (mean age
60.7 years) were older than female controls (mean age 55.5 years), p < 0.001 (see Table S2).
Common sources of information about the questionnaire cited by respondents were: ALS
Associations (39%), the Internet (21%), friends (9%), ALS patients (6%), the USA Centers for Disease
Control National ALS Registry (5%), health professionals (5%), community groups (4%), Facebook
(4%), the Canadian Neuromuscular Disease Registry (2%) and ALS researchers (2%). The composition
of the ALS and control groups was similar with regards to country of residence, ancestry and cultural
group. The majority of respondents resided in Australia, the USA and Canada, though residents of a
further 29 countries supplied responses (Table 1).
Table 1. Demographic characteristics of respondents.
ALS N (%) Control N (%)
Country of residence
United States 180 (45%) Australia 339 (75%)
Australia 116 (29%) United States 49 (11%)
Canada 57 (14%) Other * (<2% each) 36 (8%)
Other * (<2% each) 37 (9%) Spain 14 (3%)
Spain 9 (2%) New Zealand 12 (3%)
Ancestry
Other (<6% each) 184 (47%) Other (<4% each) 154 (34%)
Australian 60 (15%) Australian 131 (29%)
English 57 (15%) English 77 (17%)
American 37 (9%) Irish 41 (9%)
German 32 (8%) British 25 (6%)
Irish 23 (6%) Scottish 19 (4%)
Cultural group
American 112 (29%) Australian 286 (64%)
Australian 98 (26%) Other (<2% each) 76 (17%)
Other (<3% each) 93 (24%) American 33 (7%)
Canadian 40 (10%) English 27 (6%)
English 28 (7%) Spanish 14 (3%)
German 13 (3%) New Zealander 11 (2%)
Other * (countries of residence): Argentina, Belgium, Brazil, Cape Verde, China, Colombia, Czech Republic,
Denmark, Ecuador, Egypt, Finland, Germany, Iran, Ireland, Italy, Luxembourg, Mexico, Netherlands, Portugal,
Russia, Slovakia, South Africa, South Korea, Sweden, Switzerland, Turkey, United Kingdom (country not specified).
Eight percent of ALS respondents had at least one relative who had been diagnosed with ALS,
and were considered to have familial ALS. The other 92% of ALS respondents were considered to
have sporadic (or ‘isolated’) ALS. As reported by the ALS respondents, 58% had ‘classic’ (upper and
lower motor neuron variant) ALS, 9% progressive muscular atrophy (lower motor neuron variant), 9%
progressive bulbar palsy, 8% primary lateral sclerosis (upper motor variant), 8% ‘other’ and 8% did
not know their subtype of ALS. Control respondents were friends (12%), spouses (11%), and blood or
non-blood relatives (45%) of ALS patients, individuals from community, research or medical groups
(9%), or other categories (22%).
The median online ALS Functional Rating Scale-Revised score [28] (inverted, so that higher scores
indicated higher disability) was 13, and scores ranged from 0 to 48 (see Table S1). Most respondents
were in the range of 6-18, with decreasing numbers as the scores increased, as expected in ALS [29].
The duration of ALS at the time of completing the questionnaire was calculated by subtracting the
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year of diagnosis from the year of consenting to complete the questionnaire. The median duration of
disease was 1 year, with the great majority of respondents having disease durations of 4 years or fewer,
as expected in ALS [29] (see Table S1).
3.2. Frequency of Seafood Consumption
A similar proportion of ALS (N = 386, 97%) and control (N = 432, 96%) respondents ate seafood.
The proportions of respondents who ate seafood at different frequencies, ranging from never to daily,
did not differ between ALS and control groups (Figure 3). Chi-square testing of ALS vs. control
proportions at each of the eight frequencies showed no statistical differences (data not shown, see
Table S1), even at frequencies where there appeared to be slight differences between ALS and controls,
i.e., more for ALS at once per month and 2–3 per week, and more for controls at once per week.
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3.3. Favourite Seafoods
Of the 386 ALS respondents who said they ate seafood, 378 (98%) nominated at least one favourite
type, while of the 432 c ntrol respondents who said they ate seafood, 417 nominated at least one
favourite type (97%) (see Tabl S1). Some n inated f vourite seafoods were not listed in the USA
FDA or Australian seafood mercury reports; for the first choice these non-listed seafoods numbered 51
out of 796 cited (6%, 20 ALS and 31 controls), for the second choice 80 out of 737 cited (11%, 27 ALS
and 53 controls), and for the third choice 69 out of 636 cited (11%, 27 ALS and 42 controls). A slightly
greater proportion of ALS (N = 105, 28%) than control respondents (N = 84, 20%) cited one or more
types of shellfish as a favourite type of seafood (OR = 1.5, 95% CI: 1.1–2.1, p = 0.01). No significant
difference was found between the 5 ALS (1%) and 14 control (3%) respondents who cited cephalopods
as a favourite seafood (OR = 0.4, 95% CI: 0.1–1.1, p = 0.07).
3.4. Mercury Consumption from Favourite Seafoods
No difference between ALS and control respondents was seen in the distribution of monthly
mercury exposure from favourite seafoods (Figure 4). The monthly median value for seafood mercury
exposure was slightly lower in ALS respondents (39 µg per month for ALS, 49 µg per month for
controls) but these values did not differ significantly (p = 0.13) (see Table S1).
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3.5. Intra- nd Inter-Country Comparisons of er ption from Favourite Seafoods
The two countries with the largest n ers f res ondents were Australia and the USA, so
monthly mercury consumption from seafood as co pared between, and within, these countries, as
well as with all other countries combined (Table 2, and see Table S1). Within all three nationality groups
the amount of seafood mercury did not differ between ALS and control respondents. However, both
Australian ALS and control respondents had higher seafood mercury consumption than corresponding
USA groups. Further analysis showed this was because Australian respondents overall tended to
eat seafoods with a higher mercury content (median 54 µg/month) than USA respondents (median
31 µg/month), while the frequency of seafood consumption was similar between these two countries
(Australian median about 2–3 times per month and USA median slightly less than 2–3 times per
month). For the other combined countries, seafood mercury intake (median 52 µg per month) was
similar to that consumed by Australians, whereas the frequency of seafood consumption was higher
(at slightly more than 2–3 times per month) than for Australia and the USA.
Table 2. Intra- and inter-country comparisons of monthly mercury consumption from seafood.
Respondents N Median Mercury Consumption µg/month p r
Intra-country: Control vs. ALS
USA control 47 32
0.80 0.02USA ALS 177 31
Australia control 324 51
0.27 0.05Australia ALS 109 69
Other countries
cont ol 61 65 0.40 0.07
Other countries ALS 98 47
Inter-country: USA vs. Australia
USA control 47 32
0.02 0.12Australia control 324 51
USA ALS 177 31
<0.001 0.21Australia ALS 109 69
N: number, p: Mann-Whitney p value, r: effect size.
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3.6. Mercury-Containing Dental Fillings
The proportions of ALS (N = 262, 81%) and control (N = 338, 83%) respondents who had ever had
mercury fillings, i.e., either current (occlusal and non-occlusal) or former-only fillings, were similar
(OR = 0.8, 95% CI: 0.6–1.2, p = 0.32), and see Table S1. The distribution of numbers of current fillings
did not differ between ALS and control respondents (Figure 5A), with the median number of current
fillings being 5 in both ALS and control groups (p = 0.25). ALS respondents (N = 188, 58%) were less
likely than controls (N = 264, 65%) to have current occlusal fillings (OR = 0.7, 95% CI: 0.5–1.0, p = 0.04).
The distribution of numbers of former-only fillings was similar between ALS and control groups
(Figure 5B), with medians of 2 former-only fillings in ALS respondents and 0 in controls (p = 0.46).
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and other countries combined, or between USA and Australian ALS and control respondents (Table 3,
and see Table S1).
Table 3. Intra- and inter-country comparisons of current mercury amalgam dental fillings.
Respondents N Median No. of Current Fillings p r
Intra-country: Control vs. ALS
USA control 30 4.5
0.49 0.06USA ALS 103 5.0
Australia control 270 5.0
0.42 0.04Australia ALS 84 4.5
Other countries control 45 5.0
0.76 0.03Other countries ALS 69 5.0
Inter-country: USA vs. Australia
USA control 30 4.5
0.93 0.005Australia control 270 5.0
USA ALS 103 5.0
0.80 0.02Australia ALS 84 4.5
N: number, p: Mann-Whitney p value, r: effect size.
4. Discussion
Key findings in this study are that people with and without ALS had comparable intakes of
mercury from their favourite seafoods, and had similar numbers of current or former mercury fillings.
In fact, ALS respondents were less likely than controls to have occlusal mercury fillings, which are more
likely to be associated with higher levels of intra-oral air mercury because of chewing [30]. Our study
therefore found no convincing evidence that people with ALS are exposed to more environmental
mercury than controls from either seafood consumption or from mercury-containing dental fillings.
The U.S. Environmental Protection Agency’s acceptable daily dose for methylmercury, i.e., the
dose that would not be anticipated to result in any adverse health effects, is 0.1 µg/kg per day [31].
Multiplied by 80 kg (the weight of a typical adult) and 30.8 (the average number of days in a month),
this gives a value of 246 µg of mercury per month. The median monthly seafood mercury consumption
values for our respondents, 39 µg/month for ALS and 49 µg/month for controls, are well below what
the U.S. Environmental Protection Agency considers the maximum acceptable level of exposure for
methylmercury, assuming that all the mercury in seafood is present as methylmercury. Therefore, the
seafood-related mercury consumption we found in most of our respondents would not be expected to
be toxic in the absence of complicating susceptibility factors.
Shellfish, which were more likely to be consumed by our ALS respondents, are low in mercury
(0.003–0.100 µg/g) but have been found to contain beta-N-methylamino-L-alanine (BMAA) [32],
a postulated risk factor for ALS [33]. This finding therefore supports further research into links
between seafood consumption, BMAA and ALS.
The failure to find an increase in mercury exposure from common environmental sources in people
with ALS raises the possibility that some susceptibility factors could be responsible for activating
mercury that can lie dormant within human motor neurons [9–11]. This susceptibility could be due to
genetic polymorphisms, since a number of genetic variants are implicated in susceptibility to mercury
toxicity [34], or to acquired epigenetic differences [35,36], both in accordance with the notion that
environmental insults, combined with genetic susceptibility and ageing, trigger the common sporadic
form of ALS [37]. Of interest in this regard, a gene-environment interaction involving mercury and
mutant superoxide dismutase 1 has been described, which results in increased calcium-mediated
glutamate excitotoxicity [38]. Mercury is found often in the human nervous system, since almost half
of subjects in an autopsy population from different clinicopathological backgrounds have detectable
mercury in the brain stem locus ceruleus, a site that appears to be a marker for previous exposure to
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mercury [39]. These findings raise the possibility that mercury could be one of the non-genetic factors
in a multistep process that is thought to underlie ALS [40]. Susceptibility to mercury in ALS could also
arise from multiple toxic metal interactions [41], or from selenium deficiency, since selenium mitigates
mercury toxicity [42] and low selenium levels have been implicated in a number of neurodegenerative
diseases [43].
Our findings provide no evidence that mercury exposure from eating seafood or from dental
fillings is related to ALS, but there remain other sources of mercury exposure that were not assessed in
this study. For example, mortality rates from ALS have been found to higher in municipalities of Spain
where levels above regulatory limits of heavy metals such as mercury are released into rivers [44].
Mercury is also used in many industrial applications, such as the production of chlorine gas and caustic
soda, and is also present in thermometers, barometers, batteries, and electrical switches. If appropriate
workplace protections are not in place in these occupational settings, exposure to mercury could
occur [45]. Some occupational studies give indirect evidence that workplace exposure to mercury
in factories may be implicated in ALS because men with ALS tend to have occupations involving
lower skills and tasks, typically associated with factory workers [46]. A recent systematic review of
occupational exposures in ALS lists 15 studies in which occupational exposure to toxic metals was
reported [47]. In five of these, mercury was analysed as an individual metal [48–52], but case and
control numbers were too small in all of these reports for robust statistical analyses.
Another factor to consider, before rejecting the notion of exposure to mercury being related to ALS,
is that ocean levels of mercury are less than a quarter of those expected from known mercury emissions
such as coal burning, cement production, waste incineration and small-scale gold mining [53]. This has
led to the concept of ‘missing mercury’ [54] and implies that people may be exposed to mercury without
ever being aware of its source. These other sources of mercury exposure are not able to be identified
using epidemiological methods, so an alternative approach is to look directly for mercury in the tissues
of people with ALS. These can be either peripheral tissues, such as toenails [23], or central nervous
system tissues where mercury, together with other toxic metals, can now be localised within individual
regions and cells using methods such as autometallography [9–11,55] and laser ablation-inductively
coupled plasma-mass spectrometry [39].
Of interest is the finding that people in the USA eat seafood with a lower mercury content than do
people in Australia (and other combined countries), whereas the frequency of seafood consumption in
these two countries is similar. This did not affect our finding of no increased mercury consumption
from eating seafood in ALS respondents, but it may have implications for epidemiological studies of
mercury-associated disorders when comparisons are made between countries. This finding shows
the value of internationally-available surveys in looking at disorders that could be triggered by
environmental agents.
The limitations of online questionnaires in the investigation of ALS risk factors have recently been
summarised [56]. Limitations specific to the present study are: (1) The female ALS respondents were
older than their female controls. However, this means that the ALS females would have had a longer
period of time in which to accumulate environmental mercury from the two sources of exposure, but
no female ALS-control exposure differences were found to indicate this was the case (data not shown).
(2) We were not able to trace the mercury content of a small number of reported favourite seafoods, but
the proportion of these was similar in ALS and control respondents. (3) Recall bias is always a concern
in case-control studies, but ALS and control respondents gave similar depths of detail in response
to questions on seafood consumption and dental fillings, suggesting that recall bias is unlikely to
play a major in this study. Furthermore, since we found no differences between ALS and control
respondents, any recall bias on the part of control respondents (who could tend to be less assiduous in
recalling seafood consumption or numbers of dental fillings) implies that control respondents actually
consumed more seafood and had more amalgam filling than they reported, which would reinforce our
finding that these exposures are not risk factors for ALS.
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5. Conclusions
This international online study did not find evidence that mercury exposure from either seafood
consumption or from mercury-containing dental fillings is more common in people with ALS than
in controls. If mercury does play a role in the pathogenesis of ALS, it seems likely that other factors
such as genetic or epigenetic susceptibilities to mercury toxicity, multiple toxic metal interactions, or
selenium deficiency would need to be present to trigger the disease, or that a link between mercury and
ALS could arise from other as yet undefined environmental or workplace sources. Further international
comparisons of mercury intake in ALS from fish consumption and dental amalgam fillings will be
possible once we obtain more responses to our ongoing online risk factor questionnaire.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-4601/15/12/2874/
s1, Table S1 Seafood and dental filling data, Table S2. Ages of respondents.
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Chapter 7: General Discussion and Conclusions 
7.1 General Discussion 
The goals of this final chapter are to i) bring together the outcomes of my analyses presented 
in the previous chapters, ii) discuss the implementation and recruitment efforts conducted 
during the course of this project, and iii) consider future directions of research for the ALS 
Quest project. In summary, the aims of the project were to develop a comprehensive 
questionnaire on ALS epidemiology and locate it online, and to evaluate the data obtained 
from the questionnaire to find ALS risk factors. 
A unique feature of this ALS epidemiological study has been the use of an online multi-lingual 
questionnaire as the basis for collecting data. While the use of a monolingual online 
questionnaire for ALS has been described in the literature [1], results from that study have 
yet to be published. This makes ALS Quest the first online questionnaire to be used as the 
basis for research publications on ALS risk factors. Indeed, the development of the 
questionnaire and its implementation online encompassed a full year of this project, due to 
the importance of having a robust and valid research tool. One of the unique features of the 
ALS Quest questionnaire is the incorporation of material from a variety of other research 
questionnaires, as well as questions that have not typically been asked of people with ALS, 
into a single instrument that is available to anyone who can access the internet [2].  
A key difference in the ALS Quest questionnaire is its availability in many languages, and the 
questionnaire includes the first languages used by the great majority of people around the 
world. ALS Quest is available in 28 languages: Afrikaans, Arabic, Bahasa Indonesia, Chinese, 
Czech, Danish, Dutch, English, Finnish, French, German, Hebrew, Hindi, Italian, Japanese, 
Korean, Persian/Farsi, Polish, Portuguese/Brazilian Portuguese, Romanian, Russian, Serbian, 
Spanish, Swedish, Thai, and Vietnamese. Figures 7-1 illustrates the availability of ALS Quest in 
the various official/commonly-spoken languages of the world.  
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Figure 7-1. Map of countries where ALS Quest is available in one or more official languages  
 
 
 
 
 
 
 
 
The task of translating the questionnaire involved recruiting and managing 32 volunteer 
translators, which included providing technical assistance, developing instruction manuals to 
help them with their work, and encouraging them to complete the task. To date, more than 
500 questionnaire respondents have worked on ALS Quest in a language other than English, 
which illustrates the need for a multi-lingual platform in this setting. As a result, I have been 
able to incorporate data from respondents from more than 30 countries into the analyses, 
the largest number of individual countries yet included in an ALS epidemiological study. 
ALS Quest enabled the collection of data on unproven or unexplored risk factors for ALS. As 
with any epidemiological investigation, providing negative evidence can be as compelling, and 
at times more interesting, than positive results. Evaluations of finger ratios and mercury 
exposure were examples of negative results that add substantially to the discussion of 
potential ALS causes. In the case of finger ratios, the data obtained from ALS Quest showed 
that, contrary to a previous report with a limited number of participants [3], ALS and control 
respondents had similar 2D:4D finger ratios, indicating that prenatal testosterone is not likely 
to be the link between athletic ability and ALS [4]. This is likely to encourage ALS research 
community to direct their focus to other reasons why athletic activity appears to be related 
to ALS, such as head trauma and increased uptake of environmental toxins. 
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The findings in this project demonstrate that some of the most common sources of mercury 
in the general population, dental amalgam restorations and seafood consumption, are not to 
be related to the development of ALS [5]. The practical implications of these findings are that  
there would be little value in having amalgam fillings removed or limiting consumption of fish 
in attempts to avoid contracting ALS. Since mercury remains a toxin that could trigger ALS, 
further efforts could be undertaken to assess mercury exposures from other sources (for 
example, certain occupations) and to advocate for a reduction in mercury exposures for the 
human population in general (such as reductions in the burning of fossil fuels). A positive 
finding from this study was that people with ALS were more likely to consume shellfish, which 
points towards a possible link between exposure to  
b-methylamino-L-alanine (BMAA) in shellfish and the development of ALS [6]. Further 
investigation of this suggested relationship could shed additional light on how BMAA 
exposure is related to ALS.  
Two topics explored by this research project – personality and stress – had either not been 
evaluated in a rigorous fashion or had not been evaluated quantitatively before. For 
personality, the anecdotal evidence from clinicians, family members and friends who interact 
with people with ALS that they are “nice people” [7], but this had not been examined 
systematically using a comparison of a large group of people with ALS and non-ALS controls. 
Using the Big Five personality inventory, this project showed that people with ALS do in fact 
differ from controls in multiple facets of their personality. Both male and female ALS 
respondents exhibited higher levels of conscientiousness and extraversion than controls, and 
female ALS respondents had a higher score for agreeableness and a lower score for 
neuroticism than controls [8].  
A recent analysis has characterised the specific personality pattern exhibited by people with 
ALS as one of four personality types that exist in the general population, referring to it as a 
“role model” personality type because it is composed of “socially desirable” elements, and 
linking it to a prior personality type called “resilient” [9]. This suggests that people viewed as 
socially conforming and resilient may be thought of as “nice” by others. That study, however, 
did not suggest any hypotheses for how these personality types might arise in particular 
people.  
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Another theory regarding personality is the existence of a “General Factor of Personality”, 
which is approximately equivalent to the “role model” personality type and is referred to as 
a collection of personality factors related to “social effectiveness” [10]. While the finding that 
people with ALS exhibit a particular personality pattern is interesting, the question remains 
as to why a particular personality type would be related to ALS. This leaves open the 
possibility, as stated in in Chapter 4, that there may be one or more genetic factors in common 
between personality type and ALS that could underlie both conditions, a topic that could be 
pursued in future research.  
The findings of this personality study have practical implications. For example, these results 
could help clinicians better understand how to communicate with people with ALS by 
providing an insight into their personality tendencies. They might also help others consider 
how to relate to people with ALS, in seeing that some of their actions may originate from a 
tendency to exhibit “socially desirable” traits, when “social desirability” might not be in their 
best self-interest. For example, an ALS patient might be dissatisfied with some aspect of their 
treatment regime but might be inclined to go along with it regardless to avoid being seen as 
disagreeable. 
The results of these ALS personality analyses suggest there may also be aspects that relate to 
risk factors for ALS. Several examples of these possible connections are described in the 
Chapter 4 [8], one example being that people who tend to be extraverted (such as those who 
develop ALS) are more likely to smoke, which is considered to be a risk factor for the disease 
[11]. This hypothesis suggests that it is not so much that the personality type itself is a risk 
factor for ALS, rather that the personality type leads to certain behaviours that are themselves 
risk factors for ALS. 
Psychological stress as a possible risk factor for ALS is often mentioned by people with ALS, 
as indicated by a third of ALS respondents in the ALS Quest study citing it as a possible cause 
of their ALS (unpublished results). The ALS Quest study, however, did not find that ALS 
respondents experienced more stress in their lives than controls, either from their life 
experiences or from their occupations [12]. These findings therefore do not support any links 
between ALS and stress-induced increased uptake of toxins [13], nor do they do support links 
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between psychological stress, high oxidative stress, and decreased telomerase activity in the 
pathogenesis of ALS [14].  
ALS respondents displayed a higher level of pre-diagnostic resilience, which implies that they 
are less likely to have a negative response to stress than others, thus further limiting the 
likelihood of a connection between stress and ALS. This finding does provide a potential link 
between resilience and the ALS personality type, which has been characterised as a “resilient” 
phenotype [9]. Resilience arises from a combination of genetics and environmental and social 
factors, so there could be a genetic link between personality and resilience [15] that would 
be worth pursuing further with the large ALS genomic banks now available.  
7.2 Implementation of and Recruitment for the ALS Quest Questionnaire 
As the sole doctoral researcher working with Dr. Pamphlett on this project, I was the manager 
of the ALS Quest program and the person primarily responsible for the project. One 
responsibility was being the public face of ALS Quest for presentations, meetings and social 
media. As part of our work on finger measurements and the prenatal testosterone 
hypothesis, I visited eight Rotary groups to give presentations about ALS Quest and to obtain 
data for a finger measurement validation study (Appendix G). In addition, I travelled to MND 
Associations in New South Wales, Victoria, South Australia and Western Australia to talk with 
their staffs and people with ALS about ALS Quest and to encourage their participation. I also 
participated in an MND NSW Ask the Experts session and multiple scientific symposia. 
This project has taught me a multitude of skills that I would not otherwise have learned. Chief 
among these is the judicious use of social media to convey information about research. For 
ALS Quest, I have used Facebook, Twitter and YouTube as vehicles to disseminate information 
about participating in the questionnaire, to let people know about updates such as the 
addition of a new language translation to the questionnaire, and to publicise the publication 
of research papers. I also took footage from an interview conducted by MND Victoria staff 
and created a video for a video-sharing site. These outlets have been helpful for getting the 
word out about the project and our publications to a wide audience in an efficient manner. A 
large proportion of our respondents (about 25 percent) reported that the Internet or 
Facebook was their source for finding out about ALS Quest. 
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One area of ALS Quest where there were many people involved was in translating the 
questionnaire. For this task, I managed a team of 32 volunteers working on the various 
translations of the questionnaire over a course of many months. Many of these were students 
at the University of Sydney, and I provided them with instructions and any support that was 
needed. I maintained contact with the translators to encourage them in their task and to ask 
questions when they arose. This was an integral part of the development of ALS Quest and 
enabled collection of data from speakers of 25 different languages around the world.  
7.3 Directions for Future Research 
The ALS Quest questionnaire still has a great deal of information that can be mined from its 
data set. Additional factors that are being considered for analysis as risk factors are birth 
weight, medication use, head trauma and other injuries, athletic activity, previous illnesses, 
family medical history of diseases other than ALS, occupational history, and diesel exposures. 
Potential directions for future research by other investigators would be: i) to explore other 
reasons for a possible link between physical activity and ALS, given the lack of evidence for 
the prenatal testosterone hypothesis, ii) to further evaluate BMAA exposure from shellfish as 
a potential contributor to ALS pathogenesis, and iii) to consider potential genetic factors 
underlying personality and resilience that could have a commonality with ALS genetic factors. 
One of the goals of ALS Quest has been to collect a sufficient number of responses so that risk 
factors can be compared among different countries.  This would address a data gap that is 
persistent in the ALS literature [16]. While some country-specific analyses have been 
conducted with the data from ALS Quest [5], the number of countries that can be compared 
at the present time is essentially two (the United States and Australia), so further efforts are 
needed to continue to recruit ALS Quest respondents from other countries. 
7.4 Conclusions  
I have developed an online epidemiological questionnaire that provides a comprehensive 
data set for assessing potential ALS risk factors and is accessible worldwide in many 
languages. Using data from ALS Quest, I have investigated several ALS risk factors, including 
some that had not previously been evaluated in a comprehensive way. I have provided 
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evidence that several hypotheses for ALS risk factors are unlikely to be correct, including high 
prenatal testosterone, some sources of mercury exposure, and psychological stress. On the 
other hand, I have found that people with ALS do exhibit a different personality type and are 
more resilient from people without ALS, which has implications for future genetic studies.  
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APPENDIX A 
 
Copy of ALS Quest Questionnaire 
 
 
 
Note that this electronic PDF version is a complete version that does not demonstrate the 
skip logic used in the online version of the questionnaire (for example, controls without ALS 
would not see online questions related to ALS). Therefore, some questions appear to be 
duplicated, but in the online version these would be selectively displayed depending on how 
the participants had filled out the questionnaire. 
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ALS Quest: An online questionnaire for research into amyotrophic
lateral sclerosis and motor neuron disease
 
INFORMATION FOR PARTICIPANTS
 
Amyotrophic lateral sclerosis and motor neuron disease (ALS/MND)
Amyotrophic lateral sclerosis (ALS) and motor neuron disease (MND) are different names for
a group of disorders that damage the nerve cells that control muscles, and this leads to
progressive weakness.
We are interested in looking at the potential of environmental conditions to play a part in
causing ALS/MND. This questionnaire has therefore been set up to gather a wide range of
information that can be compared between people who have, and those who do not have,
ALS/MND. We hope this information will prove useful in searches for measures that can
prevent ALS/MND and for treatments of ALS/MND.
The questionnaire
You will be asked to fill out a questionnaire, which will take approximately 90 minutes to
complete.
You can do this in one session or in multiple sessions (there is no limit to the number of
times you can enter and leave the questionnaire). However, please note that if you do not
access the questionnaire for a period of four weeks, the questionnaire will be terminated and
you will not be able to re-access it.
All that is needed to complete the questionnaire is a computer (a PC or MAC) connected to
the Web (you cannot use a tablet or a smartphone to complete this questionnaire).
Even if you do not have time to fully complete the questionnaire, we would strongly
encourage you to submit whatever answers you have time to complete, as the answers
Qualtrics Survey Software https://s.qualtrics.com/ControlPanel/Ajax.php?action=GetSurvey...
1 of 74 8/04/2015 12:25 pmPage 102 of 221
provided will still be of assistance to the project.
The questionnaire includes a variety of questions about you and your life. Apart from a few
preliminary questions at the beginning of the questionnaire, answering all questions is
voluntary (so you can choose not to answer a question if you wish).
People who are eligible to complete the questionnaire
Both people with and without ALS/MND are eligible to complete the questionnaire. It is
important to have as many participants as possible who do not have ALS/MND also
completing the questionnaire.
 
People who have ALS/MND are eligible to complete the questionnaire if the diagnosis
has been made by a neurologist.
1. 
A person with ALS/MND can complete the questionnaire without asking anybody else to
do so. However, we encourage people with ALS/MND to ask their spouse/partner and
friends (of either gender) to also complete the questionnaire. People with ALS/MND are
asked to give their spouse/partner and friends a 6-digit code so that their answers can
be compared statistically.
2. 
Any member of the community who has an interest in ALS/MND is encouraged to
complete the questionnaire. This includes, for example, individual members of the
community, members of community organisations, health workers, and
scientists/researchers.
3. 
Minimum age
You need to be aged 18 years or more to complete the questionnaire.
Benefits of the study
While we intend that this questionnaire (and the data that arise from it) furthers medical
knowledge and may improve prevention and treatment of ALS/MND in the future, it may not
be of direct benefit to you.
Dissemination of research results
The results from the study will be presented at professional conferences and will be
published in peer-reviewed scientific journals.
Confidentiality
Since your questionnaire responses are anonymous, no identifiable information about you is
obtained for this study. Your questionnaire responses will be transferred to a secure
computer database at The University of Sydney, and will then will be removed from the
secure Qualtrics server that initially processes the questionnaire (Qualtrics is the name of
the software that drives the questionnaire).
Spouse/partners and friends will not be able to use the 6 digit code (given to them by the
person with ALS/MND) to access the questionnaire responses of the person with ALS/MND,
and vice versa.
The Qualtrics survey software initially collects the IP address (the Internet Protocol that
identifies a computer) of the computer from which the questionnaire originated. However,
this IP address will be deleted from the Qualtrics server after your response has been
transferred to the University of Sydney database, and then also deleted from The University
of Sydney database, so no record will be kept of the computer that you used to respond to
the questionnaire.
Discontinuing your participation
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Even after you have given consent to undertake the questionnaire, you are free to withdraw
your information in the questionnaire at any time, without giving any reason, simply by
leaving the questionnaire (and without clicking the "Submit" button at the end of the
questionnaire). Your non-submitted answers will be deleted by the questionnaire
administrator.
If you want to terminate the questionnaire immediately, you can remove your answers by
removing Cookies on your computer (see later for how to do this). The questionnaire
administrator will delete your non-submitted answers.
After you have clicked the “Submit” button your answers will be transferred to the database
and cannot be removed, since we have no way of identifying individuals from whom the
submitted questionnaire data have come.
 
Contacts
The questionnaire is managed by A/Prof Roger Pamphlett at the University of Sydney,
Australia. To contact the administrators of the questionnaire for any questions or comments
please email als.quest@sydney.edu.au.
This study has been approved by the Ethics Review Committee (RPAH Zone) of the Sydney
Local Health District. Any person with concerns or complaints about the conduct of this
study should contact the Executive Officer on 02 9515 6766 and quote protocol number
X14-0357.
To begin (or continue) the questionnaire, please click the forward (>>) button in the lower
right corner of the screen.
GUIDE TO COMPLETING THE QUESTIONNAIRE
GUIDE TO COMPLETING THE QUESTIONNAIRE
Setting Up the Questionnaire
 
You will need a desktop or laptop computer to complete the Questionnaire. You cannot
use a tablet or smartphone to complete the Questionnaire.   
 
This Questionnaire is compatible with the most common Internet browsers such as
Firefox, Internet Explorer, Chrome, and Safari.  If you are having problems taking the
Questionnaire with your current browser, we recommend that you try using the Firefox
Internet browser, as this browser has been shown to work best with the Questionnaire.
The Firefox browser can be downloaded free of charge from the Web at
www.mozilla.com.
 
Once you have started the Questionnaire, you need to continue using the same
computer to complete the Questionnaire.   
 
Remember that you may complete the questionnaire in multiple sessions.  This gives
you time to gather information you may not have to hand.
 
The Questionnaire is compatible with voice-recognition and speech-to-text programs.
   
One of the questions asks for measurements, so you may find it useful to have a rigid
ruler (not a tape measure) on hand before you begin.    
 
For people with ALS/MND who are unsure about the type of ALS/MND they have (see the
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ALS CLINICAL INFORMATION section for details), we recommend contacting your
neurologist or family doctor/general practitioner early for this information, since it may
take some time before you receive it.  
Viewing the Questionnaire
 
If you'd like to make the text of the Questionnaire larger or smaller on your screen, you
can use the zoom function of your Internet browser.  In Firefox, you can adjust the zoom
under the View menu. 
 
You can also use the keyboard commands CTRL (on a PC) or COMMAND (on a Mac) and
+ (plus) for zoom in, or CTRL or COMMAND and - (minus) for zoom out.    
Progressing through the Questionnaire
 
Use the Forward (>>) and Back (<<) buttons to progress through the Questionnaire.
When you click the Back button (<<) a window saying "Confirm Navigation" will appear. 
Simply select the "Go Back" box to go back to the previous page.  
 
When you click the “next” button (>>), first check to see that you are viewing the blue
“Qualtrics” banner at the top of the page.  This will ensure that you are starting at the
top of the page. 
 
You may need to scroll from left to right to view the whole width of a question and its
answers, depending on the resolution of your browser window.   
 
Use the Table of Contents icon at the top left corner of the page to jump to different
headings. (You may need to scroll to the top of the page to see this.)
 
Do not use the forward and back buttons on your Internet browser while in the
Questionnaire. If you do so inadvertently, click through the prompts in your browser to
return to the Questionnaire. You will not have lost any answers.
Answering Questions
 
To find an item in a dropdown list quickly, you can type the first few letters of the item. 
 
If you want to remove a response entered in a dropdown list, select the blank at the top
of the list.     
 
When typing in your answers, you don't have to use capitals/upper case (so you can
type in all lower case if you prefer).
 
You can change answers if you want to.      
Starting/Continuing the Questionnaire
 
You can stop and later resume your session whenever you like. Your answers are saved
automatically.
 
Your answers are saved on a "Cookie" (a piece of Internet data), which has been
automatically created by your web browser. Do not delete your Cookies during the
process of completing the Questionnaire, for example, by using CCleaner or via a
setting that automatically deletes all Cookies when you close your browser.  If Cookies
are deleted before you submit the Questionnaire, you will need to restart the
Questionnaire.        
 
Exit the Questionnaire simply by closing the window that you are working in (you will
not be asked to log out).
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Yes, I have been diagnosed with ALS/MND
No, I have not been diagnosed with ALS/MND
I am the spouse/partner of someone with ALS/MND.
(If your partner has passed away from ALS/MND, please select “I have another
connection with ALS/MND” below and specify “Partner had ALS/MND".)
I am a friend of someone with ALS/MND.
I have a relative or relatives (either present or past) with a diagnosis of
ALS/MND.
I have another connection with ALS/MND (please specify):
I have no specific connection with ALS/MND.
To resume the Questionnaire, re-enter the Web link. The Questionnaire will continue
where you left off.      
Additional Questionnaire Respondents
 
You need to submit your Questionnaire before a second person (for example, your
partner) can start their Questionnaire on the same computer.  Once you have submitted
your Questionnaire, delete all Cookies from your Internet browser (do not delete
Cookies until you have finished your Questionnaire, since this will delete all your
answers) to allow the second person access to a new Questionnaire. If you need
instructions on how to delete Cookies, search Google for “How to delete Cookies” and
include your browser name.
Thank you for participating in this research study
PRELIMINARY INFORMATION
PRELIMINARY INFORMATION
To activate the questionnaire, we need you to first answer a few questions on this page, and
then consent to taking the questionnaire. Answering any of the other questions in the
questionnaire will be optional.
Do you have amyotrophic lateral sclerosis/motor neuron disease (ALS/MND) that has been
diagnosed by a neurologist?
What is your connection with ALS/MND?
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From a person with ALS/MND
From an ALS/MND Association (for example, at a meeting or in a newsletter)
From the Internet
From a health professional
From a community group
From a friend or acquaintance who does not have ALS/MND
From a newspaper, television, or radio report
Other (please specify):
Unique number:
I do not have the unique identifying number of my spouse/partner with
ALS/MND who suggested I undertake the questionnaire.
How did you hear about this questionnaire?
For how many years have you been the spouse/partner of someone with ALS/MND? (before
they were diagnosed with ALS/MND)
 
For how many years have you been a friend of someone with ALS/MND? (before they were
diagnosed with ALS/MND)
 
Please enter the unique identifying number of the spouse/partner with ALS/MND who
suggested you undertake the questionnaire:
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Unique number:
I do not have the unique identifying number of my friend with ALS/MND who
suggested I undertake the questionnaire.
Male
Female
Please enter the unique identifying number of the friend with ALS/MND who suggested you
undertake the questionnaire:
Please create a 6-digit code, consisting of 4 letters and 2 numbers, that you can give to your
spouse/partner and friends (not blood relatives) that you ask to complete the questionnaire
(use the same code for both your spouse/partner and your friends). The letters and numbers
can be in any order, for example A12B34 (do not use this example for your code). Whether
the letters are in upper or lower case does not matter (it is not case-dependent). Do not
repeat any letters or numbers.
Please write your code down separately from the questionnaire, so that you can remember it
later if necessary.
Your spouse/partner and friends will not be able to use this code to access your
questionnaire responses.
What was your age at your last birthday?
 
What is your gender?
CONSENT
CONSENT
 
Please click on the “I Consent” button below to indicate your consent to enter data into the
questionnaire.
 
Qualtrics Survey Software https://s.qualtrics.com/ControlPanel/Ajax.php?action=GetSurvey...
7 of 74 8/04/2015 12:25 pmPage 108 of 221
By clicking this button, I:
 
1. Acknowledge that I have read the “Information for Participants” above and agree to
participate in this research.
 
2. Understand that I will not be asked for any personal information that could identify me, so
the study is anonymous and strictly confidential.
3. Freely choose to participate in the study and understand that I can withdraw my
questionnaire answers at any time until I click the “Submit” button at the end of the
questionnaire.
 
Please enter today's date using the fields below.
 
Remember, the questionnaire needs to be submitted within 4 weeks of this date, or your
response will be discarded. You may want to make a note of this date 4 weeks from now in
your diary.
Day Month Year  
Date of
Consent
    
GENERAL INFORMATION
GENERAL INFORMATION
We would like to know some basic information about yourself.
 
In which country are you currently living?
 
In which month of the year were you born?
 
In which country were you born?
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Urban (population greater than 50,000) - Inner City
Urban (population greater than 50,000) - Suburb
Regional centre (population less than 50,000)
Rural (non-farm)
Rural (farm)
Yes
No
I don't know
Yes
No
Which of the following best describes the place you were born?
Please estimate the total number of years that you have lived in each the following types of
environment. For people with ALS/MND, include only those places where you lived before
you were diagnosed with ALS/MND.
Number of
Years  
Urban (population greater than 50,000) – Inner city   
Urban (population greater than 50,000) – Suburb   
Regional centre (population less than 50,000)   
Rural (non-farm)   
Rural (farm)   
Were you delivered by Cesarean section (c-section)?
Do you have a written record of your birth weight that you can refer to?
What was your birth weight according to the written record? Please choose a unit in the first
column and enter a number in the second column.  If you'd like to enter your weight in
pounds and ounces, use the first text box for pounds and the second text box for ounces.
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Primary (elementary) school
Secondary (high) school
Non-university diploma or certificate
University undergraduate degree (Bachelor)
University postgraduate degree (Doctoral, Masters)
Unit Weight in kg or lb Weight in ounces (ifnecessary)
Value Value
Enter weight here:  
What is your ancestry?  Please select either one or two ancestries (if two, select one in each
column; if one, leave the second column blank).
Ancestry 1 Ancestry 2  
Select:    
With which cultural groups do you most identify yourself? Please select either one or two
groups (if two, select one in each column; if one, leave the second column blank). These can
be the same or different from your ancestries.
Cultural Group 1 Cultural Group 2  
Select:    
What is the highest level of education that you have completed?
How many years of education have you had in total?  If any of your education was part-time,
please estimate the total in full-time equivalent years.
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Never married
Married (registered)
Separated
Divorced
Widowed
Yes
No
Yes
No
What was the main field of study of the highest qualification you have completed?
What is your present marital status?
Do you have a de facto partner?
What language do you usually speak at home?  Please note that English is listed first in the
drop-down menu.
 
Do you see yourself as belonging to any particular religion?
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Once a week or more
Once a month or more
Sometimes, but less often than once per month
Never or rarely
Apart from such special occasions as weddings, funerals and baptisms, how often do you
attend services or meetings connected with your religion?
Please enter the amount of annual total personal income you received (before your ALS/MND
diagnosis). Please indicate the amount as a whole number (that is, no decimal point, for
example, for $75,000 enter 75000).  Please note that the Australian dollar and the United
States dollar are listed first in the drop-down menu.
Currency Amount  
 
Personal Annual
Income
  
What is your personal annual total income? Please indicate the amount as a whole number
(that is, no decimal point, for example, for $75,000 enter 75000).  Please note that the
Australian dollar and the United States dollar are listed first in the drop-down menu.
Currency Amount  
 
Personal Annual
Income
  
Please enter the amount of annual total income your family received before your ALS/MND
diagnosis.  Please indicate the amount as a whole number (that is, no decimal point, for
example, for $75,000 enter 75000).  Please note that the Australian dollar and the United
States dollar are listed first in the drop-down menu.
Currency Amount  
 
Family Annual
Income
  
What is the annual total income of your family? Please indicate the amount as a whole
Qualtrics Survey Software https://s.qualtrics.com/ControlPanel/Ajax.php?action=GetSurvey...
12 of 74 8/04/2015 12:25 pmPage 113 of 221
number (that is, no decimal point, for example, for $75,000 enter 75000).  Please note that the
Australian dollar and the United States dollar are listed first in the drop-down menu.
Currency Amount  
 
Family Annual
Income
  
PHYSICAL FEATURES
PHYSICAL FEATURES
We would appreciate knowing certain information about your physical appearance.
What is your weight? Please enter your usual weight (before your ALS/MND diagnosis).
Choose the unit of measurement in the first column and enter a numerical weight in the
second column.
Unit Weight  
Value
Enter weight here:   
PHYSICAL FEATURES
We would appreciate knowing certain information about your physical appearance.
Please enter your current weight.
Choose the unit of measurement in the first column and enter a numerical weight in the
second column.
Unit Weight  
Value
Enter weight here:   
What is your height?  Choose the unit in the first column and enter the numerical value in the
first text box.   If you choose to enter your height in feet and inches, use the first text box for
feet and the second text box for inches.
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Right-handed
Left-handed
Ambidextrous
Right foot
Left foot
I cannot straighten out the fingers on both of my hands, when I lay the back of
my hands down on a flat surface.
Unit Height in cm or ft Height in inches (ifnecessary)  
Value Value
Enter height here:   
Are you right- or left-handed?
With which foot would you kick a ball?
We would like to know the lengths of your index and ring fingers.
 
If you cannot straighten your fingers on both hands, please select the option below to skip
this question. If you can straighten the fingers on only one hand, do not select this option.
Please measure the lengths of your index (second) and ring (fourth) fingers on each hand.
The diagram below shows you how to make the measurements.
If you can only straighten out the fingers on one hand, only record the measurements for
that hand.
If possible, please take off any rings prior to measuring your fingers. 
First lay the back of your hand out flat on a level surface, with your fingers together. Then,
with a rigid millimetre ruler (not a tape measure), measure from (1) the tip of the finger to (2)
the middle of the crease at the bottom of the finger. The ring finger often has two of these
creases, so here measure from the crease that is closest to the wrist.
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Blonde or Strawberry Blonde
Brown (light, medium or dark)
Black
Red
Auburn (reddish-brown)
 
 
Left Hand (mm) Right Hand (mm)  
What is the
length of your
index (second)
finger in
millimetres?
   
What is the
length of your
ring (fourth)
finger in
millimetres?
   
What is your predominant natural hair color? If your hair is now grey, this is the colour of
your hair before you turned grey.
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1. No hair loss
2. Mild receding hair line
3. Moderate receding hair line and mild hair loss at the top of the head
4. Moderate receding hair line and marked hair loss at the top of the head
5. Marked hair loss with joining up of receding hair line and hair loss at top of
head
Not applicable (that is, you are less than 45 years old)
Brown
Blue
Green
Green-Brown (Hazel)
Grey
This question is for men aged over 45 years only.
 
Which of the following most closely approximates your hair pattern at age 45 years? 
 
Please estimate the pattern of hair loss (if any) you had when you were this age with the aid
of the figure below. You may need a photograph of yourself at about this help to jog your
memory.
          1              2            3             4             5
What is your predominant natural eye color?
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Very fair
Fair
Medium
Olive
Dark
Very dark
Black
Go very brown and deeply tan
Get moderately tan
Get mildly or occasionally tan
Get no suntan at all or only get freckled
Which colour best describes the colour of the skin on the inside of your upper arm, that is,
your skin colour without any tanning?
What would happen to your skin if it was repeatedly exposed to bright sunlight in summer
without any protection?
OCCUPATIONS
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OCCUPATIONS
Next are some questions about your occupational history. Please provide as detailed a
response as possible (you are not limited in the length of your response by the size of the
boxes). This may take several minutes, but it is important information.
 
Please provide your occupational history (including part-time employment) from your first
job (top row) up to the present day, for jobs you held for 6 months or longer.  Please only list
your occupations up until the time you were diagnosed with ALS/MND.
 
If you stayed with the same employer but changed the type of work you did (for example, you
changed from Grocery clerk to Assistant manager) please consider that as two occupations,
even though they were for the same employer. If you went back to a previous occupation
after a break, enter it a second time.
1. In the first column, “Occupation Title”, give the full title of the occupation, for example,
Childcare aide, Maths teacher, Pastry cook, Tanning machine operator, Apprentice toolmaker,
or Sheep and wheat farmer. For public servants provide the official designation and
occupation. For armed services personnel provide rank and occupation (note: there is an
additional section for Armed Forces personnel). For all unpaid work in the home, use the
Occupation Title “Domestic duties”, Employer Business “Various”, and Duties “Various”.
2. In the second column, “Employer Business” describe the industry or business of the
Employer, for example, Repairs and maintenance, Education, Agriculture, Finance, Medicine,
or Telecommunications service.
3. In the third column, “Duties”, describe what activities you performed in this occupation.
4. In the next column please enter the number of years you spent in that occupation.
5. In the final three columns, please estimate the level of physical activity, the level of stress
involved, and the amount of time outdoors for each occupation.
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OCCUPATIONS
Next are some questions about your occupational history. Please provide as detailed a
response as possible (you are not limited in the length of your response by the size of the
boxes). This may take several minutes, but it is important information.
 
Please provide your occupational history (including part-time employment) from your first
job (top row) up to the present day, for jobs you held for 6 months or longer.
If you stayed with the same employer but changed the type of work you did (for example, you
changed from Grocery clerk to Assistant manager) please consider that as two occupations,
even though they were for the same employer. If you went back to a previous occupation
after a break, enter it a second time.
1. In the first column, “Occupation Title”, give the full title of the occupation, for example,
Childcare aide, Maths teacher, Pastry cook, Tanning machine operator, Apprentice toolmaker,
or Sheep and wheat farmer. For public servants provide the official designation and
occupation. For armed services personnel provide rank and occupation (note: there is an
additional section for Armed Forces personnel). For all unpaid work in the home, use the
Occupation Title “Domestic duties”, Employer Business “Various”, and Duties “Various”.
2. In the second column, “Employer Business” describe the industry or business of the
Employer, for example, Repairs and maintenance, Education, Agriculture, Finance, Medicine,
or Telecommunications service.
3. In the third column, “Duties”, describe what activities you performed in this occupation.
4. In the next column please enter the number of years you spent in that occupation.
5. In the final three columns, please estimate the level of physical activity, the level of stress
involved, and the amount of time outdoors for each occupation.
Please enter your occupations in this table, with your first job in the first line:
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Yes
No
Occupational History Number ofYears
Physical
Activity
Involved Involved
Occupation Title EmployerBusiness Your Duties
1    
2    
3    
4    
5    
6    
7    
8    
9    
10    
11    
12    
13    
14    
15    
16    
17    
18    
19    
20    
Have you ever served in the military or armed services?
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Army
Navy
Air Force
Other (please specify):
Yes
No
Which branch of the military or armed services did you serve in?
Have you ever been deployed on active duty?
For each deployment, please select your age at the time of deployment, enter the location
where were you deployed, and specify what your role in the deployment was (for example, air
combat, cook, transport, administration).  If you have been on more than 10 deployments,
please try to list those deployments that were longest in duration.
Age Location Role  
  
Deployment 1   
Deployment 2   
Deployment 3   
Deployment 4   
Deployment 5   
Deployment 6   
Deployment 7   
Deployment 8   
Deployment 9   
Deployment 10   
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Yes
No
Have you had exposure to chemicals in your workplace?
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Acetylaldehyde
Acetone
Aliphatic chlorinated hydrocarbons
Aliphatic hydrocarbons
Amyl acetate
Aromatic hydrocarbons
Benzene
Benzidine
Carbon disulphide
Carbon tetrachloride
Cyclohexane
1,2-Dichloroethane (synonym: ethylene dichloride)
Dichloromethane (synonym: methylene chloride)
N, n-dimethylformamide
1,4-Dioxane
Epichlorhydrin
Ethyl acetate
Ethanol
Ethyl ester
Ethylene/propylene glycol
2-Ethoxyethanol (acetate)
Formaldehyde (synonym: formalin)
Glycol ethers
Heptane
Hexane
Methanol (synonym: wood alcohol)
Methyl n-butyl ketone (synonyms: MBK, 2-hexanone)
Methyl ethyl ketone (synonyms: MEK, 2-butanone)
Methyl tert butyl ether (MTBE)
Methylene chloride (synonym: chloroform)
2-Methoxyethanol (acetate)
Naptha
Perchloroethylene/Tetrachloroethylene/PCE
Stoddard solvent
Styrene
Toluene
1,1,1-Trichloroethane (synonym: methyl chloroform)
Trichloroethylene/TCE
Trichlorotrifluoroethane (CFC-113)
Xylenes (synonym: dimethylbenzene)
Other (please specify):
Other (please specify):
Have you been exposed to any of the following chemicals?  Please answer to the best of
your knowledge, and check off any that may apply.
Under “Other” (at the end of the list), you can enter chemical, trade, and/or common names if
you do not see the relevant chemical in the list.
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Lead
Mercury
Cadmium
Copper
Other metal/mineral (please specify):
Other metal/mineral (please specify):
Other metal/mineral (please specify):
None of the above
Yes
No
As part of your occupation, have you ever worked with any of the following?  Please check
any that apply.  If none, select "None of the above" in the last row.
Either as part of your occupation, or domestically (for example, during gardening) have you
ever been exposed to herbicides or pesticides regularly (once or more per week) for a period
of 6 months or more?
Which herbicides or pesticides have you been exposed to regularly for 6 months or more?
List the trade names of the products, and select whether exposure was occupational or
domestic.
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Herbicide/Pesticide Name Exposure Type  
 Occupational Domestic
Herbicide/Pesticide 1  
Herbicide/Pesticide 2  
Herbicide/Pesticide 3  
Herbicide/Pesticide 4  
Herbicide/Pesticide 5  
Herbicide/Pesticide 6  
Herbicide/Pesticide 7  
Herbicide/Pesticide 8  
Herbicide/Pesticide 9  
Herbicide/Pesticide 10  
Herbicide/Pesticide 11  
Herbicide/Pesticide 12  
Herbicide/Pesticide 13  
Herbicide/Pesticide 14  
Herbicide/Pesticide 15  
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Living near a major road or highway
Living in an inner-city
Commuting to and from work for a daily total of 2 hours or more
Driving a diesel-fueled passenger vehicle
Driving a diesel-fueled light commercial vehicle
Driving a bus
Driving a truck
Driving a land, sea or air military vehicle
Using diesel-fueled farm equipment
Working on a diesel-fueled boat or ship
Operating heavy machinery
Working on or at a railroad, mine, toll-booth, dock or garage/petrol station
Traveling on a school bus as a child
Cooking on a diesel-fueled stove
Using a diesel-fueled heater
Other (please specify):
Other (please specify):
Other (please specify):
None of the above
Yes
No
Have you ever been exposed to diesel fuel or fumes on a regular basis (at least once a week
for 6 months or more), in any of the ways listed below? Please select all that apply.
Have you ever been exposed to a severe electrical shock, that is, a shock that caused a burn
or for you to be thrown off your feet?
 
Only answer "Yes" if the shock occurred before you were diagnosed with ALS/MND.
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Yes
No
Yes
No
Have you ever been exposed to a severe electrical shock, that is, a shock that caused a burn
or for you to be thrown off your feet?
What age or ages were you when you were exposed to the electric shock?  Please list up to
three, as applicable.
Age  
First electric shock   
Second electric shock   
Third electric shock   
Did you get your first weakness in the same limb which received the electric shock?
PERSONAL HABITS AND PASTIMES
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Organic
Vegetarian
Vegan
Lactose intolerant/lactose free
Gluten free (or diet suitable for those with celiac disease)
Other (please specify):
Other (please specify):
Other (please specify):
PERSONAL HABITS AND PASTIMES
Do you have any particular dietary practices that you have used for most of your life?  Please
select any that apply, and indicate only those that you used before your ALS/MND diagnosis.
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Organic
Vegetarian
Vegan
Lactose intolerant/lactose free
Gluten free (or diet suitable for those with celiac disease)
Other (please specify):
Other (please specify):
Other (please specify):
Never
Less than once a month
Once a month
2-3 times a month
Once a week
2-3 times a week
4-6 times a week
Daily
PERSONAL HABITS AND PASTIMES
Do you have any particular dietary practices that you have used for most of your life?  Please
select any that apply.
How often do you eat fish or shellfish?
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Tap/municipal water
Well water
Water from a drilled source (bore water)
Rainwater
Water collected and stored in a tank
Flat bottled water
Sparkling bottled water
Please list up to three of your favourite fish to eat.
Fish 1
Fish 2
Fish 3
What type of water do you drink on a frequent basis (that is, on most days)?  Select any that
apply.
Caffeine consumption
How often do you have a drink containing caffeine?    
How many drinks containing caffeine do you have on a typical day?    
How often do you have five or more caffeinated drinks on one occasion?    
Alcohol Consumption
How often do you have a drink containing alcohol?    
How many drinks containing alcohol do you have on a typical day when you
are drinking?   
 
How often do you have five or more alcoholic drinks on one occasion?    
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Yes
No
Cigarette
Cigar
Pipe
Have you even been a cigarette, cigar, or pipe smoker?
Which tobacco products do/did you smoke at least once per week for six months or longer? 
Please select any that apply.
Please answer the following questions about your tobacco usage. If not applicable, choose
"Not Applicable" from the dropdown menu.
Age/Number  
What age did you start?   
What age did you stop? (if applicable)   
How many cigarettes per day do/did you
smoke?
  
How many cigars per week do/did you
smoke?
  
How many pipes per week do/did you
smoke?
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Removing old paint from furniture
Painting pictures or furniture with oil based paint
Home remodeling/renovation projects that involved scraping, stripping, burning
or sanding paint. Please list the year that you remodeled/renovated your home:
Glazing pottery or other ceramics
Working with leaded crystal glass
Stained glass or art glass using lead joints
Repairing or restoring cars, other than fixing a flat tire or changing oil
Building wooden or plastic models using glue
Developing photographs
Leather work
Metal work
Soldering
Woodworking
Silver jewelry work
Polishing or grinding gemstones using lead
Enameling
Gardening or lawn care
Outdoor hunting or shooting
Gun shooting in an indoor pistol or rifle range
Casting of bullets or reloading of ammunition
Fishing using lead weights or sinkers
None of the above
Please check off the boxes below for hobbies that you have participated in, at least one time
per month for six months or more. 
If none, select "None of the above."
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0 (that is, you have never left your country of residence)
1-10
11-20
21-30
31-40
41-50
More than 50
Please list any other hobbies or pastimes that you have, if not listed above:
(if none, enter "None" in the first box)
Hobby 1
Hobby 2
Hobby 3
Hobby 4
Hobby 5
Hobby 6
Hobby 7
Hobby 8
Hobby 9
Hobby 10
Please estimate how many countries (outside of the one you are residing in) you have
traveled to in your lifetime (for either holidays or business).
Over the past ten years, how many airline flights (of any length) have you taken, on average,
per year?
 
Please list any pets that you have had.  First list the type of pet (for example, cat or dog), with
each pet type in a different line. Then select the total number of each kind of pet, and indicate
Qualtrics Survey Software https://s.qualtrics.com/ControlPanel/Ajax.php?action=GetSurvey...
33 of 74 8/04/2015 12:25 pmPage 134 of 221
Never
Less than once a month
Once a month
2-3 times a month
Once a week
2-3 times a week
Daily
whether the pets spent most of their time indoors or outdoors.  If you have never had any
pets, enter "None" in the top left box only.
Type of Pet Total Number Indoor/Outdoor  
 Mostly indoors Mostly outdoors
Pet 1   
Pet 2   
Pet 3   
Pet 4   
Pet 5   
Pet 6   
Pet 7   
Pet 8   
Pet 9   
Pet 10   
Pet 11   
Pet 12   
Pet 13   
Pet 14   
Pet 15   
How often do you go boating or swimming in a natural freshwater body, for example in a lake
or river (not in the ocean or in a swimming pool)?
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Yes
No
I don't know
Yes
No
I don't know
Yes
No
Do you regularly (once a week or more) use an underarm deodorant that contains aluminium
(also known as aluminum)?
You can see if your deodorant contains aluminium by checking the list of contents on the
side of the container.
Have you ever used any medications containing bismuth? (for example, some medications
for digestive complaints contain bismuth – you can see this from the list of ingredients on
the container)
EXERCISE
EXERCISE
Next are a few questions about your participation in sports and physical activities.
Are you, or have you been, physically active and/or participated in organised sports?
Please list the physical and/or athletic activities you have participated in.
Please categorise the activity as either leisure activity (that is, activity in your own time),
recreational organised sport (that is, a competitive unpaid sport), or professional sport (that
is, paid sport). 
If you have participated in more than 15 activities, please list the ones you participated in for
the longest.
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Never
Less than once a month
Once a month
2-3 times a month
Once a week
2-3 times a week
4-6 times a week
Daily
Type of Activity Description ofActivity
Number of
Years
Participated
Hours per
week
(estimate)
Intensity of
Activity
 
Activity 1     
Activity 2     
Activity 3     
Activity 4     
Activity 5     
Activity 6     
Activity 7     
Activity 8     
Activity 9     
Activity 10     
Activity 11     
Activity 12     
Activity 13     
Activity 14     
Activity 15     
How often do you participate in recreational exercise (for example, going to the gym)?
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Yes
No
Have you ever engaged in sport that required strenuous physical effort (for example, running
a marathon)?
Please list the strenuous physical activities that you have participated in.
Strenuous Physical Activity Number of YearsParticipated  
 
Activity 1   
Activity 2   
Activity 3   
Activity 4   
Activity 5   
Activity 6   
Activity 7   
Activity 8   
Activity 9   
Activity 10   
Activity 11   
Activity 12   
Activity 13   
Activity 14   
Activity 15   
MEDICAL AND SURGICAL HISTORY
MEDICAL AND SURGICAL HISTORY
Next are some questions about your medical history.  Please provide as much detail as
possible.
Please list any conditions for which you have been treated medically (as opposed to
surgically), and your age at diagnosis.  If you have more than 15 conditions, please list those
that are/were most significant. 
If none, please enter "None" in the top left "Condition 1" box only.
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Yes
No
Yes
No
Medically-Treated Condition Age atDiagnosis  
 
Condition 1   
Condition 2   
Condition 3   
Condition 4   
Condition 5   
Condition 6   
Condition 7   
Condition 8   
Condition 9   
Condition 10   
Condition 11   
Condition 12   
Condition 13   
Condition 14   
Condition 15   
Have you ever had poliomyelitis (also called polio or infantile paralysis)?
At what age did you get poliomyelitis?
 
Did you suffer any permanent muscle weakness at the time of getting poliomyelitis?
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Yes
No
Yes
No
I don't know
Did this muscle weakness increase later when you were an adult?
List any conditions for which you have been treated surgically, and your age at diagnosis.  If
you have more than 15 conditions, please list those that are/were most significant. 
If none, please enter "None" in the top left "Condition 1" box only.
Surgically-Treated Condition Age atDiagnosis  
 
Condition 1   
Condition 2   
Condition 3   
Condition 4   
Condition 5   
Condition 6   
Condition 7   
Condition 8   
Condition 9   
Condition 10   
Condition 11   
Condition 12   
Condition 13   
Condition 14   
Condition 15   
Have you ever had any metallic objects, such as joint replacements or missile fragments,
placed or lodged in your body?
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What type of metallic object was it, and between what ages did you have it? List up to three
objects, as applicable.
Type of metallic object Age in Age out (ifapplicable)  
 
Object 1    
Object 2    
Object 3    
Have you ever experienced any instances where you hit your head or neck, resulting in one
or more of the following symptoms?
Being dazed, confused, disoriented or “seeing stars” at the time of the incident
Not remembering the injury
Experiencing headache, dizziness, nausea, irritability, or memory impairments following
the incident
Losing consciousness
If you have experienced any of these occurrences, please select from the dropdown menus
the age when the trauma occurred, the description of your symptoms, and the circumstances
under which the trauma occurred.
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Age of
Occurrence Description of Symptoms Circumstances of Trauma
Trauma 1    
Trauma 2    
Trauma 3    
Trauma 4    
Trauma 5    
Trauma 6    
Trauma 7    
Trauma 8    
Trauma 9    
Trauma
10
   
Trauma
11
   
Trauma
12
   
Trauma
13
   
Trauma
14
   
Trauma
15
   
Please list the times you have had non-head injuries (for example, bone fractures or bruises)
severe enough to require medical attention.  Record the nature of the injury, the part of the
body injured,  and the age you were at the time of the injury. 
If you have not had any such injuries, please enter "None" in the top left “Injury 1” box.
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Yes
No
Part of body injured Nature of injury Age at time ofinjury
  
Injury 1  
Injury 2  
Injury 3  
Injury 4  
Injury 5  
Injury 6  
Injury 7  
Injury 8  
Injury 9  
Injury 10  
Injury 11  
Injury 12  
Injury 13  
Injury 14  
Injury 15  
Have you ever had a psychological or psychiatric condition for which you consulted a health
professional?
Please list the psychological or psychiatric conditions below (up to four), and for each,
indicate your age at the initial consultation and what type of health professional you
consulted for the condition.
Condition Age at InitialConsultation
Health Professional
Consulted  
 
Condition 1    
Condition 2    
Condition 3    
Condition 4    
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Yes
No
I don't know
Yes
No
List any medications that you have taken regularly (that is, daily for at least 6 months) during
your lifetime.
If none, please enter "None" in the top Medication 1 box only.
Name of Medication  
 
Medication 1  
Medication 2  
Medication 3  
Medication 4  
Medication 5  
Medication 6  
Medication 7  
Medication 8  
Medication 9  
Medication 10  
Medication 11  
Medication 12  
Medication 13  
Medication 14  
Medication 15  
Have you ever used any vitamin or mineral supplements that contain chromium? The
contents of any vitamin or mineral supplements you use can be found on the container.
Do you have any allergies?
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Yes
No
Please list the substances that you are allergic to:
Allergen 1
Allergen 2
Allergen 3
Allergen 4
Allergen 5
Allergen 6
Allergen 7
Allergen 8
Allergen 9
Allergen 10
What is your blood type?
 
DENTAL HISTORY
DENTAL HISTORY
Have you ever had an amalgam restoration (“silver” filling) as part of dental care?
How many amalgam silver dental fillings do you currently have? For people with ALS/MND,
enter the number you had before being diagnosed. You may need somebody to help you
count the silver fillings in your mouth.
 
“Occlusal” fillings are those that involve the top surface of the tooth (where you bite).
“Non-occlusal” fillings are those that involve the side of the tooth only.
 
If you do not currently have any silver fillings, please choose "0".
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Yes
No
Number of fillings  
Occlusal silver
fillings
  
Non-occlusal silver
fillings
  
If you currently have no silver amalgam dental fillings, how many have you had any in the
past?
 
Have you ever had a gold dental filling (restoration)?
How many amalgam gold dental fillings do you currently have? For people with ALS/MND,
enter the number you had before being diagnosed. You may need somebody to help you
count the gold fillings in your mouth.
 
“Occlusal” fillings are those that involve the top surface of the tooth (where you bite).
“Non-occlusal” fillings are those that involve the side of the tooth only.
 
If you do not currently have any gold fillings, please choose "0".
Number of fillings  
Occlusal gold fillings   
Non-occlusal gold
fillings
  
If you currently have no gold amalgam dental fillings, how many have you had any in the
past?
 
PERSONALITY
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PERSONALITY
Next we ask you to complete some questions to help assess your personality.
 
Below is a collection of phrases that can describe some aspects of a person’s personality. 
For each item, select the option that best indicates how much you agree with the statements
as they apply to you. Please select the option that would have applied to you before your
ALS/MND diagnosis.
   
Not true at
all Rarely true
Sometimes
true Often true
True nearly
all the time
I am able to adapt when changes
occur.   
I have at least one close and
secure relationship that helps me
when I am stressed.
  
When there are no clear solutions
to my problems, sometimes fate
or God can help.
  
I can deal with whatever comes
my way.   
Past successes give me
confidence in dealing with new
challenges and difficulties.
  
I try to see the humorous side of
things when I am faced with
problems.
  
Having to cope with stress can
make me stronger.   
   
Not true at
all Rarely true
Sometimes
true Often true
True nearly
all the time
I tend to bounce back after illness,
injury or other hardships.   
Good or bad, I believe that most
things happen for a reason.   
I give my best effort no matter
what the outcome may be.   
I believe I can achieve my goals,
even if there are obstacles.   
Even when things look hopeless, I
don't give up.   
During times of stress/crisis, I
know where to turn for help.   
Under pressure, I stay focused
and think clearly.   
   
Not true at
all Rarely true
Sometimes
true Often true
True nearly
all the time
I prefer to take the lead in solving
problems rather than letting
others make all the decisions.
  
I am not easily discouraged by
failure.   
I think of myself as a strong
person when dealing with life's
challenges and difficulties.
  
I can make unpopular or difficult
decisions that affect other people,
if it is necessary.
  
I am able to handle unpleasant or
painful feelings like sadness, fear,
and anger.
  
In dealing with life's problems,
sometimes you have to act on a
hunch without knowing why.
  
I have a strong sense of purpose
in life.   
Not true at Sometimes True nearly
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PERSONALITY
Next we ask you to complete some questions to help assess your personality.
Below is a collection of phrases that can describe some aspects of a person’s personality. 
For each item, select the option that best indicates how much you agree with the statements
as they apply to you.
   
Not true at
all Rarely true
Sometimes
true Often true
True nearly
all the time
I am able to adapt when changes
occur.   
I have at least one close and
secure relationship that helps me
when I am stressed.
  
When there are no clear solutions
to my problems, sometimes fate
or God can help.
  
I can deal with whatever comes
my way.   
Past successes give me
confidence in dealing with new
challenges and difficulties.
  
I try to see the humorous side of
things when I am faced with
problems.
  
Having to cope with stress can
make me stronger.   
   
Not true at
all Rarely true
Sometimes
true Often true
True nearly
all the time
I tend to bounce back after illness,
injury or other hardships.   
Good or bad, I believe that most
things happen for a reason.   
I give my best effort no matter
what the outcome may be.   
I believe I can achieve my goals,
even if there are obstacles.   
Even when things look hopeless, I
don't give up.   
During times of stress/crisis, I
know where to turn for help.   
Under pressure, I stay focused
and think clearly.   
   
Not true at
all Rarely true
Sometimes
true Often true
True nearly
all the time
I prefer to take the lead in solving
problems rather than letting
others make all the decisions.
  
I am not easily discouraged by
failure.   
I think of myself as a strong
person when dealing with life's
challenges and difficulties.
  
I can make unpopular or difficult
decisions that affect other people,
if it is necessary.
  
I am able to handle unpleasant or
painful feelings like sadness, fear,
and anger.
  
In dealing with life's problems,
sometimes you have to act on a
hunch without knowing why.
  
I have a strong sense of purpose
in life.   
   
Not true at
all Rarely true
Sometimes
true Often true
True nearly
all the time
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Below is a second set of statements about personality.  For each item, please select the
option that best indicates how much you agree with the following statements as they apply
to you.  Please select the option that would have applied to you before your ALS/MND
diagnosis.
 
 
I am someone who...
   
Strongly
Disagree Disagree
Neither Agree
nor Disagree Agree
Strongly
Agree
Is talkative   
Tends to find fault with
others   
Does a thorough job   
Is depressed, blue   
Is original, comes up
with new ideas   
Is reserved   
Is helpful and unselfish
with others   
Can be somewhat
careless   
   
Strongly
Disagree Disagree
Neither Agree
nor Disagree Agree
Strongly
Agree
Is relaxed, handles
stress well   
Is curious about many
different things   
Is full of energy   
Starts quarrels with
others   
Is a reliable worker   
Can be tense   
Is ingenious, a deep
thinker   
Generates a lot of
enthusiasm   
   
Strongly
Disagree Disagree
Neither Agree
nor Disagree Agree
Strongly
Agree
Has a forgiving nature   
Tends to be
disorganized   
Worries a lot   
Has an active
imagination   
Tends to be quiet   
Is generally trusting   
Tends to be lazy   
Is emotionally stable,
not easily upset   
   
Strongly
Disagree Disagree
Neither Agree
nor Disagree Agree
Strongly
Agree
Is inventive   
Has an assertive
personality   
Can be cold and aloof   
Perseveres until the
task is finished   
Can be moody   
Values artistic,
aesthetic experiences   
Is sometimes shy,
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Below is a second set of statements about personality.  For each item, please select the
option that best indicates how much you agree with the following statements as they apply
to you.
I am someone who...
   
Strongly
Disagree Disagree
Neither Agree
nor Disagree Agree
Strongly
Agree
Is talkative   
Tends to find fault with
others   
Does a thorough job   
Is depressed, blue   
Is original, comes up
with new ideas   
Is reserved   
Is helpful and unselfish
with others   
Can be somewhat
careless   
   
Strongly
Disagree Disagree
Neither Agree
nor Disagree Agree
Strongly
Agree
Is relaxed, handles
stress well   
Is curious about many
different things   
Is full of energy   
Starts quarrels with
others   
Is a reliable worker   
Can be tense   
Is ingenious, a deep
thinker   
Generates a lot of
enthusiasm   
   
Strongly
Disagree Disagree
Neither Agree
nor Disagree Agree
Strongly
Agree
Has a forgiving nature   
Tends to be
disorganized   
Worries a lot   
Has an active
imagination   
Tends to be quiet   
Is generally trusting   
Tends to be lazy   
Is emotionally stable,
not easily upset   
   
Strongly
Disagree Disagree
Neither Agree
nor Disagree Agree
Strongly
Agree
Is inventive   
Has an assertive
personality   
Can be cold and aloof   
Perseveres until the
task is finished   
Can be moody   
Values artistic,
aesthetic experiences   
Is sometimes shy,
inhibited   
Is considerate and kind
to almost everyone   
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Below is a third set of statements about personality.  For each item, indicate to what extent
you agree or disagree that the statement would have applied to you in a typical month before
your ALS/MND diagnosis.
   
Strongly
Disagree Disagree
Neither Agree
nor Disagree Agree
Strongly
Agree
I worried a lot of the
time   
I found it difficult to
make a decision   
I often felt jumpy   
I found it hard to relax   
I often could not enjoy
things because of my
worries
  
Little things bothered
me a lot   
I often felt like I have
butterflies in my
stomach
  
   
Strongly
Disagree Disagree
Neither Agree
nor Disagree Agree
Strongly
Agree
I thought of myself as a
worrier   
I couldn’t help worrying
about even trivial things   
I often felt nervous   
My own thoughts often
made me anxious   
I got an upset stomach
due to my worrying   
I thought of myself as a
nervous person   
I always anticipated the
worst would happen   
   
Strongly
Disagree Disagree
Neither Agree
nor Disagree Agree
Strongly
Agree
I often felt shaky inside   
I thought that my
worries interfere with
my life
  
My worries often
overwhelmed me   
I sometimes felt a great
knot in my stomach   
I missed out on things
because I worry too
much
  
I often felt upset   
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Below is a third set of statements about personality.  For each item, indicate to what extent
you agree or disagree that the statement applies to your experience over the past month.
   
Strongly
Disagree Disagree
Neither Agree
nor Disagree Agree
Strongly
Agree
I worried a lot of the
time   
I found it difficult to
make a decision   
I often felt jumpy   
I found it hard to relax   
I often could not enjoy
things because of my
worries
  
Little things bothered
me a lot   
I often felt like I have
butterflies in my
stomach
  
   
Strongly
Disagree Disagree
Neither Agree
nor Disagree Agree
Strongly
Agree
I thought of myself as a
worrier   
I couldn’t help worrying
about even trivial things   
I often felt nervous   
My own thoughts often
made me anxious   
I got an upset stomach
due to my worrying   
I thought of myself as a
nervous person   
I always anticipated the
worst would happen   
   
Strongly
Disagree Disagree
Neither Agree
nor Disagree Agree
Strongly
Agree
I often felt shaky inside   
I thought that my
worries interfere with
my life
  
My worries often
overwhelmed me   
I sometimes felt a great
knot in my stomach   
I missed out on things
because I worry too
much
  
I often felt upset   
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LIFE EVENTS
LIFE EVENTS
We would like to have some information about significant events during your life.
 
Please indicate which of the following events occurred by selected the age you were when it
occurred. If it occurred more than once, select each age that it occurred (up to 5 ages).
The $200,000 mentioned in two questions is in United States dollars. Please convert this
(approximately) into the currency you use to answer these questions.
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Age at First
Occurrence
Age at
Second
Occurrence
Age at
Third
Occurrence
Age at
Fourth
Occurrence
Age at Fifth
Occurrence
My spouse died      
I got a divorce      
I separated from my
spouse
     
I spent time in jail      
A close family member
died (not a spouse)
     
I had a major illness or
injury
     
I got married      
I was fired at work      
I had a marital
reconciliation
     
I retired      
A family member
experienced a change in
health (not myself)
     
I became pregnant      
I experienced sexual
problems
     
My family gained a new
member
     
I experienced an
upheaval in my business
affairs
     
I experienced a change
in my financial state
     
A close friend died      
I changed to a different
occupation
     
My spouse and I argued
significantly more (or
significantly less)
     
I obtained a loan or
mortgage over $200,000
     
A loan or mortgage of
mine was foreclosed
     
My responsibilities at
work significantly
changed
     
My son or daughter left
home
     
I had trouble with my
in-laws
     
I had an outstanding
personal achievement
     
My spouse began or
stopped working
     
I started or finished high
school or college
     
I had a significant
change in my living
conditions
     
I had significant trouble
with my boss
     
My working hours or
conditions changed
significantly
     
I changed residences      
I changed schools      
I changed recreational
activities
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FAMILY
FAMILY
We would like to ask you some questions about your family background and medical history.
 
In which countries were your father and mother born?
Country  
Father's country of birth:   
Mother's country of birth:   
Please enter your parents' years of birth, years they died, and causes of death, as
applicable.  If they are still living, leave the year died and cause of death blank.
Year I don't know  
 
Father's year of birth   
If your father has died, the year
he died. Cause of death:   
Mother's year of birth   
If your mother has died, the
year she died. Cause of death:   
Did your parents ever smoke cigarettes?
   Yes No I don't know
Mother   
Father   
What were your parents' main occupations during their lifetimes? If you do not know one or
both of these answers, please answer "Not known" in the applicable boxes.
Father's main occupation
Mother's main occupation
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We would like to get an indication of the size of your family. Please count the number of your
relatives within the following groups:
1. First degree relatives: parents (always 2), brothers and sisters, and children.
 
Select number of first degree relatives:
 
2. Second degree relatives: uncles and aunts, nephews and nieces, grandparents (always 4),
grandchildren, and half-brothers and half-sisters.
 
Select number of second degree relatives:
 
3. Third degree relatives: first cousins, great-grandparents (always 8), great-uncles (brothers
of your grandparents) and great-aunts (sisters of your grandparents), grand-nephews and
grand-nieces (children of your nephews and nieces) and great-grandchildren.
 
Select number of third degree relatives:
 
How many brothers and sisters (present and past) do you have? Please only include full
siblings (that is, siblings with same mother and father as yourself).
 
Where do you come in the order of births of your brothers and/or sisters?
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Yes
No
Yes
No
I don't know
Do you have, or have you ever had, any biological children?
How many biological children do you have/have you had in total?
 
Please enter the number of relatives of yours with ALS/MND, in the following groups:
1. First degree relatives: your parents, brothers and sisters, and children.
Number of your male first degree relatives with ALS/MND
   
Number of your female first degree relatives with ALS/MND    
2. Second degree relatives: your uncles and aunts, nephews and nieces,
grandparents, grandchildren, and half-brothers and half-sisters.
Number of your male second degree relatives with ALS/MND
   
Number of your female second degree relatives with ALS/MND    
3. Third degree relatives: your first cousins, great-grandparents, great-uncles
(brothers of your grandparents) and great-aunts (sisters of your grandparents),
grand-nephews and grand-nieces (children of your nephews and nieces) and great-
grandchildren.
Number of your male third degree relatives with ALS/MND
   
Number of your female third degree relatives with ALS/MND    
4. More distant relatives:
Number of your male more distant relatives with ALS/MND
   
Number of your female more distant relatives with ALS/MND    
Have any of your relatives (either present or past) been diagnosed with the specific form of
dementia, frontotemporal dementia?
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Yes
No
I don't know
Yes
No
I don't know
Please enter the number of relatives of yours with frontotemporal dementia, in the following
groups:
1. First degree relatives: your parents, brothers and sisters, and children.
Number of your first degree relatives with frontotemporal dementia
   
2. Second degree relatives: your uncles and aunts, nephews and nieces,
grandparents, grandchildren, and half-brothers and half-sisters.
Number of your second degree relatives with frontotemporal dementia
   
3. Third degree relatives: your first cousins, great-grandparents, great-uncles
(brothers of your grandparents) and great-aunts (sisters of your grandparents),
grand-nephews and grand-nieces (children of your nephews and nieces) and great-
grandchildren.
Number of your third degree relatives with frontotemporal dementia
   
4. More distant relatives:
Number of your more distant relatives with frontotemporal dementia
   
Have any of your relatives with ALS/MND or frontotemporal dementia had a positive gene
test for a known ALS/MND gene?
How many of your relatives with ALS/MND or frontotemporal dementia have had a positive
gene test for a known ALS/MND gene?
 
Have any of your relatives (either present or past) been diagnosed with ALS/MND?
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Yes
No
I don't know
Please enter the number of relatives of yours with ALS/MND, in the following groups:
1. First degree relatives: your parents, brothers and sisters, and children.
Number of your male first degree relatives with ALS/MND
   
Number of your female first degree relatives with ALS/MND    
2. Second degree relatives: your uncles and aunts, nephews and nieces,
grandparents, grandchildren, and half-brothers and half-sisters.
Number of your male second degree relatives with ALS/MND
   
Number of your female second degree relatives with ALS/MND    
3. Third degree relatives: your first cousins, great-grandparents, great-uncles
(brothers of your grandparents) and great-aunts (sisters of your grandparents),
grand-nephews and grand-nieces (children of your nephews and nieces) and great-
grandchildren.
Number of your male third degree relatives with ALS/MND
   
Number of your female third degree relatives with ALS/MND    
4. More distant relatives:
Number of your male more distant relatives with ALS/MND
   
Number of your female more distant relatives with ALS/MND    
Have any of your relatives (either present or past) been diagnosed with the specific form of
dementia, frontotemporal dementia?
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Yes
No
I don't know
Please enter the number of relatives of yours with frontotemporal dementia, in the following
groups:
1. First degree relatives: your parents, brothers and sisters, and children.
Number of your first degree relatives with frontotemporal dementia
   
2. Second degree relatives: your uncles and aunts, nephews and nieces,
grandparents, grandchildren, and half-brothers and half-sisters.
Number of your second degree relatives with frontotemporal dementia
   
3. Third degree relatives: your first cousins, great-grandparents, great-uncles
(brothers of your grandparents) and great-aunts (sisters of your grandparents),
grand-nephews and grand-nieces (children of your nephews and nieces) and great-
grandchildren.
Number of your third degree relatives with frontotemporal dementia
   
4. More distant relatives:
Number of your more distant relatives with frontotemporal dementia
   
Have any of your relatives with ALS/MND or frontotemporal dementia had a positive gene
test for a known ALS/MND gene?
How many of your relatives with ALS/MND or frontotemporal dementia have had a positive
gene test for a known ALS/MND gene?
 
Have any of your first degree relatives (parents, brothers and sisters, or children) suffered
from any of the following neurological conditions (apart from ALS/MND)?
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 Number of First DegreeRelatives  
Yes No
Dementia (any type)   
Parkinson's Disease   
Multiple Sclerosis   
Other brain or spinal cord disorder (please
specify):
  
Other brain or spinal cord disorder (please
specify):
  
Other brain or spinal cord disorder (please
specify):
  
Have any of your first degree family (parents, brothers and sisters, children) suffered any
other major diseases (not involving the brain or spinal cord)? Please list the name the
disease in the left column and select the applicable family member in the right column.
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Name of Disease Family Member  
 
Disease 1   
Disease 2   
Disease 3   
Disease 4   
Disease 5   
Disease 6   
Disease 7   
Disease 8   
Disease 9   
Disease 10   
ALS/MND CLINICAL INFORMATION
ALS/MND CLINICAL INFORMATION
Now we are going to ask you some questions about your ALS/MND.
In which month and what year did you get your first symptom of ALS/MND?
Month Year  
Date of first
symptom
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Right upper limb muscle weakness
Left upper limb muscle weakness
Right lower limb muscle weakness
Left lower limb muscle weakness
Muscle twitches (fasciculations)
Slurred speech
Difficultly swallowing
Shortness of breath
Spasticity (increased muscle tone)
Other (please specify):
What was the first symptom of ALS/MND that you noticed?
 
In which month and what year were you diagnosed as having ALS/MND?
Month Year  
Date of
diagnosis
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Amyotrophic lateral sclerosis (ALS, also called "classic" ALS)
Pattern: Mixed upper and lower motor neuron signs in limbs and bulbar region
Progressive muscular atrophy
Pattern: Pure lower motor neuron syndrome
Primary lateral sclerosis
Pattern: Pure upper motor neuron syndrome
Progressive bulbar palsy
Pattern: Isolated upper or lower motor neuron signs, or both, only in bulbar
muscles (which are involved, for example, in speech and swallowing)
ALS/MND and frontotemporal dementia
Pattern: A combination of any type of ALS/MND and frontotemporal dementia
Flail arm syndrome
Pattern: Symmetrical, proximal, largely lower motor neuron weakness of upper
limbs
Flail leg syndrome
Pattern: Symmetrical, distal, largely lower motor neuron weakness of lower
limbs
Other (please specify):
I do not know what type of ALS/MND I have been diagnosed with.
We would like to know what type of ALS/MND you have.
If you do not know the type of ALS/MND you have (listed below) please contact your
neurologist or family doctor/general practitioner to ask for this information.
You can mention the types of ALS/MND listed below (with their patterns) when you contact
your neurologist or family doctor and ask them to pick which one you have.
Note that a diagnosis of “ALS” or “MND” by itself may not give information about the type of
the disease you have, because confusingly these two terms are often used to denote all the
types of ALS/MND together.
What type of ALS/MND have you been diagnosed as having?
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Yes
No
I don't know
Yes
No
Better
Much Better
About the Same
Worse
Much Worse
I am unable to make a comparison
Have you had a positive gene test for a known ALS/MND gene?
Has your personality changed since you were diagnosed with ALS/MND?
Please describe your personality 10 years before your ALS/MND diagnosis, and now.
10 years before diagnosis
Now
Please compare your memory now, to what it was before you got your first symptom of
ALS/MND. We understand this might be difficult, but we are interested in your opinion.
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Better
Much Better
About the Same
Worse
Much Worse
They are unable to make a comparison
Normal speech processes
Detectable speech disturbance
Intelligible with repeating
Speech combined with non-vocal communication
Loss of useful speech
Normal
Slight but definite excess of saliva in mouth; may have night-time drooling
Moderately excessive saliva; may have minimal drooling
Marked excess of saliva with some drooling
Marked drooling; requires constant tissue or handkerchief
Now please ask somebody who knows you well (such as partner, relative or close friend) to
compare your memory now, to what it was before you got your first symptom of ALS/MND.
We would like to get a measure of your current functional status.
Please select one of the options from each of the following 12 ALS/MND Functional Rating
Scale items.
1. Speech
2. Salivation
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Normal eating habits
Early eating problems - occasional choking
Dietary consistency changes
Needs supplemental tube feeding
Nothing by mouth (exclusively tube or intravenous feeding)
Normal
Slow or sloppy; all words are legible
Not all words are legible
Able to grip pen but unable to write
Unable to grip pen
Normal
Somewhat slow and clumsy, but no help needed
Can cut most foods, although clumsy and slow; some help needed
Food must be cut by someone, but can still feed slowly
Needs to be fed
Normal
Independent and complete self-care with effort or decreased efficiency
Intermittent assistance or substitute methods
Needs attendant for self-care
Total dependence
3. Swallowing
4. Handwriting
5. Cutting food
6. Dressing and hygiene
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Normal
Somewhat slow and clumsy, but no help needed
Can turn alone or adjust sheets, but with great difficulty
Can initiate, but not turn or adjust sheets alone
Helpless
Normal
Early walking difficulties
Walks with assistance
Non-walking functional movement only
No purposeful leg movement
Normal
Slow
Mild unsteadiness or fatigue
Needs assistance
Cannot do
None
Occurs when walking
Occurs with one or more of the following: eating, bathing, dressing
Occurs at rest, difficulty breathing when either sitting or lying
Significant difficulty, considering using mechanical respiratory support
7. Turning in bed
8. Walking
9. Climbing stairs
10. Shortness of breath
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None
Some difficulty sleeping at night due to shortness of breath. Does not routinely
use more than two pillows
Needs extra pillow in order to sleep (more than two)
Can only sleep sitting up
Unable to sleep
None
Intermittent use of positive air pressure device
Continuous use of positive air pressure device
Continuous use of positive air pressure device during the night and day
Invasive mechanical ventilation by intubation or tracheostomy
11. Shortness of breath on lying flat
12. Respiratory insufficiency
What factor or factors do you think could have played a part in your getting ALS/MND?  You
may list up to three in the boxes below.
Factor 1
Factor 2
Factor 3
If answering this questionnaire has raised any issues of concern for you, we suggest that
you contact your local ALS/MND Support Group or Association.
SUBMISSION OF QUESTIONNAIRE
SUBMISSION OF QUESTIONNAIRE
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This is the last page of the questionnaire.
 
If you want to continue entering answers or change answers in the questionnaire, use the
Table of Contents icon (top left) or the Back button (<<) to navigate through it.
 
If you have finished the questionnaire, click the "Submit" button below to record your
response. You will not be able to access your questionnaire answers again once you have
done this, so please ensure your information is complete and accurate before submitting.
 
If you have any questions, comments or suggestions on this questionnaire, please email
als.quest@sydney.edu.au
 
Thank you very much for your help with this research.
Qualtrics Survey Software https://s.qualtrics.com/ControlPanel/Ajax.php?action=GetSurvey...
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LESSONS LEARNED FROM TRANSLATING A GLOBAL WEB-BASED 
QUESTIONNAIRE INTO DIFFERENT LANGUAGES 
1. introduction 
An online questionnaire for research into potential risk factors for amyotrophic lateral 
sclerosis (ALS)/motor neuron disease (MND)[1] using the Qualtrics Research Suite 
software has been developed.[2] One available feature of this software is the ability to 
translate the questionnaire into many languages via Google Translate. One of the aims 
in developing the questionnaire was to make it accessible to as many of the people in 
the world as possible, because there are many places where potential risk factors for 
ALS/MND have not been investigated. In addition, having a questionnaire that is 
available virtually world-wide will also allow for comparisons of risk factors among 
different countries.  
This article summarises the process that was used to undertake the task of translating 
the questionnaire into an additional 27 languages from its original English version, 
including the languages spoken in countries that are members of the International 
Alliance of ALS/MND Associations.  Typical results in the literature have focused on the 
translation of a questionnaire into a single other language (or group of languages from a 
particular region) (see, for example: [3-16]); this is the first summary that documents 
the translation of an online questionnaire for global distribution. 
2. Methods 
2.1. Choosing target languages for translations 
2.1.1. Languages spoken in Australia 
The questionnaire is based in Australia. Therefore, it was desirable to make the 
questionnaire accessible to as many Australians as possible. The languages (other than 
English) most commonly spoken in Australian homes, based on the 2011 Census [17], 
were identified and included on the list of desired translations. These languages are: 
Arabic, simplified Chinese (Mandarin and Cantonese are both on the list; however, 
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written Chinese is largely the same for these dialects), Greek, Hindi, Italian, Spanish, and 
Vietnamese. Tagalog is also on this list; however, because English is an official language 
in the Philippines and because Tagalog is not available on Qualtrics translation tool, it 
was decided not to include it. 
2.1.2. Languages spoken in countries that are members of the International Alliance of 
ALS/MND Associations 
A list of members of the International Alliance of ALS/MND Associations was compiled 
from the Association’s directory [18] and the official/commonly-spoken languages in 
these countries were identified. The languages identified from this task were: Afrikaans, 
Croatian, Danish, Dutch, Finnish, French, German, Icelandic, Japanese, Korean, Latvian, 
Mongolian, Persian, Polish, Portuguese, Brazilian Portuguese, Romanian, Serbian, 
Slovenian, Swedish, and Turkish. (Some Alliance languages overlapped with languages 
identified for Australia; these are not listed here.) 
2.1.3. Other 
In considering the list of languages identified in the first two steps and its geographical 
reach, some gaps were observed. To remedy this, several other languages were added, 
with the intent to reach as large a population as possible, including in particular those 
people proximal to Australia.  The languages identified in this category were: Czech, 
Hebrew, Hungarian, Indonesian, Malaysian, Norwegian, Russian, and Thai. 
2.2. Implementing the initial translations 
Using Qualtrics’ Translate Survey tool, a questionnaire can be translated into a selected 
group of languages via Google Translate [19]. The precise list of available languages for 
the translations is determined internally by Qualtrics (but can by bypassed by using the 
technique described below). 
The initial translations of the questionnaire were conducted once the English version of 
the questionnaire was final. This was to avoid making edits to the individual translated 
versions.   
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In the first translation attempt, the desired languages were added directly onto the 
existing English version, so that one version of the questionnaire contained all available 
translations. The initial translations were performed by going question by question and 
translating each question into the desired languages, one at a time. The translation 
process itself is simple, consisting of accessing the “Translate Survey” option in Qualtrics 
for the questionnaire, selecting the language of the translation, and clicking a button. 
Qualtrics then sends the question and answer text from their server to the Google 
Translate server, and the translated version is then sent back to replace the English text 
in the translated version. The translated text is automatically shown next to the original 
English version for a side-by-side comparison.  The text can then be edited if necessary 
to achieve a more accurate translation. While there is some manual aspect to this 
process, it is largely a commitment of time rather than effort.  
One limitation of the Qualtrics Translate Survey tool is that there is no capability to redo 
a translation, so if changes were made the original English version, the text cannot be 
re-translated to reflect these edits. Rather, the translation must be edited manually.  
2.3. Technical issues and resolution 
After the original English questionnaire had been translated into approximately 20 
languages, an internal server error developed. The result of this error was that the 
questionnaire in its entirety was no longer able to be viewed or edited on the Qualtrics 
website. After some investigation by Qualtrics, it was discovered that the database file 
that had been created by the questionnaire and its many translations had exceeded a 
size that could be handled by the Qualtrics Servers. Unfortunately, the current version 
of the questionnaire was not able to be restored; fortunately, however, it was still 
functioning online so that the data collection process was not impacted.  
Qualtrics was able to recover the vast majority of the original database file, including the 
translations that had been performed to date, with the exception of one question 
(which had to be re-translated). To avoid a recurrence of the database issue, it was 
decided to create 36 separate database files (i.e., 36 separate questionnaires), one for 
each language. This was viewed as a prudent risk reduction measure to minimise the 
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loss that would occur should any particular questionnaire and its translation encounter 
a technical issue. Once all the issues were resolved, the English version was relaunched 
as an English-only version and the malfunctioning questionnaire was deactivated.  
Because there was no longer the capability to offer all the translations in a single 
questionnaire, a new survey was created to overlay onto all the other questionnaires, 
which consisted of one question asking which language in which the respondent would 
like to complete the main questionnaire.  Based on this selection, the website then 
directs the respondent to the web address associated with the questionnaire for that 
specific translation. 
One advantage of this approach is that the data for a specific language can be 
downloaded for review in a specific batch, such that the data for the different languages 
is not comingled.  This might also simplify country-by-country comparisons to some 
extent.  One disadvantage of this approach is that numerical and scale data, which are 
identical in all the translated versions, would need to be compiled for all the 
translations, whereas in the initial approach, these data would have been contained in 
one database and available for download as one unit. 
2.4. Languages not available using Qualtrics Translate Survey tool 
Two languages identified as desired translations were not available in Qualtrics built-in 
Translate Survey tool: Afrikaans and Icelandic. Qualtrics does, however, allow for adding 
languages that are not on their default list, and the corresponding translation must be 
completed outside of Qualtrics.  As Afrikaans and Icelandic are included in the list of 
languages on Google Translate, these translations were performed as follows.  First, the 
English file of the original questionnaire was downloaded from Qualtrics. Then, the file 
was translated using the Google Translate feature that allows one to translate a 
document. Finally, the translated file was uploaded back into Qualtrics to become the 
new version of the translated questionnaire. 
Smaller translation tasks (e.g., translating the first and second pages of the 
questionnaire) were performed by copying the text from Qualtrics into Google Translate 
and copying back the translated version. 
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2.5. Validating of the Google translations 
For optimal intelligibility and accuracy, the Google-translated versions need to be 
checked by fluent speakers of each language. As one example, in a question about skin 
color, the word “fair” in most languages is translated as “reasonable” rather than the 
intended meaning of “light in colour”.  To disseminate a Google translated version of a 
questionnaire without checking it would be possible, but not advisable. 
As the first task, the simplified Chinese translation was checked and validated, which is 
one of the languages where Google Translate appeared to give the greatest number of 
ambiguities.  A colleague in the organisation conducted this check so that the 
researchers could work closely with her to see how the checking process functions and 
identify any potential technical and/or textual issues. 
Although it had been endeavored to avoid questions that could be related to particular 
cultures or backgrounds, one issue arose during the check of the Chinese language 
version for a question in the ALS Functional Rating Scale. The question asks about the 
ALS/MND patient’s ability to cut food, which is not generally applicable to Chinese who 
eat with chopsticks.  To address this, the text of the question was adapted to state: 
“Cutting food (Western style).”  Similar issues have not been identified to date in 
reviews of other languages. 
The Google-translated languages that have been checked for accuracy are listed in the 
list of available translations of the questionnaire on the ALS Quest website 
(alsquest.org). 
2.5.1. Finding volunteer translators 
There are a few potential options for undertaking the checking and validating of the 
questionnaire translations. The choice might depend on where one falls on the cost-
speed-quality continuum. For speed and quality, one option would be to use Qualtrics’ 
“Paid Translations” service, where the questionnaire will be translated and checked by 
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two native speakers of a language, or otherwise hire a professional translator to check 
the translation. However, this would likely be the option with the highest cost.   
As this study was located in a university setting with a large number of international 
students, it was decided to ask for volunteers from among the student population to 
check and validate the Google translated versions of our questionnaire.  Dr. Pamphlett 
gives occasional lectures to medical and dental students, so he was able to ask these 
students directly about being potential volunteers.  In addition, it was felt that students 
with these backgrounds might be more interested in assisting with an epidemiological 
study of a rare disease.  Email recruitment was also conducted of medical school classes 
and students at another medical campus associated with the University of Sydney. 
This approach of using volunteer translation checkers has the advantage of being 
essentially free.  In general, it has been found that the quality of the work by our 
volunteers is very good.  The most significant disadvantage of this approach is a lack of 
speed, as students tend to be quite busy and therefore can take weeks to months to 
complete the work.  This has not been too great of a concern relative to this project, 
however, as the timeframe for collecting responses is anticipated to be at least five to 
ten years, thus rendering any delays largely immaterial. 
2.5.2. Working with volunteer translators 
The primary technical challenge to having the volunteers check the translations was 
providing them with access to the online questionnaire translation.  One option would 
have been to provide them with access to the project’s Qualtrics account; however, this 
would present certain unacceptable security risks, as then they would have access to all 
of our questionnaires and data. 
The method for obviating these risks was to create separate user accounts for each 
translator.  We were able to do this by adding an “Administration” feature to the 
Qualtrics account, which gave the capability to create additional user accounts under 
one master account.  The administrator also has the ability to constrain the capabilities 
of the user accounts.  In this case, the translation users are primarily limited to using the 
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translate survey feature.  This minimises the risk that they might alter the questionnaire 
in some other way. 
After creating the account, the version of the questionnaire that has been translated 
into the language that the volunteer is checking is “shared” with their account using 
Qualtrics “Collaborate” feature. Each of the accounts therefore has access to only one 
copy of the questionnaire (in one particular language) and does not have access to any 
of the project data. 
To help the translators get started, a “user’s manual” was developed to provide a 
summary of how the process of checking the translation works and to disseminate “tips” 
learned from prior translators in the course of conducting their translation checks. 
In addition to checking the translation via Qualtrics website, other options for the 
translators include providing them with a csv file (that can be opened in Microsoft Excel) 
or an xml file of the translation, which they can then check and edit offline.  Qualtrics 
allows a user to download a questionnaire in csv or xml, and then upload an edited file 
to replace the existing version of the questionnaire.  Although most translators used the 
web-based checking option, the xml option was preferred by some and presented no 
particular technical challenges, as long as the checker did not alter any of the xml tags in 
the file. 
3. Results and Discussion 
3.1. Deploying the translations 
In contrast to the main body of the questionnaire, which has individual survey files for 
each translation, the first and second web pages of the questionnaire are two single and 
separate pages that can be displayed in any of the available translations. In fact, each of 
these pages is set up as a “survey” on Qualtrics – the first page consists solely of a single 
text box survey “question,” and the second page has only one question, which asks the 
respondents to select their preferred language for the main questionnaire. 
After respondents have selected their preferred language from the list of available 
translations, they then enter the main body of the questionnaire. Participants can select 
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from any of the available languages, regardless of the language in which the 
questionnaire is displayed. Once one language is selected, the main body of the 
questionnaire is available to display only in the selected language and in English.  
Of note is that the Qualtrics site automatically displays its pages in a particular language 
if one of the available translated languages is selected as default on a respondent’s 
Internet browser. For example, a respondent who has their browser language set to 
Français will automatically see a French translation of the first and second pages of the 
questionnaire.  Assuming that they then select Français as their desired language, the 
main body of the questionnaire will also display in French (without the respondent 
taking any specific action on their part). 
For answers requiring text entry, respondents are able enter answers in their own 
language. Since only a few questions are answered by entering text, translations back 
into English will not be onerous. 
3.2. Questionnaire dissemination 
Once the questionnaire translations have been checked, the international ALS/MND 
community was made aware of their availability.  To accomplish this, emailed letters 
were sent to the appropriate ALS/MND associations when the language of their country 
became available. ALS Quest also has a Facebook page [20] and a Twitter account [21], 
where updates are posted to announce when a language are added to the 
questionnaire.  The International Alliance of ALS/MND Associations has also assisted this 
project by disseminating emails to their distribution list regarding ALS Quest and 
notifying their members of its availability in many languages.  
3.3. Results to date 
The greatest numbers of respondents by language are English, Spanish, 
Portuguese/Brazilian Portuguese, Russian, French, Dutch, Danish, German, Chinese, 
Romanian, Afrikaans, Korean, Finnish, Italian, Arabic, Persian, Indonesian, Serbian, 
Polish, Vietnamese, Czech, Japanese, Hebrew, and Swedish. 
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Abstract
Background: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease with a typical survival of three
to five years. Epidemiological studies using paper-based questionnaires in individual countries or continents have failed to find
widely accepted risk factors for the disease. The advantages of online versus paper-based questionnaires have been extensively
reviewed, but few online epidemiological studies into human neurodegenerative diseases have so far been undertaken.
Objective: To design a Web-based questionnaire to identify environmental risk factors for ALS and enable international
comparisons of these risk factors.
Methods: A Web-based epidemiological questionnaire for ALS has been developed based on experience gained from administering
a previous continent-wide paper-based questionnaire for this disease. New and modified questions have been added from our
previous paper-based questionnaire, from literature searches, and from validated ALS questionnaires supplied by other investigators.
New criteria to allow the separation of familial and sporadic ALS cases have been included. The questionnaire addresses many
risk factors that have already been proposed for ALS, as well as a number that have not yet been rigorously examined. To encourage
participation, responses are collected anonymously and no personally identifiable information is requested. The survey is being
translated into a number of languages which will allow many people around the world to read and answer it in their own language.
Results: After the questionnaire had been online for 4 months, it had 379 respondents compared to only 46 respondents for the
same initial period using a paper-based questionnaire. The average age of the first 379 web questionnaire respondents was 54
years compared to the average age of 60 years for the first 379 paper questionnaire respondents. The questionnaire is soon to be
promoted in a number of countries through ALS associations and disease registries.
Conclusions: Web-based questionnaires are a time- and resource-efficient method for performing large epidemiological studies
of neurodegenerative diseases such as ALS. The ability to compare risk factors between different countries using the same analysis
tool will be of particular value for finding robust risk factors that underlie ALS.
(JMIR Res Protoc 2015;4(3):e96)   doi:10.2196/resprot.4840
KEYWORDS
amyotrophic lateral sclerosis (ALS); motor neuron disease (MND); web-based; online; questionnaire; epidemiology; risk factor;
case-control study; international; language translation
Introduction
Amyotrophic lateral sclerosis (ALS, also known as motor neuron
disease or MND) is a progressive neurodegenerative disease of
adults with a usual survival of three to five years after
diagnosis [1]. Epidemiological studies using traditional methods
of collecting data via mailed paper questionnaires or via
telephonic or in-person interviews have so far not revealed any
widely accepted environmental or lifestyle risk factors for ALS.
JMIR Res Protoc 2015 | vol. 4 | iss. 3 | e96 | p.1http://www.researchprotocols.org/2015/3/e96/
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Our first publication – August 2015
Full text freely available at: 
http://www.researchprotocols.org/2015/3/e96/
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Translations
4
Countries in green are those in which ALS Quest can be completed in at least one official language 
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Respondent Demographics
5
Countries in red are those in which residents have completed ALS Quest surveys
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Sources of information about ALS Quest as 
reported by respondents
6
CNDR: Canadian Neuromuscular Disease Registry 
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ALS Quest
› Advantages
- Larger numbers of respondents possible at lower cost than other methods 
(e.g., paper, telephone)
- Study can be accessed worldwide
- Provides the ability to translate questionnaire into many languages
- Questionnaire responses are captured automatically in a secure online 
database
› Limitations
- Cannot classify cases using El Escorial criteria nor independently confirm an 
ALS diagnosis; however, another study found 94 percent of respondents to an 
online questionnaire were accurate about their ALS diagnosis
- Unable to obtain biological samples from patients (e.g., DNA samples)
7
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Results from ALS Quest
8
First results paper – August 2017
Full text freely available at: 
http://bmjopen.bmj.com/content/7/8/e016924
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What’s next for ALS Quest
› Additional papers summarising the results of the study are forthcoming. 
› We are still collecting responses. The final aim is to have 5,000 
people with ALS/MND and 5,000 controls complete the questionnaire. 
To date we have almost 1,100 completed responses, 430 ALS patients 
and 660 controls.
› The questionnaire is available to all at www.alsquest.org
› Find us on Facebook at: www.facebook.com/ALSQuestSydneyUni
› Follow us on Twitter: @ALS_Quest
9
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• To	compare	ALS	risk	factors	between	different	countries,	
an	online	questionnaire	available	in	multiple	languages	is	
needed
• ALS	Quest	was	launched	online	in	2015	and	to	date	more	
than	1,000	responses	have	been	received	
• The	questionnaire	will	be	active	for	10	years,	with	the	aim	
of	collecting	5,000	ALS	and	5,000	control	responses
• Questions	include	details	of	occupations,	chemical	and	
pesticide	exposures,	physical	activity,	family	sizes,	medical	
histories,	personality	types,	and	life	stressors
• The	questionnaire	(which	has	been	translated	into	27	
languages)	takes	about	90	minutes	to	complete,	and	can	
be	conducted	in	multiple	sessions	on	computers,	tablets	
and	smart	phones
• Recruitment	is	via	several	methods,	including	ALS/MND	
Associations,	ALS	Registries,	the	Internet,	and	social	media
ALS QUEST: AN INTERNATIONAL ONLINE
QUESTIONNAIRE TO FIND RISK FACTORS FOR ALS
• ALS/MND	Associations	and	ALS	Registries	in	
many	countries	who	have	encouraged	people	to	
complete	the	questionnaire
• The	generous	donation	of	survey	questions	from	
a	number	of	ALS	researchers
• Our	volunteer	translators
Parkin Kullmann JA,	Hayes	S,	Wang	MX,	Pamphlett R.	Designing	
an	Internationally	Accessible	Web-Based	Questionnaire	to	
Discover	Risk	Factors	for	Amyotrophic	Lateral	Sclerosis:	A	Case-
Control	Study.	JMIR	Res	Protoc.	2015;4:e96.
Respondents	to	date
Respondents	reported	that	they	found	out	
about	ALS	Quest	from:
CNDR:	Canadian	Neuromuscular	Disease	Registry	
Countries	in	green are	those	in	which	ALS	Quest	can	be	
completed	in	at	least	one	official	language	
An	international	survey	to	look	for	robust	ALS	risk	factors
Countries	in	red are	those	in	which	residents	have	
completed	ALS	Quest	surveys
ALS	Quest	would	not	be	possible	without:
Jane	Parkin Kullmann and	Roger	Pamphlett
• Some	risk	factors	are	already	being	analysed with	
the	current	responses
• International	comparisons	will	be	feasible	once	
more	responses	are	received
• The	aim	is	to	make	the	data	open	source, once	
sufficient	numbers	of	responses	from	different	
countries	are	received,	so	that	researchers	from	
around	the	world	will	have	access	to	the	data
Progress
Methods
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PRELIMINARY	FINDINGS	FOR	INDEX:RING	FINGER	RATIOS
• Men	with	MND	have	smaller index:ring	finger	ratios
• Women	with	MND	have	larger index:ring	finger	ratios
This	suggests	a	link	between	finger	ratio	differences,	MND,	and	
prenatal	exposure	to	hormones.
INTRODUCTION
Epidemiological	studies	using	paper-based	
questionnaires	have	failed	to	find	widely	accepted	risk	
factors	for	motor	neuron	disease	(MND).
Web-based	questionnaires	have	many	advantages	over	
paper-based	ones,	but	few	online	epidemiological	
studies	into	neurodegenerative	diseases	have	been	
undertaken.
METHODS
• We	have	developed	a	web-based	questionnaire	to	
identify	environmental	and	lifestyle	risk	factors	for	MND
• Questions	were	included	from	the	Australian	MND	DNA	
Bank	questionnaire,	literature	searches,	and	validated	
MND	questionnaires	supplied	by	international	
investigators
• Risk	factors	that	have	not	yet	been	extensively	examined	
include	prenatal	exposure	to	testosterone	(indicated	by	
finger	ratios),	stress,	personality	type,	and	dental	history
• The	questionnaire	is	being	translated	into	a	number	of	
languages	to	ensure	international	access	and	to	find	
robust	risk	factors,	i.e.,	those	present	in	more	than	one	
country
• For	more	details	please	see	our	online	publication,	
Designing	an	internationally	accessible	Web-based	
questionnaire	to	discover	risk	factors	for	amyotrophic	
lateral	sclerosis:	a	case-control	study.	JMIR	Res	Protoc	
2015
PRELIMINARY	RESULTS
After	the	questionnaire	had	been	online	for	4	months	it	had	
379	respondents,	compared	to	only	46	respondents	for	the	
same	time	period	using	a	paper-based	questionnaire.
Preliminary	results	are	in	line	with	previously-identified	risk	
factors	for	MND,	such	as	prenatal	exposure	to	testosterone	(as	
indicated	by	index	to	ring	finger	ratios)	and	exposure	to	certain	
chemicals.
CONCLUSIONS
• Early	results	from	this	questionnaire	validate	a	number	of	
risk	factors	for	MND	and	suggest	some	new	ones
• The	questionnaire	has	the	potential	to	identify	more	MND	
risk	factors,	and	allow	comparisons	among	a	large	number	
of	countries	to	see	how	reproducible	the	factors	are
You	can	help	this	research!
Take	the	questionnaire	at:	
alsquest.org
On	Twitter:	@ALS_Quest
On	Facebook:	ALS	Quest	Sydney	Uni
ODDS	RATIOS	FOR	SELECTED	ENVIRONMENTAL	EXPOSURES
ALS QUEST: AN INTERNATIONALLY-ACCESSIBLE WEB-BASED RISK
FACTOR QUESTIONNAIRE FOR MOTOR NEURON DISEASE
Jane	Parkin	Kullmann	and	Roger	Pamphlett
Available	in	official	language	of	country:			Currently															By	early	2016
How	do	your	finger	
ratios	compare?
This	diagram	from	
the	questionnaire	
shows	how	to	
measure	fingers:
Bars	above	the	baseline	indicate	factors	that	people	with	
MND	are	more	likely	to	have	been	exposed	to,	and	those	
below	the	baseline	less	likely.	Note	that	people	with	MND	
have	smoked	at	the	same	rate	as	those	without	MND.
For	all	exposures,	greater	numbers	of	respondents	are	
needed	to	determine	biological significance.
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Does the ratio of the index to the ring finger length 
(2D:4D) differ in ALS?  
 
(poster presentation at the International MND 
Symposium, 2017) 
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RESULTS
The	ratio	of	the	length	of	the	index	finger	(2D)	to	the	ring	finger	(4D)	(2D:4D)	has	been	reported	to	be	lower	(i.e.,	
2D<4D)	in	people	with	ALS	in	comparison	to	controls.	So	might	increased	exposure	to	prenatal	testosterone,	
which	lowers	this	ratio,	also	be	a	risk	factor	for	ALS?
METHODS
• Responses	were	collected	via	a	web-based	questionnaire.	Respondents	
self-measured	and	self-reported	the	lengths	of	their	index	and	ring	fingers	
on	their	left	and	right	hands
• 202	ALS	respondents	(125	males,	77	females)	and	370	controls	(112	males,	
258	females)	remained	after	filtering	for	inability	to	straighten	fingers,	
statistical	outliers,	and	age	<40	years
• Unpaired	t-tests	with	95%	confidence	intervals	were	used	to	assess	
differences	in	mean	2D:4Ds
• These	findings	do	not	support	the	
hypothesis	that	exposure	to	
increased	prenatal	testosterone	is	a	
risk	factor	for	ALS
• A	lower	2D:4D	has	been	proposed	to	
explain	the	link	between	ALS	and	
exercise,	but	other	exercise-related	
factors	seem	more	likely	to	explain	
this	association
DOES THE RATIO OF THE INDEX TO THE RING
FINGER LENGTH (2D:4D) DIFFER IN ALS?
Mean	2D:4Ds	are	smaller	in	males
compared	to	females,	in	both	
control	and	ALS	groups	(orange	
bars).	This	gender	difference	is	
well	established
ROC	curves	of	2D:4Ds	in	both	males	and	females	are	
close	to	the	diagonal	line	of	no-discrimination,	
indicating	that	the	2D:4Ds	are	neither	sensitive	nor	
specific	to	ALS	status
The	diagram	in	the	questionnaire	to	help	
respondents	measure	their	finger	lengths
Line	of	no	difference
No differences	are	seen	in	mean	
2D:4Ds	between	control and	
ALS respondents,	for	either	
males	or	females	(black	bars)
CONCLUSIONS
HYPOTHESIS
To	test	this	hypothesis,	we	examined	2D:4Ds	from	large	numbers	of	ALS	respondents	and	controls.
Parkin Kullmann JA,	Pamphlett R.	Does	the	index-to-ring	finger	length	ratio	(2D:4D)	differ	in	amyotrophic	lateral	sclerosis	(ALS)?	
Results	from	an	international	online	case-control	study.	BMJ	Open.	2017;7:e016924.
Jane	Parkin Kullmann and	Roger	Pamphlett
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USING AN ONLINE TOOL FOR SELF-MEASUREMENT AND SELF-REPORTING OF 2D 
AND 4D FINGER LENGTHS PROVIDES ACCEPTABLE RESULTS: FINDINGS FROM A 
VALIDATION STUDY 
 
Jane Parkin Kullmann (JPK) 
Roger Pamphlett (RP) 
ABSTRACT 
Background: The ratio of lengths between the index and ring fingers (the 2D:4D ratio) is 
increasingly being measured in neurological disorders to give an indication of intrauterine 
testosterone exposure, which may relate to the later appearance of disease. However, 
obtaining sufficient numbers of participants for statistical analyses, which is typically done 
via in-person recruiting, has been difficult. We therefore developed a web-based question 
that allows respondents to self-measure their finger lengths, but the reliability of these 
measurements needed to be assessed. 
New Method: Volunteers were given a printed copy of the question from the online 
questionnaire which asked them to measure and record their index and ring finger lengths 
in millimeters. Digital photographs of their hands were taken and then used to measure 
their fingers again on a computer screen by two researchers. 2D:4D ratios were calculated 
using participants’ and researchers’ measurements and compared using paired t-tests. 
Inter-class correlation coefficients were also calculated for the researchers’ ratios. 
Results: A consistent difference of approximately 0.02 (all p-values <0.001) was observed 
between the ratios calculated using participants’ and researchers’ measurements, 
indicating a high but consistent bias for participants. Differences were not markedly 
dissimilar for the left and right hands. Inter-rater reliability between researchers was 
excellent. 
Comparison with Existing Method(s): Research on the accuracy of self-measurement and 
self-reporting of finger lengths has typically compared self-measurements with 
measurements from photocopies; however, the use of photocopies has limitations. Using 
photographs, we have demonstrated that self-report of finger measurements is a valid 
approach. 
Conclusions: Our study shows that self-report of finger lengths is an acceptably valid data-
gathering approach for calculating 2D:4D ratios. 
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INTRODUCTION 
Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND), is a 
progressive fatal neurodegenerative disease with a median survival time of approximately 
three to five years [1]. While the etiology of the disease is largely unknown, one element 
that has been suggested as a potential risk factor is prenatal exposure to testosterone [2]. 
Exposure to testosterone in utero is assessed by calculating the ratio of the lengths of the 
index (2D) and ring (4D) fingers on each hand (i.e., the 2D:4D ratio), where a lower 2D:4D 
ratio (i.e., a longer ring finger relative to the index) indicates higher prenatal exposure to 
testosterone [3,4].  
However, obtaining sufficient numbers of participants for statistical analyses, which is 
typically done via in-person recruiting, has been difficult. Therefore, in our international 
web-based questionnaire of potential risk factors for ALS [5], we have included a question 
wherein respondents are asked to self-measure and self-report their 2D and 4D finger 
lengths on each hand. The measurements of finger lengths can be used to calculate a 
2D:4D ratio for each hand of the respondent, and then the ratios for ALS patients and 
controls can be compared to evaluate the potential link between prenatal testosterone 
exposure and ALS.  
Research on the accuracy of self-measurement and self-reporting of finger lengths has 
typically compared self-measurements with measurements from photocopies; however, 
the use of photocopies has limitations [6,7]. Therefore, we performed a validation study 
of the process of reporting self-measurements of 2D and 4D finger lengths, using 
photographs rather than photocopies, which also served to test the validity of the diagram 
created to show participants how to perform these measurements (Figure 1). 
[Figure 1] 
METHODS 
Adult volunteers from Rotary International Clubs were recruited as participants for the 
validation study (N=131) throughout 2015. Participation was strictly voluntary, and 
participants completed the measuring task as part of a regular meeting of their Rotary 
Club. At each meeting, a presentation was given to the participants summarising the web-
based ALS questionnaire and the objectives of the epidemiological study. This was done to 
provide a level of understanding of the project that would be equivalent to that of the 
respondents that would be filling out the questionnaire. Afterwards, participants were 
provided with a hard plastic ruler and a paper handout that is an exact replica of the 
instructions and diagram from the finger length question of the web-based questionnaire 
(Figure 1). Prior to distribution, the handouts were labeled with a unique alphanumeric 
code for each participant, so that each handout could later be linked with its associated 
digital photograph. 
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Figure 1. Instructions for Finger Measurement Question 
 
 
Participants were asked to measure the 2D and 4D fingers on both hands. However, if 
they had an injury to one or both fingers on a hand, they did not record measurements for 
that hand. To best approximate the experience of the questionnaire, no questions were 
allowed and no further instructions (beyond the handout) were given while participants 
performed the task. The participants recorded their finger measurements directly on the 
handout. After completing the measurements, a digital photograph was taken of the 
underside of their hands overlaid on top of their handout (matching the layout of the 
hand image on the handout), so that the picture contained the code associated with their 
handout. 
The self-reported measurements were entered into a Microsoft Excel spreadsheet, and 
identified by the participant code. 2D:4D ratios for each hand were calculated by dividing 
the length of the 2D finger on a given hand by the length of the 4D finger on the same 
hand.  
Two researchers (JPK and RP) viewed the digital photographs on a computer screen and 
from there measured the lengths of the 2D and 4D fingers of the participants’ hands with 
the same type of ruler used by the participants. Two participants were excluded due to 
poor photo quality. The researchers viewed the photos and recorded their measurements 
independently. 2D:4D ratios were then calculated for each hand of each participant using 
each of the researchers’ measurements. Because the measurements were used to 
calculate a ratio and were not used as absolute values, it was not relevant what size the 
pictures were on-screen when measured by the researchers. Raw data for the validation 
study are provided in the Supplemental Material. 
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To compare the 2D:4D ratios calculated from the participants’ and researchers’ 
measurements, paired t-tests were conducted using the participants’ ratios and the 
researchers’ ratios for each hand (i.e., participant left/JPK left, participant left/RP left, 
participant right/JPK right, participant right/RP right). To evaluate the inter-rater reliability 
of JPK and RP, absolute two-way mixed single measure inter-class correlation coefficients 
(ICCs) were also calculated, pursuant to recommendations from the literature [8-10]. 
Statistics were calculated using IBM SPSS Statistics for Macintosh, Version 22.0. 
RESULTS 
Paired t-tests comparing the 2D:4D ratios calculated from the participants’ and 
researchers’ measurements show that a consistent mean paired difference of 
approximately 0.020-0.026 was observed between the ratios for the participants and the 
researchers, indicating a consistently high bias in the ratios calculated using the 
participants’ measurements. Results for the left and right hands were similar, so 
measurements of each of the hands were considered to be of similar accuracy. The finger 
ratios, mean differences between the ratios, 95th confidence intervals, t-values, post-hoc 
power values, and effect sizes are summarised in Table 1. P-values for these results are 
<0.001. 
Table 1. Summary of 2D:4D ratios and paired sample t-test results for the validation study. 
Comparison Evaluated 
Ratio Means Paired Differences   
Resp Mean 
(SD) 
JPK/RP 
Mean 
(SD) 
Mean 
Difference 
(SD) 
95% Confidence 
Interval of the 
Difference 
t-value Power 
Effect 
Size Lower Upper 
Pair 1 Resp Left Ratio - JPK Left Ratio 
0.988 
(0.0424) 
0.968 
(0.0368) 
0.0198 
(0.0465) 0.0117 0.0279 4.83 0.998 0.426 
Pair 2 Resp Left Ratio - RP Left Ratio 
0.988 
(0.0424) 
0.968 
(0.0464) 
0.0204 
(0.0573) 0.0104 0.0304 4.04 0.980 0.356 
Pair 3 Resp Right Ratio - JPK Right Ratio 
0.986 
(0.0436) 
0.966 
(0.0355) 
0.0199 
(0.0346) 0.0122 0.0275 5.14 >0.999 0.575 
Pair 4 Resp Right Ratio - RP Right Ratio 
0.986 
(0.0436) 
0.960 
(0.0417) 
0.0262 
(0.0446) 0.0184 0.0340 6.61 >0.999 0.587 
 
Inter-rater reliability between researchers JPK and RP was high: the ICC for the left hand 
2D:4D ratio was 0.784, and the ICC for the right hand 2D: 4D ratio was 0.796, indicating 
excellent agreement [11]. 
DISCUSSION 
The results of comparisons between participants’ and researchers’ 2D:4D ratios are similar 
to those reported by Caswell and Manning [7]. For our study, we found that the 
differences in the ratios between the participants and the researchers are quite 
consistent, which could indicate that participants are generally under-measuring their 4D 
(ring) finger, perhaps by measuring from the higher of the two creases that are typically 
present on this finger (see Figure 1 for an illustration of the creases), or over-measuring 
their index finger. It has also been suggested that this difference may be attributable to 
the rendering of a three-dimensional object into a two-dimensional image, which would 
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result in a consistent difference between self-made measurements and measurements 
from a photo or photocopy [7]. 
Overall, there is reasonably good agreement between the participants’ and researchers’ 
ratios, which demonstrates the reproducibility and accuracy of the measurements being 
used to support the analysis of the data collected as a part of the case-control study. 
Further, the ICCs of the two researchers’ ratios show excellent agreement (comparable to 
ICCs observed in a similar study [8]). 
Comparison to Prior Work 
The results of our validation study are very similar to those in the literature [7], although 
the prior study used photocopies rather than photographs. However, it is possible that the 
use of two-dimensional images, whether photocopies or photographs, has the same effect 
on viewers’ perceptions of the fingers, the resulting measurements of finger lengths, and 
the calculated 2D:4D ratios. 
CONCLUSIONS 
Our validation study shows that self-measurement and self-report of 2D and 4D finger 
lengths is an acceptably valid approach for obtaining this information in a web-based 
questionnaire for use in calculating 2D:4D finger ratios. 
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Genetic and 
environmental 
factors
OccupationOccupation
Occupation
Occupation
Alcohol
Smoking
Exercise
Smoking
Agreeableness
ALS
Neuroticism
ALS
Conscientiousness
ALS
Extraversion
ALS
Trauma
Dietary fish
RESULTS	
INTRODUCTION
• It	has	been	suggested	that	people	with	ALS	have	a	particularly	“nice”	personality
• Previous	personality	studies	in	ALS	have	had	small	numbers	of	subjects	and	conflicting	results
• We	used	an	online	questionnaire	to	collect	personality	data	from	large	numbers	of	people	with	ALS	and	controls
METHODS
• Responses	to	the	44	Big	Five	personality	statements	(agree	or	disagree,	on	a	scale	of	1	to	5)	were	collected	via	the	
web-based	questionnaire	“ALS	Quest”
• Respondents	were	339	people	with	ALS	(212	male,	127	female)	and	402	controls	(120	male,	282	female),	aged	40	
years	and	over
• People	with	ALS	were	asked	to	respond	to	the	statements	as	they	applied	to	them	before their	diagnosis	
• People	with	ALS	as	a	group	have	personality	traits	that	are	likely	
to	underlie	the	perception	they	are	particularly	“nice”	
• ALS-associated	personality	traits	could	influence	lifestyle	
choices,	a	number	of	which	are	suggested	risk	factors	for	ALS
• Personality	testing	should	be	included	in	future	risk	factor	
studies	of	ALS
ARE PEOPLE WITH ALS REALLY “NICE”?
Male	ALS	respondents	had	higher	mean	scores	
for	Conscientiousness	and	Extraversion	
Increased	Conscientiousness in	ALS	could	be	associated	with	
increased	exercise,	decreased	alcohol	intake,	and	increased	fish	
consumption.	Increased	Extraversion could	be	associated	with	
increased	smoking,	and	risk-taking	behavior	leading	to	trauma.	All	
factors	could	influence	choices	of	occupations.	
Jane	Parkin	Kullmann	and	Roger	Pamphlett
-0.6 -0.4 -0.2 0.0 0.2 0.4 0.6
Openness
Neuroticism
Extraversion
Conscientiousness
Agreeableness
ALS-Control: All (mean difference ± 95%CI)
-0.6 -0.4 -0.2 0.0 0.2 0.4 0.6
Openness
Neuroticism
Extraversion
Conscientiousness
Agreeableness
ALS-Control: Male (mean difference ± 95%CI)
-0.6 -0.4 -0.2 0.0 0.2 0.4 0.6
Openness
Neuroticism
Extraversion
Conscientiousness
Agreeableness
ALS-Control: Female (mean difference ± 95%CI)
A
B
C
Lower	score	in	ALS														Higher	score	in	ALS
-0.6 -0.4 -0.2 0.0 0.2 0.4 0.6
Openness
Neuroticism
Extraversion
Conscienti usn ss
Agreeableness
ALS-Control: All (mean difference ± 95%CI)
-0.6 -0.4 -0.2 0.0 0.2 0.4 0.6
Openness
Neuroticism
Extraversion
Conscientiousness
Agreeableness
ALS-Control: Male (mean difference ± 95%CI)
-0.6 -0.4 -0.2 0.0 0.2 0.4 0.6
Openness
Neuroticism
Extraversion
Conscientiousness
Agreeableness
ALS-Control: Female (mean difference ± 95%CI)
A
B
C
Lower	score	in	ALS														Higher	score	in	ALS
Female	ALS	respondents	had	higher	mean	scores	
for	Agreeableness,	Conscientiousness,	and	
Extraversion,	and	a	lower	score	for	Neuroticism	
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PERSONALITY	ASSOCIATIONS	WITH	ALS	RISK	FACTORS	
CONCLUSIONS	AND	RECOMMENDATIONS
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Is psychological stress a predisposing factor for ALS?  
An online international case-control study of premorbid 
stressful life events, resilience and anxiety  
 
(platform presentation at the International MND 
Symposium, 2018) 
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Is psychological stress a predisposing factor 
for ALS? 
An online international case-control study of premorbid stressful 
life events, resilience and anxiety 
NEUROPATHOLOGY | BRAIN AND MIND CENTRE
JANE PARKIN KULLMANN
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Background and Aims
• Stress is frequently mentioned as a possible disease trigger by ALS patients (29% 
in our survey)
• Stress has been implicated as a risk factor for other neurodegenerative diseases
• Stress could relate to ALS in the following ways:
- Increased free radical activity
- Reduced telomerase activity and telomere shortening due to early life stress
• In ALS, only one study (Okamoto et al. Ann Epidemiol 2009) has been published 
that looked at stress on a dichotomous basis (high/low)
• Aim of current study was to evaluate measures of stress along with modifying 
factors to look for a potential relationship between stress and ALS
2
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Methods – ALS Quest Risk Factor Questionnaire
3
www.alsquest.org
Page 210 of 221
Methods – Stress-Related Measurements
4
mSRRS: modified Social Readjustment Rating Scale
CDRS: Connor-Davidson Resilience Scale
mGAI: modified Geriatric Anxiety Inventory
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Results – Respondents 
5
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Results – Preliminary
• Factors evaluated:
- Life Events: all, age 0-20 years, age 21-40 years, prior 2 years, prior 5 years, prior 10 years
- Occupational Stress
- Resilience
- Anxiety
• Non-parametric statistics were used due to non-normality of data
• Male-Female comparisons:
- All were statistically significant, except for resilience
- Further evaluations were performed separated by gender
6
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Results – Life Events Stressor Score
7
Parkin Kullmann JA et al (2018) PLoS ONE 13(9): e0204424
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Results – Resilience
8
Parkin Kullmann JA et al (2018) PLoS ONE 13(9): e0204424
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Results – Anxiety
9
Parkin Kullmann JA et al (2018) PLoS ONE 13(9): e0204424
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Results – ALS vs. Controls
• Life Events Stressor Score:
- No significant differences between male ALS respondents and male controls
- Female ALS respondents had lower life events scores for the prior 5 years and 
prior 10 years in comparison to controls (p=0.01 and p=0.018)
• Occupational Stress:
- No significant differences
• Resilience:
- For both males and females, ALS respondents had higher resilience than their 
respective controls (p=0.028 and p<0.001)
• Anxiety:
- No significant differences
10
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Conclusions
• Stress does not appear to be a risk factor for ALS
• ALS respondents have higher resilience, which implies a more robust 
coping response to life stressors
• Resilience is thought to arise from a combination of factors that are 
genetic or biological, social or environmental, and personality-related 
• Resilience may have genetic variants in common with ALS
• Resilience is also linked to greater conscientiousness, higher 
extraversion, and lower neuroticism, personality types that are more 
common in ALS (Parkin Kullmann JA et al Brain Behav 2018; e01119)
11
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• Questionnaire respondents
• Questionnaire translators
The questionnaire is open to all at www.alsquest.org
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APPENDIX J 
 
Mercury exposure from seafood and dental fillings is 
similar in people with and without ALS  
 
(poster presentation at the International MND 
Symposium, 2018) 
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Exposures to toxic metals such as mercury have been suggested to be risk factors for ALS. Human intake of mercury commonly occurs 
via the consumption of seafood or from mercury-containing amalgam dental restorations (‘mercury fillings’). We therefore compared 
mercury exposures from these two sources in people with and without ALS. 
• Responses from people with ALS, as well as from non-ALS controls, were collected using an 
international multilingual online questionnaire looking for environmental and lifestyle risk 
factors for ALS (Designing an internationally accessible Web-based questionnaire to discover 
risk factors for amyotrophic lateral sclerosis: a case-control study. JMIR Res Protos 2015).
• Information collected from respondents included how often they ate seafood and what their 
favorite types of seafoods were.
• Mercury concentrations in favorite seafoods were averaged, multiplied by a standard seafood 
meal weight, and by the frequency of seafood consumption, to calculate monthly mercury 
exposure from eating seafood (Figure on right). 
• Respondents were also asked to record how many current or former mercury-containing 
'silver' amalgam dental fillings they had, and, if current, whether these were occlusal or non-
occlusal. 
• No evidence was found that mercury exposure from eating 
seafood or from having mercury-containing dental fillings was 
associated with the risk of developing ALS. 
• If mercury does play a role in the pathogenesis of ALS, either: 
o i. Other sources of exposure to mercury in the environment   
or workplace need to be considered, or
o ii. A particular susceptibility to mercury toxicity in ALS, such   
as genetic or epigenetic variations, multiple toxic metal 
interactions, or selenium deficiency, may be present. 
The proportion of respondents eating seafood at different frequencies. ALS and control 
respondents ate seafood at similar frequencies, ranging from never to daily. None of the slight 
differences in frequency proportions between ALS and controls was statistically significant. 
Distribution of mercury exposure from seafood. No difference is seen in the 
distribution of monthly mercury exposure from seafoods in micrograms 
between ALS and control respondents. Bar: median monthly exposure (µg).
Estimating mercury exposure from seafood consumption. 
The average mercury concentration in µg/g from up to three 
favorite seafoods was multiplied by a standard portion size of 
seafood (227 g), then multiplied by the monthly frequency of 
seafood consumption to estimate monthly mercury exposure 
from seafood in micrograms.
• Respondents aged 40 years and over were 401 with ALS (252 male, 
149 female) and 452 non-ALS controls (130 male, 322 female). 
• ALS respondents and controls did not differ in their frequency of 
seafood consumption (Figure below).
• ALS and control respondents had similar numbers of 
current combined occlusal and non-occlusal mercury 
fillings (Figure below). 
• ALS respondents and controls did not differ in the monthly 
mercury intake from their favorite seafoods (Figure below).
• Australians ate seafoods with higher mercury concentrations than 
USA respondents, but within individual countries no ALS-control 
differences were found in mercury seafood  intake.
• ALS respondents ate more shellfish as a favorite seafood. 
• ALS and control respondents had similar numbers of 
former mercury fillings (Figure below). 
• People with ALS were less likely than controls to 
have current occlusal mercury fillings. 
Distribution of numbers of current mercury fillings. The distribution of numbers of mercury fillings 
are similar between ALS and control groups for (A) current fillings. Bar: median number of fillings.
Distribution of numbers of former mercury fillings. The distribution of numbers of mercury fillings 
are similar between ALS and control groups for (B) former fillings. Bar: median number of fillings.
MERCURY EXPOSURE FROM SEAFOOD AND DENTAL
FILLINGS IS SIMILAR IN PEOPLE WITH AND WITHOUT ALS
Jane Parkin Kullmann and Roger Pamphlett
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